Browse by Title

Type here to filter the list

#
1: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance)

Kari Rosenkranz, MD – Dartmouth Health ### 1850711###Abstract Presenter###Associate Professor###Dartmouth Health###
Abstract Presenter: Kari Rosenkranz, MD – Dartmouth Health
### @@@ Kari Rosenkranz, MD – Dartmouth Health ### 1850711###First Author###Associate Professor###Dartmouth Health###
First Author: Kari Rosenkranz, MD – Dartmouth Health
### @@@ Judy C. Boughey, MD, FACS, FSSO (she/her/hers) – Mayo Clinic ### 937371###Author###Professor of Surgery, W.H. Odell Professor in Individualized Medicine, Chair-Division of Breast and Melanoma Surgical Oncology, Department of Surgery###Mayo Clinic###
Author: Judy C. Boughey, MD, FACS, FSSO (she/her/hers) – Mayo Clinic
### she/her/hers @@@ Bruce Haffty, MD. MS – Rutgers Cancer Institute of New Jersey ### 1850714###Author###Chair, Radiation Oncology###Rutgers Cancer Institute of New Jersey###
Author: Bruce Haffty, MD. MS – Rutgers Cancer Institute of New Jersey
### @@@ Karla Ballmam, PhD – Weill Cornell MMedical Center ### 1850712###Author###Chief of Biostatistics and Epidemiology###Weill Cornell MMedical Center###
Author: Karla Ballmam, PhD – Weill Cornell MMedical Center
### @@@ Linda McCall, MS – Alliance Statistics and Data Center ### 1850713###Author###Statistician###Alliance Statistics and Data Center###
Author: Linda McCall, MS – Alliance Statistics and Data Center
### @@@ Laurie Cuttino, MD – Sarah Cannon Cancer Institute ### 1850716###Author###Radiation Oncologist###Sarah Cannon Cancer Institute###
Author: Laurie Cuttino, MD – Sarah Cannon Cancer Institute
### @@@ Charlotte Kubicky, MD – Sutter Health ### 1850717###Author###Radiation Oncologist###Sutter Health###
Author: Charlotte Kubicky, MD – Sutter Health
### @@@ H. Clarissa LePetross, MD – MD Anderson Cancer Center ### 1850718###Author###Radiologist###MD Anderson Cancer Center###
Author: H. Clarissa LePetross, MD – MD Anderson Cancer Center
### @@@ Armando Giuliano, MD, FACS – Cedars-Sinai Medical Center ### 1850520###Author###Professor of Surgery###Cedars-Sinai Medical Center###
Author: Armando Giuliano, MD, FACS – Cedars-Sinai Medical Center
### @@@ Kimberly J. Van Zee, MS, MD – Memorial Sloan Kettering Cancer Center ### 1850700###Author###Breast Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Kimberly J. Van Zee, MS, MD – Memorial Sloan Kettering Cancer Center
### @@@ Kelly K. Hunt, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 937327###Author###Chair, Department of Breast Surgical Oncology###The University of Texas MD Anderson Cancer Center###
Author: Kelly K. Hunt, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers @@@ Olwen Hahn, MD – University of Chicago ### 1850719###Author###Associate Professor of Medicine###University of Chicago###
Author: Olwen Hahn, MD – University of Chicago
### @@@ Lisa Anne Carey, MD – University of North Carolina ### 1850720###Author###Professor of Breast Cancer Research###University of North Carolina###
Author: Lisa Anne Carey, MD – University of North Carolina
### @@@ Ann Partridge, MD, MPH – Dana Farber Cancer Institute ### 1849946###Author###Professor of Medicine, Chair in Breast Cancer Research###Dana Farber Cancer Institute###
Author: Ann Partridge, MD, MPH – Dana Farber Cancer Institute
###
10: Epigenetic Drug Therapy Increases Immune Activation and Expression of Genes in the Oncotype Dx Score in Breast Cancer

Rebecca M. Platoff, MD, MSc (she/her/hers) – Cooper University Hospital ### 1186187###Abstract Presenter###Resident in General Surgery###Cooper University Hospital###
Abstract Presenter: Rebecca M. Platoff, MD, MSc (she/her/hers) – Cooper University Hospital
### she/her/hers @@@ Rebecca M. Platoff, MD, MSc (she/her/hers) – Cooper University Hospital ### 1186187###Author###Resident in General Surgery###Cooper University Hospital###
Author: Rebecca M. Platoff, MD, MSc (she/her/hers) – Cooper University Hospital
### she/her/hers @@@ Ping Zhang, PhD – Cooper University Hospital Department of Surgery ### 1850752###Author###Research Scientist###Cooper University Hospital Department of Surgery###
Author: Ping Zhang, PhD – Cooper University Hospital Department of Surgery
### @@@ Jaroslav Jelinek, MD PhD – Coriell Institute for Medical Research ### 1850753###Author###Chief Research Officer###Coriell Institute for Medical Research###
Author: Jaroslav Jelinek, MD PhD – Coriell Institute for Medical Research
### @@@ Jozef Madzo, PhD – Coriell Institute for Medical Research ### 1850754###Author###Director of Bioinformatics###Coriell Institute for Medical Research###
Author: Jozef Madzo, PhD – Coriell Institute for Medical Research
### @@@ Gennaro Calendo, MS – Coriell Institute for Medical Research ### 1850755###Author###Research Scientist###Coriell Institute for Medical Research###
Author: Gennaro Calendo, MS – Coriell Institute for Medical Research
### @@@ Matthew Walt, MS – Coriell Institute for Medical Research ### 1850756###Author###Research Scientist###Coriell Institute for Medical Research###
Author: Matthew Walt, MS – Coriell Institute for Medical Research
### @@@ Umur Atabek, MD – Cooper University Hospital Department of Surgery ### 1850757###Author###Professor of Surgery###Cooper University Hospital Department of Surgery###
Author: Umur Atabek, MD – Cooper University Hospital Department of Surgery
### @@@ Francis R. Spitz, MD – Cooper University Hospital ### 1213569###Author###Vice Chairman of Surgery###Cooper University Hospital###
Author: Francis R. Spitz, MD – Cooper University Hospital
### @@@ Young K. Hong, MD,MPH,FACS,FSSO – Cooper University Hospital ### 1529718###Author###Assistant Professor of Surgery###Cooper University Hospital###
Author: Young K. Hong, MD,MPH,FACS,FSSO – Cooper University Hospital
###
100: Robotic Subtotal Gastrectomy with D2 Lymph Node Dissection using Indocyanine Green Sentinel Lymphatic Mapping

Pamela W. Lu, MD, MPH (she/her/hers) – MD Anderson Cancer Center ### 1850111###Video Presenter###Clinical fellow###MD Anderson Cancer Center###
Video Presenter: Pamela W. Lu, MD, MPH (she/her/hers) – MD Anderson Cancer Center
### she/her/hers @@@ Pamela W. Lu, MD, MPH (she/her/hers) – MD Anderson Cancer Center ### 1850111###First Author###Clinical fellow###MD Anderson Cancer Center###
First Author: Pamela W. Lu, MD, MPH (she/her/hers) – MD Anderson Cancer Center
### she/her/hers @@@ Yuki Hirata, MD – MD Anderson Cancer Center ### 1850893###Author###Postdoctoral fellow###MD Anderson Cancer Center###
Author: Yuki Hirata, MD – MD Anderson Cancer Center
### @@@ Paul Mansfield, MD – The University of Texas MD Anderson Cancer Center ### 1850483###Author###Professor###The University of Texas MD Anderson Cancer Center###
Author: Paul Mansfield, MD – The University of Texas MD Anderson Cancer Center
### @@@ Brian Badgwell, MD, MS – The University of Texas MD Anderson Cancer Center ### 915754###Author###Professor###The University of Texas MD Anderson Cancer Center###
Author: Brian Badgwell, MD, MS – The University of Texas MD Anderson Cancer Center
### @@@ Naruhiko Ikoma, MD, MS – The University of Texas MD Anderson Cancer Center ### 944396###Author###Assistant Professor###The University of Texas MD Anderson Cancer Center###
Author: Naruhiko Ikoma, MD, MS – The University of Texas MD Anderson Cancer Center
###
101: Robotic Transhiatal Esophagectomy

Moran Slavin, MD (she/her/hers) – Digestive Health Institute Tampa ### 1850803###Video Presenter###Advanced Foregut and HPB Fellow###Digestive Health Institute Tampa###
Video Presenter: Moran Slavin, MD (she/her/hers) – Digestive Health Institute Tampa
### she/her/hers @@@ Moran Slavin, MD (she/her/hers) – Digestive Health Institute Tampa ### 1850803###First Author###Advanced Foregut and HPB Fellow###Digestive Health Institute Tampa###
First Author: Moran Slavin, MD (she/her/hers) – Digestive Health Institute Tampa
### she/her/hers @@@ Sharona Ross, MD FSSO – Digestive Health Institute Tampa ### 1850629###Author###Director Foregut and Pancreatic Surgery###Digestive Health Institute Tampa###
Author: Sharona Ross, MD FSSO – Digestive Health Institute Tampa
### @@@ Iswanto Sucandy MD FACS, MD, FACS – AdventHealth Tampa ### 918124###Author###Associate Professor of Surgery, University of Central Florida, College of Medicine Advanced Gastrointestinal Surgery | Hepatobiliary and Pancreatic Surgery ###AdventHealth Tampa###
Author: Iswanto Sucandy MD FACS, MD, FACS – AdventHealth Tampa
### @@@ Alexander Rosemurgy, MD FACS FSSO – Digestive Health Institute Tampa ### 1850631###Author###Attending HPB Surgeon###Digestive Health Institute Tampa###
Author: Alexander Rosemurgy, MD FACS FSSO – Digestive Health Institute Tampa
###
102: Robotic-assisted minimally invasive radical total gastrectomy with intracorporeal side-to-side esophagojejunostomy

Ricardo E. Núñez-Rocha, Universidad de los Andes – School of Medicine, Universidad de los Andes ### 1850361###Video Presenter###Medical Student###School of Medicine, Universidad de los Andes###
Video Presenter: Ricardo E. Núñez-Rocha, Universidad de los Andes – School of Medicine, Universidad de los Andes
### @@@ Ricardo E. Núñez-Rocha, Universidad de los Andes – School of Medicine, Universidad de los Andes ### 1850361###First Author###Medical Student###School of Medicine, Universidad de los Andes###
First Author: Ricardo E. Núñez-Rocha, Universidad de los Andes – School of Medicine, Universidad de los Andes
### @@@ Gabriel Herrera-Almario, Surgical oncologist, Fundación Santa Fe de Bogotá – Fundación Santa Fe de Bogotá ### 1850558###Author###Surgical oncologist###Fundación Santa Fe de Bogotá###
Author: Gabriel Herrera-Almario, Surgical oncologist, Fundación Santa Fe de Bogotá – Fundación Santa Fe de Bogotá
###
103: Endoscopic-assisted Laparoscopic Transgastric Partial Gastrectomy for Gastroesophageal Junction Gastrointestinal Stromal Tumor

Elizabeth J. Olecki, MD – Pennsylvania State College of Medicine ### 970064###Video Presenter###Resident###Pennsylvania State College of Medicine###
Video Presenter: Elizabeth J. Olecki, MD – Pennsylvania State College of Medicine
### @@@ Elizabeth J. Olecki, MD – Pennsylvania State College of Medicine ### 970064###First Author###Resident###Pennsylvania State College of Medicine###
First Author: Elizabeth J. Olecki, MD – Pennsylvania State College of Medicine
### @@@ Charles Dye, MD – Penn State Health ### 1850931###Author###Professor###Penn State Health###
Author: Charles Dye, MD – Penn State Health
### @@@ June S. Peng, MD – Penn State College of Medicine ### 970219###Author###Assistant Professor###Penn State College of Medicine###
Author: June S. Peng, MD – Penn State College of Medicine
###
104: Neoadjuvant Imatinib Permits Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor

Britney Niemann, MD (she/her/hers) – West Virginia University ### 1850658###Video Presenter###Surgical Resident###West Virginia University###
Video Presenter: Britney Niemann, MD (she/her/hers) – West Virginia University
### she/her/hers @@@ Britney Niemann, MD (she/her/hers) – West Virginia University ### 1850658###First Author###Surgical Resident###West Virginia University###
First Author: Britney Niemann, MD (she/her/hers) – West Virginia University
### she/her/hers @@@ Amanda Puleo, DO – West Virginia University ### 1850659### Author###Resident###West Virginia University###
Author: Amanda Puleo, DO – West Virginia University
### @@@ Carl Schmidt, MD – West Virginia University ### 1850772###Author###Chief of Division of Surgical Oncology###West Virginia University###
Author: Carl Schmidt, MD – West Virginia University
### @@@ Brian A. Boone, MD – West Virginia University WVU Cancer Institute WV Clinical and Translational Science Institute ### 937410###Author###Assistant Professor###West Virginia University WVU Cancer Institute WV Clinical and Translational Science Institute###
Author: Brian A. Boone, MD – West Virginia University WVU Cancer Institute WV Clinical and Translational Science Institute
###
11: Genomic Landscape of Malignant Phyllodes Tumors Reveals Multiple Targetable Opportunities

Laura H. Rosenberger, MD, MS (she/her/hers) – Duke University Medical Center ### 970199###Abstract Presenter###Associate Professor of Surgery ###Duke University Medical Center###
Abstract Presenter: Laura H. Rosenberger, MD, MS (she/her/hers) – Duke University Medical Center
### she/her/hers @@@ Laura H. Rosenberger, MD, MS (she/her/hers) – Duke University Medical Center ### 970199###Author###Associate Professor of Surgery ###Duke University Medical Center###
Author: Laura H. Rosenberger, MD, MS (she/her/hers) – Duke University Medical Center
### she/her/hers @@@ Richard F. Riedel, MD – Duke Univesity Medical Center ### 1849859###Author###Associate Professor of Medicine###Duke Univesity Medical Center###
Author: Richard F. Riedel, MD – Duke Univesity Medical Center
### @@@ Emilia Diego, MD – University of Pittsburgh ### 1047219###Author###Chief, Section of Breast Surgery###University of Pittsburgh###
Author: Emilia Diego, MD – University of Pittsburgh
### @@@ Natalie A. Danziger, BS – Foundation Medicine Inc ### 1850669###Author###Senior Research Associate###Foundation Medicine Inc###
Author: Natalie A. Danziger, BS – Foundation Medicine Inc
### @@@ Ethan Sokol, PhD – Foundation Medicine Inc ### 1850670###Author###Principal Scientist###Foundation Medicine Inc###
Author: Ethan Sokol, PhD – Foundation Medicine Inc
### @@@ Jeffrey S. Ross, MD – Foundation Medicine Inc ### 1850671###Author###Medical Director, Foundation Medicine###Foundation Medicine Inc###
Author: Jeffrey S. Ross, MD – Foundation Medicine Inc
### @@@ Sarah L. Sammons, MD – Duke University ### 1850672###Author###Assistant Professor of Medicine###Duke University###
Author: Sarah L. Sammons, MD – Duke University
###
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)

Walter P. Weber, MD (he/him/his) – Department of chest, abdomen and pelvis University hospital Basel, Basel, Switzerland ### 1850364###Abstract Presenter###Chief Physician###Department of chest, abdomen and pelvis University hospital Basel, Basel, Switzerland###
Abstract Presenter: Walter P. Weber, MD (he/him/his) – Department of chest, abdomen and pelvis University hospital Basel, Basel, Switzerland
### he/him/his @@@ Zoltan Matrai, MD, PhD – Hamad Medical Corporation, General Surgery, Doha, Qatar ### 1850389### Author###MD###Hamad Medical Corporation, General Surgery, Doha, Qatar###
Author: Zoltan Matrai, MD, PhD – Hamad Medical Corporation, General Surgery, Doha, Qatar
### @@@ Stefanie Hayoz, PhD – SAKK Coordinating Center, Bern, Switzerland ### 1850390###Author###Head of Statistics###SAKK Coordinating Center, Bern, Switzerland###
Author: Stefanie Hayoz, PhD – SAKK Coordinating Center, Bern, Switzerland
### @@@ Christoph Tausch, MD – Breast Center Zurich, Zurich, Switzerland ### 1850404###Author###MD###Breast Center Zurich, Zurich, Switzerland###
Author: Christoph Tausch, MD – Breast Center Zurich, Zurich, Switzerland
### @@@ Guido Henke, MD – Department of Radiation Oncology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland; Breast Center, St. Gallen Cantonal Hospital, St. Gallen, Switzerland ### 1850391###Author###MD###Department of Radiation Oncology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland; Breast Center, St. Gallen Cantonal Hospital, St. Gallen, Switzerland###
Author: Guido Henke, MD – Department of Radiation Oncology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland; Breast Center, St. Gallen Cantonal Hospital, St. Gallen, Switzerland
### @@@ Daniel R. Zwahlen, MD – Department of Radiation Oncology, Cantonal Hospital Winterthur, Winterthur,Switzerland ### 1850392###Author###MD###Department of Radiation Oncology, Cantonal Hospital Winterthur, Winterthur,Switzerland###
Author: Daniel R. Zwahlen, MD – Department of Radiation Oncology, Cantonal Hospital Winterthur, Winterthur,Switzerland
### @@@ Günther Gruber, MD – Institute of Radiotherapy, Clinic Hirslanden, Zurich, Switzerland ### 1850417###Author###MD###Institute of Radiotherapy, Clinic Hirslanden, Zurich, Switzerland###
Author: Günther Gruber, MD – Institute of Radiotherapy, Clinic Hirslanden, Zurich, Switzerland
### @@@ Frank Zimmermann, MD – University of Basel, Basel, Switzerland; Clinic of Radiation Oncology, University Hospital Basel, Basel, Switzerland ### 1850393###Author###MD###University of Basel, Basel, Switzerland; Clinic of Radiation Oncology, University Hospital Basel, Basel, Switzerland###
Author: Frank Zimmermann, MD – University of Basel, Basel, Switzerland; Clinic of Radiation Oncology, University Hospital Basel, Basel, Switzerland
### @@@ Markus Ackerknecht, PhD – University of Basel, Basel, Switzerland; Department of Biomedicine, University Hospital Basel, Basel, Switzerland ### 1850394###Author###Assistant / Postdoc###University of Basel, Basel, Switzerland; Department of Biomedicine, University Hospital Basel, Basel, Switzerland###
Author: Markus Ackerknecht, PhD – University of Basel, Basel, Switzerland; Department of Biomedicine, University Hospital Basel, Basel, Switzerland
### @@@ Vesna Bjelic-Radisic, MD – Breast Unit, Helios University Clinic, University Witten/Herdecke, Germany ### 1850418###Author###MD###Breast Unit, Helios University Clinic, University Witten/Herdecke, Germany###
Author: Vesna Bjelic-Radisic, MD – Breast Unit, Helios University Clinic, University Witten/Herdecke, Germany
### @@@ Christian Kurzeder, MD – Breast Center, University Hospital Basel, Basel, Switzerland,University of Basel, Basel, Switzerland ### 1850419###Author###MD###Breast Center, University Hospital Basel, Basel, Switzerland,University of Basel, Basel, Switzerland###
Author: Christian Kurzeder, MD – Breast Center, University Hospital Basel, Basel, Switzerland,University of Basel, Basel, Switzerland
### @@@ Viktor Smanykó, MD – Centre of Radiotherapy, National Institute of Oncology, Budapest, Hungary ### 1850420###Author###MD###Centre of Radiotherapy, National Institute of Oncology, Budapest, Hungary###
Author: Viktor Smanykó, MD – Centre of Radiotherapy, National Institute of Oncology, Budapest, Hungary
### @@@ Inna Meyer, MD – Lindenhof Hospital, Praxis Frauenzentrum, Bern, Switzerland ### 1850395###Author###MD###Lindenhof Hospital, Praxis Frauenzentrum, Bern, Switzerland###
Author: Inna Meyer, MD – Lindenhof Hospital, Praxis Frauenzentrum, Bern, Switzerland
### @@@ Dieter J. Müller, MD – Bethesda Spital AG, Basel, Switzerland ### 1850397###Author###MD###Bethesda Spital AG, Basel, Switzerland###
Author: Dieter J. Müller, MD – Bethesda Spital AG, Basel, Switzerland
### @@@ Michael Gnant, MD – Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria ### 1850398###Author###MD###Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria###
Author: Michael Gnant, MD – Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
### @@@ Florian Fitzal, MD – Department of Surgery and Breast Health Center, Medical University of Vienna, Vienna, Austria; ABCSG, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria ### 1850399###Author###MD###Department of Surgery and Breast Health Center, Medical University of Vienna, Vienna, Austria; ABCSG, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria###
Author: Florian Fitzal, MD – Department of Surgery and Breast Health Center, Medical University of Vienna, Vienna, Austria; ABCSG, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria
### @@@ Pagona Markellou, MD – Breast Center, St. Gallen Cantonal Hospital, St. Gallen, Switzerland ### 1850400###Author###MD###Breast Center, St. Gallen Cantonal Hospital, St. Gallen, Switzerland###
Author: Pagona Markellou, MD – Breast Center, St. Gallen Cantonal Hospital, St. Gallen, Switzerland
### @@@ Daniel Egle, MD – Breast Cancer Center Tirol, Department of Gynecology, Medical University Innsbruck, Innsbruck, Austria ### 1850401###Author###MD###Breast Cancer Center Tirol, Department of Gynecology, Medical University Innsbruck, Innsbruck, Austria###
Author: Daniel Egle, MD – Breast Cancer Center Tirol, Department of Gynecology, Medical University Innsbruck, Innsbruck, Austria
### @@@ Jörg Heil, MD – Breast Center Heidelberg, Heidelberg, Germany ### 1850402###Author###MD###Breast Center Heidelberg, Heidelberg, Germany###
Author: Jörg Heil, MD – Breast Center Heidelberg, Heidelberg, Germany
### @@@ Michael Knauer, MD – Tumor and Breast Center Eastern Switzerland, St. Gallen, Switzerland ### 1850403###Author###MD###Tumor and Breast Center Eastern Switzerland, St. Gallen, Switzerland###
Author: Michael Knauer, MD – Tumor and Breast Center Eastern Switzerland, St. Gallen, Switzerland
### @@@ Walter P. Weber, MD (he/him/his) – Department of chest, abdomen and pelvis University hospital Basel, Basel, Switzerland ### 1850364###First Author###Chief Physician###Department of chest, abdomen and pelvis University hospital Basel, Basel, Switzerland###
First Author: Walter P. Weber, MD (he/him/his) – Department of chest, abdomen and pelvis University hospital Basel, Basel, Switzerland
### he/him/his
13: Luminal A vs B After Choosing Wisely: Do Phenotypes Affect Oncologic Outcomes?

Cynthia Ong (she/her/hers) – Virginia Commonwealth University School of Medicine ### 1850540###Abstract Presenter###Medical Student###Virginia Commonwealth University School of Medicine###
Abstract Presenter: Cynthia Ong (she/her/hers) – Virginia Commonwealth University School of Medicine
### she/her/hers @@@ Cynthia Ong (she/her/hers) – Virginia Commonwealth University School of Medicine ### 1850540###First Author###Medical Student###Virginia Commonwealth University School of Medicine###
First Author: Cynthia Ong (she/her/hers) – Virginia Commonwealth University School of Medicine
### she/her/hers @@@ Christian Blue, MS – Virginia Commonwealth University School of Medicine ### 1850537###Author###Medical Student###Virginia Commonwealth University School of Medicine###
Author: Christian Blue, MS – Virginia Commonwealth University School of Medicine
### @@@ Jamal Khan, MS – Virginia Commonwealth University School of Medicine ### 1850539###Author###Medical Student###Virginia Commonwealth University School of Medicine###
Author: Jamal Khan, MS – Virginia Commonwealth University School of Medicine
### @@@ Xiaoyan Deng, MS – Virginia Commonwealth University Department of Biostatistics ### 1850709###Author###Senior Biostatistician###Virginia Commonwealth University Department of Biostatistics###
Author: Xiaoyan Deng, MS – Virginia Commonwealth University Department of Biostatistics
### @@@ Raphael Louie, MD MPH – Virginia Commonwealth University, Department of Surgery ### 1850538###Author###Assistant Professor of Surgery###Virginia Commonwealth University, Department of Surgery###
Author: Raphael Louie, MD MPH – Virginia Commonwealth University, Department of Surgery
### @@@ Kandace P. McGuire, MD, FACS – Virginia Commonwealth University ### 1074926###Author###Professor of Surgery###Virginia Commonwealth University###
Author: Kandace P. McGuire, MD, FACS – Virginia Commonwealth University
###
14: Should patients with HR+HER2- breast cancer and 1-3 positive sentinel nodes undergo axillary dissection to determine candidacy for abemaciclib?

Austin D. Williams, MD, MSEd (he/him/his) – Fox Chase Cancer Center ### 1850577###Abstract Presenter###Assistant Professor###Fox Chase Cancer Center###
Abstract Presenter: Austin D. Williams, MD, MSEd (he/him/his) – Fox Chase Cancer Center
### he/him/his @@@ Austin D. Williams, MD, MSEd (he/him/his) – Fox Chase Cancer Center ### 1850577###First Author###Assistant Professor###Fox Chase Cancer Center###
First Author: Austin D. Williams, MD, MSEd (he/him/his) – Fox Chase Cancer Center
### he/him/his @@@ Karen Ruth, MA – Fox Chase Cancer Center ### 1849877###Author###Data Analyst###Fox Chase Cancer Center###
Author: Karen Ruth, MA – Fox Chase Cancer Center
### @@@ Mahtab Vasigh, MBBS – Fox Chase Cancer Center ### 1850578###Author###Research Fellow###Fox Chase Cancer Center###
Author: Mahtab Vasigh, MBBS – Fox Chase Cancer Center
### @@@ Mary Pronovost, MD – Fox Chase Cancer Center ### 1850579###Author###Associate Professor of Clinical Surgery###Fox Chase Cancer Center###
Author: Mary Pronovost, MD – Fox Chase Cancer Center
### @@@ Allison Aggon, DO – Fox Chase Cancer Center ### 1850580###Author###Associate Professor###Fox Chase Cancer Center###
Author: Allison Aggon, DO – Fox Chase Cancer Center
### @@@ Andrea Porpiglia, MD, MSc – Fox Chase Cancer Center ### 1850581###Author###Assistant Professor###Fox Chase Cancer Center###
Author: Andrea Porpiglia, MD, MSc – Fox Chase Cancer Center
### @@@ Richard J. Bleicher, MD – Fox Chase Cancer Center ### 894396###Author###Professor of Surgical Oncology; Leader, Breast Cancer Program; Director, Breast Fellowship Program###Fox Chase Cancer Center###
Author: Richard J. Bleicher, MD – Fox Chase Cancer Center
###
15: A Prospective Study of Sentinel Node Biopsy Omission in Women Age ≥ 65 with Early Invasive ER+ Breast Cancer Undergoing Breast Conserving Surgery

Alice Chung, MD – Cedars Sinai Medical Center ### 955440###Abstract Presenter###Associate Professor of Surgery###Cedars Sinai Medical Center###
Abstract Presenter: Alice Chung, MD – Cedars Sinai Medical Center
### @@@ Catherine Dang, MD, FACS – Cedars-Sinai Medical Center ### 1850516###First Author###Assistant Professor of Surgery###Cedars-Sinai Medical Center###
First Author: Catherine Dang, MD, FACS – Cedars-Sinai Medical Center
### @@@ Scott Karlan, MD, FACS – Cedars-Sinai Medical Center ### 1850517###Author###Assistant Professor of Surgery###Cedars-Sinai Medical Center###
Author: Scott Karlan, MD, FACS – Cedars-Sinai Medical Center
### @@@ Farin Amersi, MD – Cedars Sinai Medical Center ### 1048230###Author###Associate Professor of Surgery ###Cedars Sinai Medical Center###
Author: Farin Amersi, MD – Cedars Sinai Medical Center
### @@@ Edward Phillips, MD, FACS – Cedars-Sinai Medical Center ### 1850518###Author###Professor of Surgery###Cedars-Sinai Medical Center###
Author: Edward Phillips, MD, FACS – Cedars-Sinai Medical Center
### @@@ Yujie Cui, MS – Cedars-Sinai Medical Center ### 1850519###Author###Statistician###Cedars-Sinai Medical Center###
Author: Yujie Cui, MS – Cedars-Sinai Medical Center
### @@@ Armando Giuliano, MD, FACS – Cedars-Sinai Medical Center ### 1850520###Author###Professor of Surgery###Cedars-Sinai Medical Center###
Author: Armando Giuliano, MD, FACS – Cedars-Sinai Medical Center
###
16: Association of Medicaid Expansion with reduction in racial disparities in the timely delivery of up-front surgical care for patients with early stage breast cancer

Nina Tamirisa, MD – MD Anderson Cancer Center ### 1850458###Abstract Presenter###Assistant Professor###MD Anderson Cancer Center###
Abstract Presenter: Nina Tamirisa, MD – MD Anderson Cancer Center
### @@@ Nina Tamirisa, MD – MD Anderson Cancer Center ### 1850458###First Author###Assistant Professor###MD Anderson Cancer Center###
First Author: Nina Tamirisa, MD – MD Anderson Cancer Center
### @@@ Xiudong Lei, PhD – American Society of Clinical Oncology Center for Research and Analytics ### 1850459###Author###Director of Biostatistics###American Society of Clinical Oncology Center for Research and Analytics###
Author: Xiudong Lei, PhD – American Society of Clinical Oncology Center for Research and Analytics
### @@@ Catalina Malinowski, BA – MD Anderson Cancer Center ### 1850460###Author###Research Data Coordinator###MD Anderson Cancer Center###
Author: Catalina Malinowski, BA – MD Anderson Cancer Center
### @@@ Meng Li, PhD – MD Anderson Cancer Center ### 1850461###Author###Assistant Professor###MD Anderson Cancer Center###
Author: Meng Li, PhD – MD Anderson Cancer Center
### @@@ Isabelle Bedrosian, MD – The University of Texas MD Anderson Cancer Center ### 1214698###Author###Professor, Department of Breast Surgical Oncology###The University of Texas MD Anderson Cancer Center###
Author: Isabelle Bedrosian, MD – The University of Texas MD Anderson Cancer Center
### @@@ Mariana Chavez-MacGregor, MD – MD Anderson Cancer Center ### 1850462###Author###Associate Professor###MD Anderson Cancer Center###
Author: Mariana Chavez-MacGregor, MD – MD Anderson Cancer Center
###
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)

Walter P. Weber, MD (he/him/his) – Department of chest, abdomen and pelvis University hospital Basel, Basel, Switzerland ### 1850364###Abstract Presenter###Chief Physician###Department of chest, abdomen and pelvis University hospital Basel, Basel, Switzerland###
Abstract Presenter: Walter P. Weber, MD (he/him/his) – Department of chest, abdomen and pelvis University hospital Basel, Basel, Switzerland
### he/him/his @@@ Zoltan Matrai, MD, PhD – Hamad Medical Corporation, General Surgery, Doha, Qatar ### 1850389### Author###MD###Hamad Medical Corporation, General Surgery, Doha, Qatar###
Author: Zoltan Matrai, MD, PhD – Hamad Medical Corporation, General Surgery, Doha, Qatar
### @@@ Stefanie Hayoz, PhD – SAKK Coordinating Center, Bern, Switzerland ### 1850390###Author###Head of Statistics###SAKK Coordinating Center, Bern, Switzerland###
Author: Stefanie Hayoz, PhD – SAKK Coordinating Center, Bern, Switzerland
### @@@ Guido Henke, MD – Department of Radiation Oncology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland; Breast Center, St. Gallen Cantonal Hospital, St. Gallen, Switzerland ### 1850391###Author###MD###Department of Radiation Oncology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland; Breast Center, St. Gallen Cantonal Hospital, St. Gallen, Switzerland###
Author: Guido Henke, MD – Department of Radiation Oncology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland; Breast Center, St. Gallen Cantonal Hospital, St. Gallen, Switzerland
### @@@ Daniel R. Zwahlen, MD – Department of Radiation Oncology, Cantonal Hospital Winterthur, Winterthur,Switzerland ### 1850392###Author###MD###Department of Radiation Oncology, Cantonal Hospital Winterthur, Winterthur,Switzerland###
Author: Daniel R. Zwahlen, MD – Department of Radiation Oncology, Cantonal Hospital Winterthur, Winterthur,Switzerland
### @@@ Günther Gruber, MD – Institute of Radiotherapy, Clinic Hirslanden, Zurich, Switzerland ### 1850417###Author###MD###Institute of Radiotherapy, Clinic Hirslanden, Zurich, Switzerland###
Author: Günther Gruber, MD – Institute of Radiotherapy, Clinic Hirslanden, Zurich, Switzerland
### @@@ Frank Zimmermann, MD – University of Basel, Basel, Switzerland; Clinic of Radiation Oncology, University Hospital Basel, Basel, Switzerland ### 1850393###Author###MD###University of Basel, Basel, Switzerland; Clinic of Radiation Oncology, University Hospital Basel, Basel, Switzerland###
Author: Frank Zimmermann, MD – University of Basel, Basel, Switzerland; Clinic of Radiation Oncology, University Hospital Basel, Basel, Switzerland
### @@@ Markus Ackerknecht, PhD – University of Basel, Basel, Switzerland; Department of Biomedicine, University Hospital Basel, Basel, Switzerland ### 1850394###Author###Assistant / Postdoc###University of Basel, Basel, Switzerland; Department of Biomedicine, University Hospital Basel, Basel, Switzerland###
Author: Markus Ackerknecht, PhD – University of Basel, Basel, Switzerland; Department of Biomedicine, University Hospital Basel, Basel, Switzerland
### @@@ Sherko Kümmel, MD – Breast Unit, Clinic Essen-Mitte, Essen, Germany; Department of Gynecology and Breast Center, Charité University Hospital, Berlin, Germany ### 1850421###Author###MD###Breast Unit, Clinic Essen-Mitte, Essen, Germany; Department of Gynecology and Breast Center, Charité University Hospital, Berlin, Germany###
Author: Sherko Kümmel, MD – Breast Unit, Clinic Essen-Mitte, Essen, Germany; Department of Gynecology and Breast Center, Charité University Hospital, Berlin, Germany
### @@@ Inna Meyer, MD – Lindenhof Hospital, Praxis Frauenzentrum, Bern, Switzerland ### 1850395###Author###MD###Lindenhof Hospital, Praxis Frauenzentrum, Bern, Switzerland###
Author: Inna Meyer, MD – Lindenhof Hospital, Praxis Frauenzentrum, Bern, Switzerland
### @@@ Susanne Bucher, MD – Breast Center, Cantonal Hospital Lucerne, Lucerne, Switzerland ### 1850422###Author###MD###Breast Center, Cantonal Hospital Lucerne, Lucerne, Switzerland###
Author: Susanne Bucher, MD – Breast Center, Cantonal Hospital Lucerne, Lucerne, Switzerland
### @@@ Cornelia Leo, MD – Breast Center, Cantonal Hospital Baden, Baden, Switzerland ### 1850396###Author###MD###Breast Center, Cantonal Hospital Baden, Baden, Switzerland###
Author: Cornelia Leo, MD – Breast Center, Cantonal Hospital Baden, Baden, Switzerland
### @@@ Giang Thanh Lam, MD – Breast Center, University Hospital of Geneva, Geneva, Switzerland ### 1850423###Author###MD###Breast Center, University Hospital of Geneva, Geneva, Switzerland###
Author: Giang Thanh Lam, MD – Breast Center, University Hospital of Geneva, Geneva, Switzerland
### @@@ Dieter J. Müller, MD – Bethesda Spital AG, Basel, Switzerland ### 1850397###Author###MD###Bethesda Spital AG, Basel, Switzerland###
Author: Dieter J. Müller, MD – Bethesda Spital AG, Basel, Switzerland
### @@@ Michael Gnant, MD – Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria ### 1850398###Author###MD###Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria###
Author: Michael Gnant, MD – Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
### @@@ Florian Fitzal, MD – Department of Surgery and Breast Health Center, Medical University of Vienna, Vienna, Austria; ABCSG, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria ### 1850399###Author###MD###Department of Surgery and Breast Health Center, Medical University of Vienna, Vienna, Austria; ABCSG, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria###
Author: Florian Fitzal, MD – Department of Surgery and Breast Health Center, Medical University of Vienna, Vienna, Austria; ABCSG, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria
### @@@ Loïc Lelièvre, MD – Breast center, CHUV, Lausanne, Switzerland ### 1850424###Author###MD###Breast center, CHUV, Lausanne, Switzerland###
Author: Loïc Lelièvre, MD – Breast center, CHUV, Lausanne, Switzerland
### @@@ Daniel Egle, MD – Breast Cancer Center Tirol, Department of Gynecology, Medical University Innsbruck, Innsbruck, Austria ### 1850401###Author###MD###Breast Cancer Center Tirol, Department of Gynecology, Medical University Innsbruck, Innsbruck, Austria###
Author: Daniel Egle, MD – Breast Cancer Center Tirol, Department of Gynecology, Medical University Innsbruck, Innsbruck, Austria
### @@@ Jörg Heil, MD – Breast Center Heidelberg, Heidelberg, Germany ### 1850402###Author###MD###Breast Center Heidelberg, Heidelberg, Germany###
Author: Jörg Heil, MD – Breast Center Heidelberg, Heidelberg, Germany
### @@@ Christian Kurzeder, MD – Breast Center, University Hospital Basel, Basel, Switzerland,University of Basel, Basel, Switzerland ### 1850419###Author###MD###Breast Center, University Hospital Basel, Basel, Switzerland,University of Basel, Basel, Switzerland###
Author: Christian Kurzeder, MD – Breast Center, University Hospital Basel, Basel, Switzerland,University of Basel, Basel, Switzerland
### @@@ Walter P. Weber, MD (he/him/his) – Department of chest, abdomen and pelvis University hospital Basel, Basel, Switzerland ### 1850364###First Author###Chief Physician###Department of chest, abdomen and pelvis University hospital Basel, Basel, Switzerland###
First Author: Walter P. Weber, MD (he/him/his) – Department of chest, abdomen and pelvis University hospital Basel, Basel, Switzerland
### he/him/his
18: Clinical Impact of Semi-Annual Mammography in Patients Undergoing Breast Conserving Surgery Following Neoadjuvant Therapy

Ton Wang, MD – Cedars-Sinai Medical Center ### 1850642###Abstract Presenter###Breast Surgical Oncology Fellow###Cedars-Sinai Medical Center###
Abstract Presenter: Ton Wang, MD – Cedars-Sinai Medical Center
### @@@ Ton Wang, MD – Cedars-Sinai Medical Center ### 1850642###First Author###Breast Surgical Oncology Fellow###Cedars-Sinai Medical Center###
First Author: Ton Wang, MD – Cedars-Sinai Medical Center
### @@@ Christina Weed, MD, MPH (she/her/hers) – Cedars-Sinai Medical Center ### 1850643###Author###Breast Surgical Oncology Fellow###Cedars-Sinai Medical Center###
Author: Christina Weed, MD, MPH (she/her/hers) – Cedars-Sinai Medical Center
### she/her/hers @@@ Joshua Tseng, MD – Cedars-Sinai Medical Center - Los Angeles, CA ### 1850476###Author###General Surgeon###Cedars-Sinai Medical Center - Los Angeles, CA###
Author: Joshua Tseng, MD – Cedars-Sinai Medical Center - Los Angeles, CA
### @@@ Alice Chung, MD – Cedars Sinai Medical Center ### 955440###Author###Associate Professor of Surgery###Cedars Sinai Medical Center###
Author: Alice Chung, MD – Cedars Sinai Medical Center
### @@@ Alison Moody, MD, MPH – Ascension Medical Group ### 1850645###Author###Attending Surgeon###Ascension Medical Group###
Author: Alison Moody, MD, MPH – Ascension Medical Group
### @@@ Sara Grossi, MD – University of California, San Diego ### 1850852###Author###Assistant Professor of Surgery###University of California, San Diego###
Author: Sara Grossi, MD – University of California, San Diego
### @@@ Marissa Boyle, MD – Cedars Sinai Medical Center ### 1850644###Author###Attending Surgeon###Cedars Sinai Medical Center###
Author: Marissa Boyle, MD – Cedars Sinai Medical Center
### @@@ Armando Giuliano, MD, FACS – Cedars-Sinai Medical Center ### 1850520###Author###Professor of Surgery###Cedars-Sinai Medical Center###
Author: Armando Giuliano, MD, FACS – Cedars-Sinai Medical Center
### @@@ Farin Amersi, MD – Cedars Sinai Medical Center ### 1048230###Author###Associate Professor of Surgery ###Cedars Sinai Medical Center###
Author: Farin Amersi, MD – Cedars Sinai Medical Center
###
19: Sexual Well-being in Patients with Breast Cancer Surgery: Trends, Associated Factors, and Interventions.

Minji Kim, BS – Memorial Sloan Kettering ### 1850764###Abstract Presenter###Research fellow, Plastic and Reconstructive Surgical Service, Department of Surgery###Memorial Sloan Kettering###
Abstract Presenter: Minji Kim, BS – Memorial Sloan Kettering
### @@@ Minji Kim, BS – Memorial Sloan Kettering ### 1850764###First Author###Research fellow, Plastic and Reconstructive Surgical Service, Department of Surgery###Memorial Sloan Kettering###
First Author: Minji Kim, BS – Memorial Sloan Kettering
### @@@ Carrie Stern, MD – Memorial Sloan Kettering ### 1850765###Author###Attending, Plastic and Reconstructive Surgical Service, Department of Surgery###Memorial Sloan Kettering###
Author: Carrie Stern, MD – Memorial Sloan Kettering
### @@@ Kevin Zhang, BS – Memorial Sloan Kettering ### 1850768###Author###Research fellow, Plastic and Reconstructive Surgical Service, Department of Surgery###Memorial Sloan Kettering###
Author: Kevin Zhang, BS – Memorial Sloan Kettering
### @@@ Perri Vingan, BS – Memorial Sloan Kettering ### 1850766###Author###Research fellow, Plastic and Reconstructive Surgical Service, Department of Surgery###Memorial Sloan Kettering###
Author: Perri Vingan, BS – Memorial Sloan Kettering
### @@@ Elizabeth Smith-Montes, MS – Memorial Sloan Kettering ### 1850769###Author###Research fellow, Plastic and Reconstructive Surgical Service, Department of Surgery###Memorial Sloan Kettering###
Author: Elizabeth Smith-Montes, MS – Memorial Sloan Kettering
### @@@ Lillian Boe, PhD – Memorial Sloan Kettering ### 1850767###Author###Statistician, Department of Epidemiology and Biostatistics###Memorial Sloan Kettering###
Author: Lillian Boe, PhD – Memorial Sloan Kettering
### @@@ Jeanne Carter, PhD – Memorial Sloan Kettering ### 1850770###Author###Psychologist, Department of Psychiatry and Behavioral Sciences###Memorial Sloan Kettering###
Author: Jeanne Carter, PhD – Memorial Sloan Kettering
### @@@ Babak J. Mehrara, MD – Memorial Sloan Kettering Cancer Center ### 1849950###Author###Plastic and Reconstructive Surgical Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Babak J. Mehrara, MD – Memorial Sloan Kettering Cancer Center
### @@@ Audree Tadros, MD MPH – Memorial Sloan Kettering Cancer Center ### 1502404###Author###Assistant Attending###Memorial Sloan Kettering Cancer Center###
Author: Audree Tadros, MD MPH – Memorial Sloan Kettering Cancer Center
### @@@ Robert J. Allen, Jr., MD – Memorial Sloan Kettering Cancer Center ### 1850729###Author###Plastic and Reconstructive Surgical Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Robert J. Allen, Jr., MD – Memorial Sloan Kettering Cancer Center
### @@@ Jonas A. Nelson, MD, MPH – Memorial Sloan Kettering Cancer Center ### 1849917###Author###Plastic and Reconstructive Surgical Service, Department of Surgery###Memorial Sloan Kettering Cancer Center###
Author: Jonas A. Nelson, MD, MPH – Memorial Sloan Kettering Cancer Center
###
2: Racial disparities in locoregional recurrence in patients with stage I-III, hormone receptor positive breast cancer enrolled in the NSABP B-42 trial

Charity C. Glass, MD MPP – Dana-Farber Cancer Institute/ Brigham & Women's Hospital/ Massachusetts General Hospital ### 1850510###Abstract Presenter###Fellow###Dana-Farber Cancer Institute/ Brigham & Women's Hospital/ Massachusetts General Hospital###
Abstract Presenter: Charity C. Glass, MD MPP – Dana-Farber Cancer Institute/ Brigham & Women's Hospital/ Massachusetts General Hospital
### @@@ Charity C. Glass, MD MPP – Dana-Farber Cancer Institute/ Brigham & Women's Hospital/ Massachusetts General Hospital ### 1850510###First Author###Fellow###Dana-Farber Cancer Institute/ Brigham & Women's Hospital/ Massachusetts General Hospital###
First Author: Charity C. Glass, MD MPP – Dana-Farber Cancer Institute/ Brigham & Women's Hospital/ Massachusetts General Hospital
### @@@ Robert M. Pride, MD – Dana Farber Cancer Institute/Brigham & Women's Hospital/Massachusetts General Hospital ### 1850685### Author###Breast Surgical Oncology Fellow###Dana Farber Cancer Institute/Brigham & Women's Hospital/Massachusetts General Hospital###
Author: Robert M. Pride, MD – Dana Farber Cancer Institute/Brigham & Women's Hospital/Massachusetts General Hospital
### @@@ Rachel A. Freedman, MD, MPH – Dana-Farber Cancer Institute ### 937374###Author###Medical Oncology###Dana-Farber Cancer Institute###
Author: Rachel A. Freedman, MD, MPH – Dana-Farber Cancer Institute
### @@@ Erica L. Mayer, MD MPH – Dana-Farber Cancer Institute ### 1850504###Author###Medical Oncologist###Dana-Farber Cancer Institute###
Author: Erica L. Mayer, MD MPH – Dana-Farber Cancer Institute
### @@@ Esther R. Ogayo, BS – Dana-Farber Cancer Institute ### 1850503###Author###Research Assistant###Dana-Farber Cancer Institute###
Author: Esther R. Ogayo, BS – Dana-Farber Cancer Institute
### @@@ Mariana Chavez-MacGregor, MD – MD Anderson Cancer Center ### 1850462###Author###Associate Professor###MD Anderson Cancer Center###
Author: Mariana Chavez-MacGregor, MD – MD Anderson Cancer Center
### @@@ Tari A. King, MD, FSSO, FASCO (she/her/hers) – Brigham and Womens Hospital, Dana Farber/Brigham Cancer Center ### 1791617###Author###Chief, Division of Breast Surgery###Brigham and Womens Hospital, Dana Farber/Brigham Cancer Center###
Author: Tari A. King, MD, FSSO, FASCO (she/her/hers) – Brigham and Womens Hospital, Dana Farber/Brigham Cancer Center
### she/her/hers @@@ Elizabeth A. Mittendorf, MD PhD – Brigham and Womens Hospital/Harvard Medical School ### 1530213###Author###Rob and Karen Hale Distinguished Chair in Surgical Oncology###Brigham and Womens Hospital/Harvard Medical School###
Author: Elizabeth A. Mittendorf, MD PhD – Brigham and Womens Hospital/Harvard Medical School
### @@@ Olga Kantor, MD MS – Brigham and Women's Hospital ### 1186247###Author###Breast Surgeon###Brigham and Women's Hospital###
Author: Olga Kantor, MD MS – Brigham and Women's Hospital
###
20: Multi-omic Analysis Reveals Potential Mechanisms of EGFR-inhibitor Resistance in Right Sided Colon Cancer Liver Metastases

Montana Morris, BA – Yale University School of Medicine ### 1850939###Abstract Presenter###Medical Student###Yale University School of Medicine###
Abstract Presenter: Montana Morris, BA – Yale University School of Medicine
### @@@ Abhishek Jain, PhD – Yale University School of Public Health ### 1850940###Author###Post Doctoral Scholar###Yale University School of Public Health###
Author: Abhishek Jain, PhD – Yale University School of Public Health
### @@@ Caroline Johnson, PhD – Yale School of Public Health ### 1850941###Author###Assistant Professor###Yale School of Public Health###
Author: Caroline Johnson, PhD – Yale School of Public Health
### @@@ Sajid Khan, MD – Yale University ### 1214732###Author###Associate Professor of Surgery###Yale University###
Author: Sajid Khan, MD – Yale University
###
2018-2020 Clinical Investigator Award-Characterization of Skin Resident Memory T Cells in Melanoma Survivors

Christina V. Angeles, MD – University of Michigan, Rogel Cancer Center ### 937458###Presenter###Assistant Professor of Surgery###University of Michigan, Rogel Cancer Center###
Presenter: Christina V. Angeles, MD – University of Michigan, Rogel Cancer Center
###
21: Organ Preservation, Compliance and Toxicity in Rectal Cancer Patients Treated with Total Neoadjuvant Therapy: A Post Hoc Analysis of the of the OPRA Phase II Trial

Floris Verheij – Netherlands Cancer Institute ### 1195754###Abstract Presenter###PhD student###Netherlands Cancer Institute ###
Abstract Presenter: Floris Verheij – Netherlands Cancer Institute
### @@@ Dana M. Omer, MD – Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850650### Author###Research Fellow###Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: Dana M. Omer, MD – Department of Surgery, Memorial Sloan Kettering Cancer Center
### @@@ Sabrina T. Lin, MS – Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center ### 1850651###Author###Assistant Research Biostatistician###Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center###
Author: Sabrina T. Lin, MS – Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center
### @@@ Jonathan B. Yuval, MD – Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850652###Author###Fellow###Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: Jonathan B. Yuval, MD – Department of Surgery, Memorial Sloan Kettering Cancer Center
### @@@ Hannah M. Thompson, MD – Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850653###Author###Research Fellow###Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: Hannah M. Thompson, MD – Department of Surgery, Memorial Sloan Kettering Cancer Center
### @@@ Jin K. Kim, MD – Memorial Sloan Kettering Cancer Center ### 1186270###Author###Research Fellow###Memorial Sloan Kettering Cancer Center###
Author: Jin K. Kim, MD – Memorial Sloan Kettering Cancer Center
### @@@ Sebastian C. Valdivieso, MD – Columbia University College of Physicians and Surgeons ### 1850656###Author###Resident###Columbia University College of Physicians and Surgeons###
Author: Sebastian C. Valdivieso, MD – Columbia University College of Physicians and Surgeons
### @@@ Li-Xuan Qin, PhD – Department of Epidemiology and Biostatistics, Memorial Sloan Kettering ### 1850657###Author###Associate Attending Epidemiology-Biostatistics###Department of Epidemiology and Biostatistics, Memorial Sloan Kettering###
Author: Li-Xuan Qin, PhD – Department of Epidemiology and Biostatistics, Memorial Sloan Kettering
### @@@ Abraham J. Wu, MD – Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center ### 1850654###Author###Radiation Oncologist###Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center###
Author: Abraham J. Wu, MD – Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center
### @@@ Leonard B. Saltz, MD – Department of Medicine, Memorial Sloan Kettering Cancer Center ### 1850655###Author###Medical Oncologist###Department of Medicine, Memorial Sloan Kettering Cancer Center###
Author: Leonard B. Saltz, MD – Department of Medicine, Memorial Sloan Kettering Cancer Center
### @@@ Julio Garcia-Aguilar, MD, PhD – Memorial Sloan Kettering Cancer Center ### 1184651###Author###Chief Attending ###Memorial Sloan Kettering Cancer Center###
Author: Julio Garcia-Aguilar, MD, PhD – Memorial Sloan Kettering Cancer Center
### @@@ Floris Verheij – Netherlands Cancer Institute ### 1195754###First Author###PhD student###Netherlands Cancer Institute ###
First Author: Floris Verheij – Netherlands Cancer Institute
###
22: The Long non-coding RNA RAMS11 Promotes Chemotherapy Resistance in-vivo in Metastatic Colorectal Cancer.

Abimbola Oyedeji, MD (he/him/his) – Washington University in St. Louis ### 1850365###Abstract Presenter###Post-Doctoral Research Associate###Washington University in St. Louis###
Abstract Presenter: Abimbola Oyedeji, MD (he/him/his) – Washington University in St. Louis
### he/him/his @@@ Yesol Kim, Ph.D – Washington University in St. Louis ### 1850366###First Author###Post-Doctoral Research Associate###Washington University in St. Louis###
First Author: Yesol Kim, Ph.D – Washington University in St. Louis
### @@@ Nicole White, Ph.D – Washington University in St. Louis ### 1850367###Author###Assistant Professor###Washington University in St. Louis###
Author: Nicole White, Ph.D – Washington University in St. Louis
### @@@ Christopher Maher, Ph.D – Washington University in St. Louis ### 1850369###Author###Associate Professor###Washington University in St. Louis###
Author: Christopher Maher, Ph.D – Washington University in St. Louis
### @@@ Jacqueline Mudd, B.Sc. – Washington University in St. Louis ### 1850368###Author###Staff Scientist###Washington University in St. Louis###
Author: Jacqueline Mudd, B.Sc. – Washington University in St. Louis
### @@@ Duanwen Shen, Ph.D – Washington University in St. Louis ### 1850371###Author###Senior Scientist###Washington University in St. Louis###
Author: Duanwen Shen, Ph.D – Washington University in St. Louis
### @@@ Peter Goedegebuure, PhD – Washington University in St. Louis, Department of Surgery, St. Louis, MO ### 1850370###Author###Associate Professor###Washington University in St. Louis, Department of Surgery, St. Louis, MO###
Author: Peter Goedegebuure, PhD – Washington University in St. Louis, Department of Surgery, St. Louis, MO
### @@@ Ryan C. Fields, MD – Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine ### 937339###Author###Chief, Surgical Oncology; Professor of Surgery###Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine###
Author: Ryan C. Fields, MD – Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine
###
23: Single-cell RNA Sequencing Reveals Distinct Populations of Tumor Associated Macrophages in Colorectal Metastasis.

Muhammad bilal Mirza, MD – Department of surgery ### 1850959###Abstract Presenter###Post-doctoral research fellow###Department of surgery###
Abstract Presenter: Muhammad bilal Mirza, MD – Department of surgery
### @@@ Muhammad bilal Mirza, MD – Department of surgery ### 1850959###First Author###Post-doctoral research fellow###Department of surgery###
First Author: Muhammad bilal Mirza, MD – Department of surgery
### @@@ Lorenzo Tomassini, PhD – Colombia ### 1850961###Author###Post-doc###Colombia###
Author: Lorenzo Tomassini, PhD – Colombia
### @@@ Abdullah Naveed, MD – VUMC ### 1850960###Author###Post-doc###VUMC###
Author: Abdullah Naveed, MD – VUMC
### @@@ David Hanna, MD – Vanderbilt University Medical Center ### 1186183###Author###Resident Physician###Vanderbilt University Medical Center###
Author: David Hanna, MD – Vanderbilt University Medical Center
### @@@ Marincola Smith, MD, PhD – VUMC ### 1850962###Author###Cheif resident###VUMC###
Author: Marincola Smith, MD, PhD – VUMC
### @@@ Chandrasekhar Padmanabhan, MD – Vanderbilt University Medical Center ### 1849986###Author###Assistant Professor of Surgery###Vanderbilt University Medical Center###
Author: Chandrasekhar Padmanabhan, MD – Vanderbilt University Medical Center
### @@@ Deepa Magge, MD, FACS – Vanderbilt University Medical Center ### 1252043###Author###Assistant Professor of Surgery ###Vanderbilt University Medical Center###
Author: Deepa Magge, MD, FACS – Vanderbilt University Medical Center
### @@@ Christina E. Bailey, MD, MSCI – Vanderbilt University Medical Center ### 937365###Author###Associate Professor of Surgery, General Surgery Program Director###Vanderbilt University Medical Center###
Author: Christina E. Bailey, MD, MSCI – Vanderbilt University Medical Center
### @@@ Robert D. Beauchamp, MD – VUMC ### 1850963###Author###J.C. Foshee Distinguished Professor of Surgery, Professor of Cell and Developmental Biology Co-Leade###VUMC###
Author: Robert D. Beauchamp, MD – VUMC
### @@@ Mustafa Raoof, MD, FACS – Department of Surgery, Cancer Genetics and Epigenetics ### 915788###Author###Assistant Professor###Department of Surgery, Cancer Genetics and Epigenetics###
Author: Mustafa Raoof, MD, FACS – Department of Surgery, Cancer Genetics and Epigenetics
### @@@ Andrea Califano, PhD – Colombia ### 1850965###Author###Clyde and Helen Wu Professor of Chemical and Systems Biology Chair, Department of Systems Biology###Colombia###
Author: Andrea Califano, PhD – Colombia
### @@@ Young Kim, MD, PhD – Regeneron ### 1850964###Author###Vice president###Regeneron###
Author: Young Kim, MD, PhD – Regeneron
### @@@ Kamran Idrees, MD, MSCI, MMHC – Vanderbilt University Medical Center ### 937418###Author###Chief, Division of Surgical Oncology and Endocrine Surgery###Vanderbilt University Medical Center###
Author: Kamran Idrees, MD, MSCI, MMHC – Vanderbilt University Medical Center
###
24: Sufficient Regional Lymph Node Examination for Staging High-Grade Appendix Cancer

Felipe Lopez-Ramirez, MD (he/him/his) – Mercy Medical Center ### 1186173###Abstract Presenter###Research fellow###Mercy Medical Center###
Abstract Presenter: Felipe Lopez-Ramirez, MD (he/him/his) – Mercy Medical Center
### he/him/his @@@ Felipe Lopez-Ramirez, MD (he/him/his) – Mercy Medical Center ### 1186173###First Author###Research fellow###Mercy Medical Center###
First Author: Felipe Lopez-Ramirez, MD (he/him/his) – Mercy Medical Center
### he/him/his @@@ Armando Sardi, MD, FACS (he/him/his) – The Institute for Cancer Care, Mercy Medical Center ### 1534856###Author###Director ###The Institute for Cancer Care, Mercy Medical Center###
Author: Armando Sardi, MD, FACS (he/him/his) – The Institute for Cancer Care, Mercy Medical Center
### he/him/his @@@ Mary Caitlin King, BS – Mercy Medical Center ### 1850506###Author###Research Supervisor###Mercy Medical Center###
Author: Mary Caitlin King, BS – Mercy Medical Center
### @@@ Andrei Nikiforchin, MD (he/him/his) – The Institute for Cancer Care, Mercy Medical Center ### 918111###Author###Research Fellow###The Institute for Cancer Care, Mercy Medical Center###
Author: Andrei Nikiforchin, MD (he/him/his) – The Institute for Cancer Care, Mercy Medical Center
### he/him/his @@@ Philipp Barakat, MD – Mercy Medical Center ### 1850507###Author###Research Fellow###Mercy Medical Center###
Author: Philipp Barakat, MD – Mercy Medical Center
### @@@ Luis Felipe Falla Zuniga, MD – Mercy Medical Center ### 1850505###Author###Research Fellow###Mercy Medical Center###
Author: Luis Felipe Falla Zuniga, MD – Mercy Medical Center
### @@@ Carol Nieroda, MD – Mercy Medical Center ### 1850508###Author###Research Advisor###Mercy Medical Center###
Author: Carol Nieroda, MD – Mercy Medical Center
### @@@ Vadim Gushchin, MD, FACS – Mercy Medical Center ### 1850509###Author###Director, HIPEC Program at Mercy###Mercy Medical Center###
Author: Vadim Gushchin, MD, FACS – Mercy Medical Center
###
25: Combination Immunotherapy with Oncolytic Virus Induces Immunogenic Cell Death and T-cell Proliferation in Colon Cancer

Paul Wong, BS – University of California, San Francisco ### 1850730###Abstract Presenter###Medical Student###University of California, San Francisco###
Abstract Presenter: Paul Wong, BS – University of California, San Francisco
### @@@ Paul Wong, BS – University of California, San Francisco ### 1850730###First Author###Medical Student###University of California, San Francisco###
First Author: Paul Wong, BS – University of California, San Francisco
### @@@ Guilin Qiao, PhD – University of California, San Francisco ### 1850731###Author###Associate Adjunct Professor###University of California, San Francisco###
Author: Guilin Qiao, PhD – University of California, San Francisco
### @@@ Prem Seth, PhD – NorthShore University HealthSystem ### 1850732###Author###Director###NorthShore University HealthSystem###
Author: Prem Seth, PhD – NorthShore University HealthSystem
### @@@ Bellur Prabhakar, PhD – University of Illinois, Chicago ### 1850733###Author###Professor###University of Illinois, Chicago###
Author: Bellur Prabhakar, PhD – University of Illinois, Chicago
### @@@ Ajay V. Maker, MD – University of California, San Francisco ### 1850734###Author###Professor###University of California, San Francisco###
Author: Ajay V. Maker, MD – University of California, San Francisco
###
26: Neoadjuvant Chemoradiation Does Not Improve Outcomes for Patients Undergoing Resection for Upper Rectal Cancer: A US Rectal Cancer Consortium Analysis

Caroline Medin, MD (she/her/hers) – Emory University ### 1530218###Abstract Presenter###Resident###Emory University###
Abstract Presenter: Caroline Medin, MD (she/her/hers) – Emory University
### she/her/hers @@@ Caroline Medin, MD (she/her/hers) – Emory University ### 1530218###First Author###Resident###Emory University###
First Author: Caroline Medin, MD (she/her/hers) – Emory University
### she/her/hers @@@ Adriana C. Gamboa, MD – Emory University ### 1850582###Author###Resident###Emory University###
Author: Adriana C. Gamboa, MD – Emory University
### @@@ Emilie K. Warren, MD – Winship Cancer Institute, Emory University ### 1850583###Author###Research Fellow###Winship Cancer Institute, Emory University###
Author: Emilie K. Warren, MD – Winship Cancer Institute, Emory University
### @@@ Scott E. Regenbogen, MD, MPH – University of Michigan ### 1850584###Author###Professor of Surgery###University of Michigan###
Author: Scott E. Regenbogen, MD, MPH – University of Michigan
### @@@ Samantha K. Hendren, MD – University of Michigan ### 1850585###Author###Associate Professor###University of Michigan###
Author: Samantha K. Hendren, MD – University of Michigan
### @@@ Jennifer M. Holder-Murray, MD – University of Pittsburgh Medical Center ### 1850586###Author###Associate Professor of Surgery###University of Pittsburgh Medical Center###
Author: Jennifer M. Holder-Murray, MD – University of Pittsburgh Medical Center
### @@@ Matthew Kalady, MD (he/him/his) – The Ohio State University and James Comprehensive Cancer Center ### 1791614###Author###Professor of Surgery, Chief, Division of Colon and Rectal Surgery###The Ohio State University and James Comprehensive Cancer Center###
Author: Matthew Kalady, MD (he/him/his) – The Ohio State University and James Comprehensive Cancer Center
### he/him/his @@@ Aslam Ejaz, MD, MPH – The Ohio State University ### 1502392###Author###Assistant Professor of Surgery###The Ohio State University###
Author: Aslam Ejaz, MD, MPH – The Ohio State University
### @@@ Alexander T. Hawkins, MD, MPH – Vanderbilt University Medical Center ### 1850587###Author###Associate Professor of Surgery###Vanderbilt University Medical Center###
Author: Alexander T. Hawkins, MD, MPH – Vanderbilt University Medical Center
### @@@ Matthew L. Silviera, MD – Washington University School of Medicine in St. Louis ### 1850588###Author###Assistant Professor of Surgery###Washington University School of Medicine in St. Louis###
Author: Matthew L. Silviera, MD – Washington University School of Medicine in St. Louis
### @@@ Shishir K. Maithel, MD – Emory ### 917909###Author###Professor of Surgery###Emory###
Author: Shishir K. Maithel, MD – Emory
### @@@ Glen C. Balch, MD, MBA – Winship Cancer Institute, Emory University ### 1850589###Author###Professor of Surgery###Winship Cancer Institute, Emory University###
Author: Glen C. Balch, MD, MBA – Winship Cancer Institute, Emory University
###
27: The Prognostic Value of Pre- and Post-Neoadjuvant Chemotherapy Serum Carcinoembryonic Antigen Levels in Patients Having Resection of Colorectal Liver Metastases

Yi Song, MD, MS (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 1850434###Abstract Presenter###Clinical research fellow###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Yi Song, MD, MS (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Yi Song, MD, MS (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 1850434###First Author###Clinical research fellow###Memorial Sloan Kettering Cancer Center###
First Author: Yi Song, MD, MS (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Hannah Kalvin, MSPH – Memorial Sloan Kettering Cancer Center ### 1849730###Author###Assistant Research Biostatistician###Memorial Sloan Kettering Cancer Center###
Author: Hannah Kalvin, MSPH – Memorial Sloan Kettering Cancer Center
### @@@ Alice C. Wei, MD MSc FRCSC FACS (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 937479###Author###Associate Attending Surgeon###Memorial Sloan Kettering Cancer Center###
Author: Alice C. Wei, MD MSc FRCSC FACS (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Kevin C. Soares, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850358###Author###Hepatobiliary Surgeon###Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: Kevin C. Soares, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
### @@@ T. Peter Kingham, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850357###Author###Director of Global Cancer Disparities Initiatives###Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: T. Peter Kingham, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
### @@@ Jeffrey A. Drebin, MD, PhD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850356###Author###Chair, Department of Surgery; Murray F. Brennan Chair in Surgery###Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: Jeffrey A. Drebin, MD, PhD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
### @@@ William R. Jarnagin, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850359###Author###Chief, Hepatobiliary Service; Leslie Blumgart Chair in Surgery###Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: William R. Jarnagin, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
### @@@ Mithat Gonen, PhD – Department of Biostatistics, Memorial Sloan Kettering Cancer Center ### 1849709###Author###Chief of the Biostatistics Service###Department of Biostatistics, Memorial Sloan Kettering Cancer Center###
Author: Mithat Gonen, PhD – Department of Biostatistics, Memorial Sloan Kettering Cancer Center
### @@@ Michael I. D’Angelica, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850355###Author###Enid A. Haupt Chair in Surgery###Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: Michael I. D’Angelica, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
###
28: Tumor Deposits Are Associated with a Higher Risk of Peritoneal Disease in Non-Metastatic Colorectal Cancer Patients

Hamza Khan, MD – Valley Health System ### 1850865###Abstract Presenter###Resident###Valley Health System###
Abstract Presenter: Hamza Khan, MD – Valley Health System
### @@@ Hamza Khan, MD – Valley Health System ### 1850865###First Author###Resident###Valley Health System###
First Author: Hamza Khan, MD – Valley Health System
### @@@ Shannon N. Radomski, MD (she/her/hers) – Department of Surgery, Johns Hopkins Hospital ### 1850375###Author###Resident###Department of Surgery, Johns Hopkins Hospital###
Author: Shannon N. Radomski, MD (she/her/hers) – Department of Surgery, Johns Hopkins Hospital
### she/her/hers @@@ Amn Siddiqi, MD – Johns Hopkins University Department of Surgery ### 1850866###Author###Research Associate###Johns Hopkins University Department of Surgery###
Author: Amn Siddiqi, MD – Johns Hopkins University Department of Surgery
### @@@ Nancy Zhou, BS – Johns Hopkins University School of Medicine ### 1850867###Author###Medical Student###Johns Hopkins University School of Medicine###
Author: Nancy Zhou, BS – Johns Hopkins University School of Medicine
### @@@ Fabian M. Johnston, MD, MHS – Johns Hopkins University ### 917904###Author###Associate Professor of Surgery###Johns Hopkins University###
Author: Fabian M. Johnston, MD, MHS – Johns Hopkins University
### @@@ Jonathan B. Greer, MD – Johns Hopkins University School of Medicine ### 915765###Author###Assistant Professor of Surgery and Oncology###Johns Hopkins University School of Medicine###
Author: Jonathan B. Greer, MD – Johns Hopkins University School of Medicine
###
29: Development of a novel PET agent for parathyroid imaging targeting the Calcium-Sensing Receptor (CaSR)

Lawrence Kim, MD, FACS, FACE – University of North Carolina at Chapel Hill ### 1214734###First Author###Professor###University of North Carolina at Chapel Hill###
First Author: Lawrence Kim, MD, FACS, FACE – University of North Carolina at Chapel Hill
### @@@ tu xianshuang, PhD – University of North Carolina ### 1850749###Author###Postdoctoral fellow###University of North Carolina###
Author: tu xianshuang, PhD – University of North Carolina
### @@@ Han Zhaoguo, MD – University of North Carolina ### 1850750###Author###Postdoctoral fellow###University of North Carolina###
Author: Han Zhaoguo, MD – University of North Carolina
### @@@ Mia MacDonald, MD – University of North Carolina ### 1850648###Abstract Presenter###Resident###University of North Carolina###
Abstract Presenter: Mia MacDonald, MD – University of North Carolina
### @@@ Mia MacDonald, MD – University of North Carolina ### 1850648###Author###Resident###University of North Carolina###
Author: Mia MacDonald, MD – University of North Carolina
### @@@ Wang Jason, MS – University of North Carolina ### 1850751###Author###Research Associate###University of North Carolina###
Author: Wang Jason, MS – University of North Carolina
### @@@ Hui Wang, PhD – University of North Carolina ### 1850771###Author###Research Associate###University of North Carolina###
Author: Hui Wang, PhD – University of North Carolina
### @@@ Wei Chen, PhD – University of North Carolina ### 1850773###Author###Postdoctoral fellow###University of North Carolina###
Author: Wei Chen, PhD – University of North Carolina
### @@@ Hong Yuan, PhD – University of North Carolina ### 1850774###Author###Professor###University of North Carolina###
Author: Hong Yuan, PhD – University of North Carolina
### @@@ Zibo Li, PhD – University of North Carolina ### 1850775###Author###Professor###University of North Carolina###
Author: Zibo Li, PhD – University of North Carolina
### @@@ Xilin Sun, MD – Harbin Medical University, Harbin, China ### 1850776###Author###Professor###Harbin Medical University, Harbin, China###
Author: Xilin Sun, MD – Harbin Medical University, Harbin, China
### @@@ Xiaofen Ma, MD – Guangdong Second Provincial General Hospital. Guangzhou, China ### 1850777###Author###Professor###Guangdong Second Provincial General Hospital. Guangzhou, China###
Author: Xiaofen Ma, MD – Guangdong Second Provincial General Hospital. Guangzhou, China
### @@@ Zhanhong Wu, PhD – University of North Carolina ### 1850778###Author###Associate Professor###University of North Carolina###
Author: Zhanhong Wu, PhD – University of North Carolina
###
3: Changes in axillary surgical management over 10 years – report on > 1400 breast cancer patients treated with neoadjuvant chemotherapy on I-SPY2

Judy C. Boughey, MD, FACS, FSSO (she/her/hers) – Mayo Clinic ### 937371###Abstract Presenter###Professor of Surgery, W.H. Odell Professor in Individualized Medicine, Chair-Division of Breast and Melanoma Surgical Oncology, Department of Surgery###Mayo Clinic###
Abstract Presenter: Judy C. Boughey, MD, FACS, FSSO (she/her/hers) – Mayo Clinic
### she/her/hers @@@ Judy C. Boughey, MD, FACS, FSSO (she/her/hers) – Mayo Clinic ### 937371###Author###Professor of Surgery, W.H. Odell Professor in Individualized Medicine, Chair-Division of Breast and Melanoma Surgical Oncology, Department of Surgery###Mayo Clinic###
Author: Judy C. Boughey, MD, FACS, FSSO (she/her/hers) – Mayo Clinic
### she/her/hers @@@ Laura Esserman, MD, MBA – UCSF ### 1850554###Author###Director of UCSF Breast Care Center, Co-leader of the Breast Oncology Program###UCSF###
Author: Laura Esserman, MD, MBA – UCSF
### @@@ Qian Ding, M.S. – Quantum Leap Healthcare Collaborative ### 1850555###Author###Principal Statistician###Quantum Leap Healthcare Collaborative###
Author: Qian Ding, M.S. – Quantum Leap Healthcare Collaborative
### @@@ Hongmei Yu, Ph.D. – Quantum Leap Healthcare Collaborative ### 1850556###Author###Data Scientist###Quantum Leap Healthcare Collaborative###
Author: Hongmei Yu, Ph.D. – Quantum Leap Healthcare Collaborative
### @@@ The ISPY2 Surgical Working Group, n/a – multiple organizations ### 1850557###Author###Working Group of surgeons across all ISPY2 sites###multiple organizations###
Author: The ISPY2 Surgical Working Group, n/a – multiple organizations
### @@@ Rita Mukhtar, MD – University of California San Francisco ### 937434###Author###Assistant Professor of Clinical Surgery###University of California San Francisco###
Author: Rita Mukhtar, MD – University of California San Francisco
###
30: Cytoreduction in Patients with Metastatic Pancreatic Neuroendocrine Tumors and the Clinical Factors Driving Outcomes

Jace P. Landry, MD (he/him/his) – LSU HSC New Orleans ### 969989###Abstract Presenter###Surgery Resident###LSU HSC New Orleans###
Abstract Presenter: Jace P. Landry, MD (he/him/his) – LSU HSC New Orleans
### he/him/his @@@ Jace P. Landry, MD (he/him/his) – LSU HSC New Orleans ### 969989###First Author###Surgery Resident###LSU HSC New Orleans###
First Author: Jace P. Landry, MD (he/him/his) – LSU HSC New Orleans
### he/him/his @@@ Yvette Mattison, PhD – LSU HSC New Orleans ### 1850549###Author###Clinical Research Scientist###LSU HSC New Orleans###
Author: Yvette Mattison, PhD – LSU HSC New Orleans
### @@@ Denise Danos, PhD – LSU HSC New Orleans ### 1850550###Author###Biostatistician###LSU HSC New Orleans###
Author: Denise Danos, PhD – LSU HSC New Orleans
### @@@ Philip Boudreaux, MD – LSU HSC New Orleans ### 1850551###Author###Professor###LSU HSC New Orleans###
Author: Philip Boudreaux, MD – LSU HSC New Orleans
### @@@ Ramcharan Thiagarajan, MD – LSU HSC New Orleans ### 1850552###Author###Professor###LSU HSC New Orleans###
Author: Ramcharan Thiagarajan, MD – LSU HSC New Orleans
### @@@ Mary Maluccio, MD – LSU HSC New Orleans ### 1850553###Author###Professor###LSU HSC New Orleans###
Author: Mary Maluccio, MD – LSU HSC New Orleans
###
31: Factors Predicting Immunotherapy Utilization for Metastatic Merkel Cell Carcinoma from 2015-2018

James Sun, MD (he/him/his) – University Hospitals Cleveland Medical Center ### 1850943###Abstract Presenter###Chief Resident###University Hospitals Cleveland Medical Center###
Abstract Presenter: James Sun, MD (he/him/his) – University Hospitals Cleveland Medical Center
### he/him/his @@@ James Sun, MD (he/him/his) – University Hospitals Cleveland Medical Center ### 1850943###First Author###Chief Resident###University Hospitals Cleveland Medical Center###
First Author: James Sun, MD (he/him/his) – University Hospitals Cleveland Medical Center
### he/him/his @@@ Hanna Kakish, Doctor of Medicine (he/him/his) – University Hospitals, Cleveland Medical Center ### 1849872###Author###Research fellow###University Hospitals, Cleveland Medical Center###
Author: Hanna Kakish, Doctor of Medicine (he/him/his) – University Hospitals, Cleveland Medical Center
### he/him/his @@@ John B. Ammori, M.D. – University Hospitals Cleveland Medical Center/Case Western Reserve University ### 1849906###Author###Associate Professor of Surgery/Program Director, Division of Surgical Oncology###University Hospitals Cleveland Medical Center/Case Western Reserve University###
Author: John B. Ammori, M.D. – University Hospitals Cleveland Medical Center/Case Western Reserve University
### @@@ Richard S. Hoehn, MD – University Hospitals, Cleveland Medical Center ### 1849874###Author###Assistant Professor of Surgery###University Hospitals, Cleveland Medical Center###
Author: Richard S. Hoehn, MD – University Hospitals, Cleveland Medical Center
### @@@ Luke D. Rothermel, M.D., M.P.H. – University Hospitals, Cleveland Medical Center ### 1849875###Author###Assistant Professor of Surgery, Division of Surgical Oncology###University Hospitals, Cleveland Medical Center###
Author: Luke D. Rothermel, M.D., M.P.H. – University Hospitals, Cleveland Medical Center
###
32: Impact of Primary Tumor Resection on Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors

Ashley Russo, MD – Cedars-Sinai Medical Center - Los Angeles, CA ### 1850475###Abstract Presenter###Complex General Surgical Oncology Fellow###Cedars-Sinai Medical Center - Los Angeles, CA###
Abstract Presenter: Ashley Russo, MD – Cedars-Sinai Medical Center - Los Angeles, CA
### @@@ Ashley Russo, MD – Cedars-Sinai Medical Center - Los Angeles, CA ### 1850475###First Author###Complex General Surgical Oncology Fellow###Cedars-Sinai Medical Center - Los Angeles, CA###
First Author: Ashley Russo, MD – Cedars-Sinai Medical Center - Los Angeles, CA
### @@@ Timothy P. DiPeri, MD – The University of Texas MD Anderson Cancer Center ### 1530268###Author###T32 Research Fellow###The University of Texas MD Anderson Cancer Center###
Author: Timothy P. DiPeri, MD – The University of Texas MD Anderson Cancer Center
### @@@ Joshua Tseng, MD – Cedars-Sinai Medical Center - Los Angeles, CA ### 1850476###Author###General Surgeon###Cedars-Sinai Medical Center - Los Angeles, CA###
Author: Joshua Tseng, MD – Cedars-Sinai Medical Center - Los Angeles, CA
### @@@ Courtney Chen, MD – Cedars-Sinai Medical Center - Los Angeles, CA ### 1850477###Author###General Surgery Resident###Cedars-Sinai Medical Center - Los Angeles, CA###
Author: Courtney Chen, MD – Cedars-Sinai Medical Center - Los Angeles, CA
### @@@ Nicholas Nissen, MD – Cedars-Sinai Medical Center - Los Angeles, CA ### 1850478###Author###Director of Hepatobiliary and Pancreatic Surgery###Cedars-Sinai Medical Center - Los Angeles, CA###
Author: Nicholas Nissen, MD – Cedars-Sinai Medical Center - Los Angeles, CA
### @@@ Farin Amersi, MD – Cedars Sinai Medical Center ### 1048230###Author###Associate Professor of Surgery ###Cedars Sinai Medical Center###
Author: Farin Amersi, MD – Cedars Sinai Medical Center
### @@@ Andrew Hendifar, MD – Cedars-Sinai Medical Center - Los Angeles, CA ### 1850479###Author###Hematologist/Oncologist - Associate Professor of Medicine###Cedars-Sinai Medical Center - Los Angeles, CA###
Author: Andrew Hendifar, MD – Cedars-Sinai Medical Center - Los Angeles, CA
### @@@ Alexandra Gangi, MD – Cedars Sinai Medical Center ### 915762###Author###Assistant Professor Director, Gastrointestinal Tumor Program###Cedars Sinai Medical Center###
Author: Alexandra Gangi, MD – Cedars Sinai Medical Center
###
33: Validated Predictive Model for Prognosis and Treatment of Papillary Thyroid Carcinoma

Samuel M. Zuber, MD (he/him/his) – North Shore University Health System ### 1850909###Abstract Presenter###Endocrine Surgery Fellow###North Shore University Health System###
Abstract Presenter: Samuel M. Zuber, MD (he/him/his) – North Shore University Health System
### he/him/his @@@ Kristine Kuchta, MS – North Shore University Health System ### 1850910###First Author###Statistician###North Shore University Health System###
First Author: Kristine Kuchta, MS – North Shore University Health System
### @@@ Mandakini Venkatramani, MD – Northshore University HealthSystems ### 1534902###Author###Fellow###Northshore University HealthSystems###
Author: Mandakini Venkatramani, MD – Northshore University HealthSystems
### @@@ Amna Khokar, MD (she/her/hers) – John H. Stroger Jr. Cook County Hospital ### 1850911###Author###Endocrine Surgeon###John H. Stroger Jr. Cook County Hospital###
Author: Amna Khokar, MD (she/her/hers) – John H. Stroger Jr. Cook County Hospital
### she/her/hers @@@ Tricia A. Moo-Young, MD – North Shore University Health System ### 1850912###Author###Endocrine Surgeon###North Shore University Health System###
Author: Tricia A. Moo-Young, MD – North Shore University Health System
### @@@ Richard A. Prinz, MD – North Shore University Health System ### 1850913###Author###Endocrine Surgeon###North Shore University Health System###
Author: Richard A. Prinz, MD – North Shore University Health System
### @@@ David J. Winchester, MD (he/him/his) – North Shore University Health System ### 1850914###Author###Endocrine Surgeon###North Shore University Health System###
Author: David J. Winchester, MD (he/him/his) – North Shore University Health System
### he/him/his
34: An Artificial Intelligence Approach to Determining Optimal Margin Width in Patients Undergoing Hepatectomy for Intrahepatic Cholangiocarcinoma

Laura Alaimo, MD – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center ### 1850706###Author###Research Scholar###Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center###
Author: Laura Alaimo, MD – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
### @@@ Zorays Moazzam, MD – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center ### 1849935###Author###Research Scholar###Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center###
Author: Zorays Moazzam, MD – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
### @@@ Henrique Araujo Lima, MD – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center ### 1850705###Author###Research Scholar###Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center###
Author: Henrique Araujo Lima, MD – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
### @@@ Yutaka Endo, MD, PhD – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center ### 1850707###Author###Research Scholar###Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center###
Author: Yutaka Endo, MD, PhD – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
### @@@ Andrea Ruzzenente, MD, PhD – Department of Surgery, Dentistry, Gynecology, and Pediatrics, Division of General and Hepato-Biliary Surgery, University of Verona, University Hospital G.B. Rossi, Verona, Italy ### 1850907###Author###Professor###Department of Surgery, Dentistry, Gynecology, and Pediatrics, Division of General and Hepato-Biliary Surgery, University of Verona, University Hospital G.B. Rossi, Verona, Italy###
Author: Andrea Ruzzenente, MD, PhD – Department of Surgery, Dentistry, Gynecology, and Pediatrics, Division of General and Hepato-Biliary Surgery, University of Verona, University Hospital G.B. Rossi, Verona, Italy
### @@@ Alfredo Guglielmi, MD – Department of Surgery, Dentistry, Gynecology, and Pediatrics, Division of General and Hepato-Biliary Surgery, University of Verona, University Hospital G.B. Rossi, Verona, Italy ### 1850908###Author###Professor###Department of Surgery, Dentistry, Gynecology, and Pediatrics, Division of General and Hepato-Biliary Surgery, University of Verona, University Hospital G.B. Rossi, Verona, Italy###
Author: Alfredo Guglielmi, MD – Department of Surgery, Dentistry, Gynecology, and Pediatrics, Division of General and Hepato-Biliary Surgery, University of Verona, University Hospital G.B. Rossi, Verona, Italy
### @@@ Aslam Ejaz, MD, MPH – The Ohio State University ### 1502392###Author###Assistant Professor of Surgery###The Ohio State University###
Author: Aslam Ejaz, MD, MPH – The Ohio State University
### @@@ Jordan M. Cloyd, MD – The Ohio State University ### 915758###Author###Assistant Professor###The Ohio State University###
Author: Jordan M. Cloyd, MD – The Ohio State University
### @@@ Joal D. Beane, MD – The Ohio State University Wexner Medical Center- Division of Surgical Oncology ### 1849833###Author###Assistant Professor###The Ohio State University Wexner Medical Center- Division of Surgical Oncology###
Author: Joal D. Beane, MD – The Ohio State University Wexner Medical Center- Division of Surgical Oncology
### @@@ Alex C. Kim, MD, PhD – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute ### 1529408###Author###Assistant Professor of Surgery###The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute###
Author: Alex C. Kim, MD, PhD – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute
### @@@ Timothy M. Pawlik, MD, PhD – The Ohio State University Wexner Medical Center ### 937481###Author###Chair of Surgery###The Ohio State University Wexner Medical Center###
Author: Timothy M. Pawlik, MD, PhD – The Ohio State University Wexner Medical Center
### @@@ Yutaka Endo, MD, PhD – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center ### 1850707###Abstract Presenter###Research Scholar###Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center###
Abstract Presenter: Yutaka Endo, MD, PhD – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
###
35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome

Yi Song, MD, MS (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 1850434###Abstract Presenter###Clinical research fellow###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Yi Song, MD, MS (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Yi Song, MD, MS (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 1850434###Author###Clinical research fellow###Memorial Sloan Kettering Cancer Center###
Author: Yi Song, MD, MS (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Thomas Boerner, MD, MS – Memorial Sloan Kettering Cancer Center ### 1850435###Author###Senior Research Scientist###Memorial Sloan Kettering Cancer Center###
Author: Thomas Boerner, MD, MS – Memorial Sloan Kettering Cancer Center
### @@@ Esther Drill, DrPH – Memorial Sloan Kettering Cancer Center ### 1850436###Author###Principal Biostatistician###Memorial Sloan Kettering Cancer Center###
Author: Esther Drill, DrPH – Memorial Sloan Kettering Cancer Center
### @@@ Paul Shin, MD, PhD – Memorial Sloan Kettering Cancer Center ### 1850437###Author###Research Associate###Memorial Sloan Kettering Cancer Center###
Author: Paul Shin, MD, PhD – Memorial Sloan Kettering Cancer Center
### @@@ Andrea Cercek, MD – Memorial Sloan Kettering Cancer Center ### 1850438###Author###Associate Attending###Memorial Sloan Kettering Cancer Center###
Author: Andrea Cercek, MD – Memorial Sloan Kettering Cancer Center
### @@@ Nancy E. Kemeny, MD – Memorial Sloan Kettering Cancer Center ### 1850439###Author###Attending###Memorial Sloan Kettering Cancer Center###
Author: Nancy E. Kemeny, MD – Memorial Sloan Kettering Cancer Center
### @@@ Ghassan Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center ### 1214110###Author###Professor###Memorial Sloan Kettering Cancer Center###
Author: Ghassan Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center
### @@@ Christine Iacobuzio-Donahue, MD, PhD – Memorial Sloan Kettering Cancer Center ### 1850440###Author###Attending###Memorial Sloan Kettering Cancer Center###
Author: Christine Iacobuzio-Donahue, MD, PhD – Memorial Sloan Kettering Cancer Center
### @@@ Nikolaus Schultz, PhD – Memorial Sloan Kettering Cancer Center ### 1850441###Author###Computational Oncologist###Memorial Sloan Kettering Cancer Center###
Author: Nikolaus Schultz, PhD – Memorial Sloan Kettering Cancer Center
### @@@ Henry Walch, MS – Memorial Sloan Kettering Cancer Center ### 1850442###Author###Computational Biologist###Memorial Sloan Kettering Cancer Center###
Author: Henry Walch, MS – Memorial Sloan Kettering Cancer Center
### @@@ Carlie Sigel, MD – Memorial Sloan Kettering Cancer Center ### 1850443###Author###Associate Attending###Memorial Sloan Kettering Cancer Center###
Author: Carlie Sigel, MD – Memorial Sloan Kettering Cancer Center
### @@@ T. Peter Kingham, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850357###Author###Director of Global Cancer Disparities Initiatives###Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: T. Peter Kingham, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
### @@@ Kevin C. Soares, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850358###Author###Hepatobiliary Surgeon###Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: Kevin C. Soares, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
### @@@ Alice C. Wei, MD MSc FRCSC FACS (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 937479###Author###Associate Attending Surgeon###Memorial Sloan Kettering Cancer Center###
Author: Alice C. Wei, MD MSc FRCSC FACS (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Michael I. D’Angelica, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850355###Author###Enid A. Haupt Chair in Surgery###Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: Michael I. D’Angelica, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
### @@@ Jeffrey A. Drebin, MD, PhD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850356###Author###Chair, Department of Surgery; Murray F. Brennan Chair in Surgery###Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: Jeffrey A. Drebin, MD, PhD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
### @@@ Rohit Chandwani, MD, PhD – Weill Cornell Medical College ### 1850444###Author###Attending###Weill Cornell Medical College###
Author: Rohit Chandwani, MD, PhD – Weill Cornell Medical College
### @@@ James J. Harding, MD – Memorial Sloan Kettering Cancer Center ### 1850445###Author###Assistant Attending###Memorial Sloan Kettering Cancer Center###
Author: James J. Harding, MD – Memorial Sloan Kettering Cancer Center
### @@@ William R. Jarnagin, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850359###Author###Chief, Hepatobiliary Service; Leslie Blumgart Chair in Surgery###Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: William R. Jarnagin, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
###
36: KRAS-G12V and TP53 But Not KRAS-G12V Mutation Alone Is Associated with Worse Survival in Patients with Resected Colorectal Liver Metastasis

Reed I. Ayabe, MD – MD Anderson Cancer Center ### 1850916###Abstract Presenter###Complex General Surgical Oncology Fellow###MD Anderson Cancer Center###
Abstract Presenter: Reed I. Ayabe, MD – MD Anderson Cancer Center
### @@@ Harufumi Maki, MD – MD Anderson Cancer Center ### 1850917###Author###Postdoctoral Fellow###MD Anderson Cancer Center###
Author: Harufumi Maki, MD – MD Anderson Cancer Center
### @@@ Yujiro Nishioka, MD – MD Anderson Cancer Center ### 1850918###Author###Postdoctoral Fellow###MD Anderson Cancer Center###
Author: Yujiro Nishioka, MD – MD Anderson Cancer Center
### @@@ Timothy E. Newhook, MD, FACS – MD Anderson Cancer Center ### 970062###Author###Assistant Professor###MD Anderson Cancer Center###
Author: Timothy E. Newhook, MD, FACS – MD Anderson Cancer Center
### @@@ Hop S. Tran Cao, MD (he/him/his) – The University of Texas MD Anderson Cancer Center ### 1238388###Author###Associate Professor of Surgery###The University of Texas MD Anderson Cancer Center###
Author: Hop S. Tran Cao, MD (he/him/his) – The University of Texas MD Anderson Cancer Center
### he/him/his @@@ Yun Shin Chun, MD, FACS – The University of Texas MD Anderson Cancer Center ### 1850632###Author###Associate Professor###The University of Texas MD Anderson Cancer Center###
Author: Yun Shin Chun, MD, FACS – The University of Texas MD Anderson Cancer Center
### @@@ Ching-Wei D. Tzeng, MD (he/him/his) – The University of Texas MD Anderson Cancer Center ### 894419###Author###Associate Professor###The University of Texas MD Anderson Cancer Center###
Author: Ching-Wei D. Tzeng, MD (he/him/his) – The University of Texas MD Anderson Cancer Center
### he/him/his @@@ Jean-Nicolas Vauthey, MD (he/him/his) – The University of Texas MD Anderson Cancer Center ### 1824907###Author###Professor of Surgery###The University of Texas MD Anderson Cancer Center###
Author: Jean-Nicolas Vauthey, MD (he/him/his) – The University of Texas MD Anderson Cancer Center
### he/him/his
37: Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study

Lily V. Saadat, MD – Memorial Sloan Kettering Cancer Center ### 1530252###Abstract Presenter###Resident/Research Fellow###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Lily V. Saadat, MD – Memorial Sloan Kettering Cancer Center
### @@@ Lily V. Saadat, MD – Memorial Sloan Kettering Cancer Center ### 1530252###First Author###Resident/Research Fellow###Memorial Sloan Kettering Cancer Center###
First Author: Lily V. Saadat, MD – Memorial Sloan Kettering Cancer Center
### @@@ Joanne Chou, MPH – Department of Biostatistics, Memorial Sloan Kettering Cancer Center ### 1850548###Author###Senior Biostatistician###Department of Biostatistics, Memorial Sloan Kettering Cancer Center###
Author: Joanne Chou, MPH – Department of Biostatistics, Memorial Sloan Kettering Cancer Center
### @@@ Mithat Gonen, PhD – Department of Biostatistics, Memorial Sloan Kettering Cancer Center ### 1849709###Author###Chief of the Biostatistics Service###Department of Biostatistics, Memorial Sloan Kettering Cancer Center###
Author: Mithat Gonen, PhD – Department of Biostatistics, Memorial Sloan Kettering Cancer Center
### @@@ Rachel M. Lee, MD, MSPH – Emory University ### 915774###Author###General Surgery Resident###Emory University###
Author: Rachel M. Lee, MD, MSPH – Emory University
### @@@ Shishir K. Maithel, MD – Emory ### 917909###Author###Professor of Surgery###Emory###
Author: Shishir K. Maithel, MD – Emory
### @@@ Amy Y. Li, MD (she/her/hers) – Stanford University School of Medicine ### 1850603###Author###Resident###Stanford University School of Medicine###
Author: Amy Y. Li, MD (she/her/hers) – Stanford University School of Medicine
### she/her/hers @@@ George Poultsides, MD (he/him/his) – Stanford University ### 1214754###Author###Chief, Section of Surgical Oncology; Professor of Surgery###Stanford University###
Author: George Poultsides, MD (he/him/his) – Stanford University
### he/him/his @@@ Taylor J. Aiken, MD – University of Wisconsin Hospitals and Clinics ### 970112###Author###General Surgery Resident###University of Wisconsin Hospitals and Clinics###
Author: Taylor J. Aiken, MD – University of Wisconsin Hospitals and Clinics
### @@@ Patrick B. Schwartz, MD – University of Wisconsin School of Medicine and Public Health ### 915793###Author###General Surgery Resident and Postdoctoral Research Fellow###University of Wisconsin School of Medicine and Public Health###
Author: Patrick B. Schwartz, MD – University of Wisconsin School of Medicine and Public Health
### @@@ Daniel E. Abbott, MD – Division of Surgical Oncology, Department of Surgery, University of Wisconsin–Madison ### 1850376###Author###Professor###Division of Surgical Oncology, Department of Surgery, University of Wisconsin–Madison###
Author: Daniel E. Abbott, MD – Division of Surgical Oncology, Department of Surgery, University of Wisconsin–Madison
### @@@ Keenan J. Robbins, MBBS MPHS – Washington University School of Medicine ### 1850722###Author###Research Fellow###Washington University School of Medicine###
Author: Keenan J. Robbins, MBBS MPHS – Washington University School of Medicine
### @@@ Ryan C. Fields, MD – Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine ### 937339###Author###Chief, Surgical Oncology; Professor of Surgery###Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine###
Author: Ryan C. Fields, MD – Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine
### @@@ Ashwini Paranjpe, MD – University of Miami ### 1850723###Author###Resident###University of Miami###
Author: Ashwini Paranjpe, MD – University of Miami
### @@@ Jashodeep Datta, MD – University of Miami ### 1849948###Author###Assistant Professor###University of Miami###
Author: Jashodeep Datta, MD – University of Miami
### @@@ William R. Jarnagin, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850359###Author###Chief, Hepatobiliary Service; Leslie Blumgart Chair in Surgery###Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: William R. Jarnagin, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
### @@@ Andrea Cercek, MD – Memorial Sloan Kettering Cancer Center ### 1850438###Author###Associate Attending###Memorial Sloan Kettering Cancer Center###
Author: Andrea Cercek, MD – Memorial Sloan Kettering Cancer Center
### @@@ Nancy E. Kemeny, MD – Memorial Sloan Kettering Cancer Center ### 1850439###Author###Attending###Memorial Sloan Kettering Cancer Center###
Author: Nancy E. Kemeny, MD – Memorial Sloan Kettering Cancer Center
### @@@ Daniel Sze, MD, PhD – Stanford University ### 1850724###Author###Professor of Interventional Radiology###Stanford University###
Author: Daniel Sze, MD, PhD – Stanford University
### @@@ Constantinos Sofocleous, MD PhD – Memorial Sloan Kettering Cancer Center ### 1850725###Author###Attending Physician, Interventional Oncology###Memorial Sloan Kettering Cancer Center###
Author: Constantinos Sofocleous, MD PhD – Memorial Sloan Kettering Cancer Center
### @@@ Michael I. D’Angelica, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850355###Author###Enid A. Haupt Chair in Surgery###Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: Michael I. D’Angelica, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
###
38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy

Luis I. Ruffolo, MD – University of Rochester Medical Center ### 969999###Abstract Presenter###Surgical Resident###University of Rochester Medical Center###
Abstract Presenter: Luis I. Ruffolo, MD – University of Rochester Medical Center
### @@@ Luis I. Ruffolo, MD – University of Rochester Medical Center ### 969999###First Author###Surgical Resident###University of Rochester Medical Center###
First Author: Luis I. Ruffolo, MD – University of Rochester Medical Center
### @@@ Katherine Jackson, MD – St. John's Cancer Institute ### 1850591###Author###Surgical Oncology Fellow###St. John's Cancer Institute###
Author: Katherine Jackson, MD – St. John's Cancer Institute
### @@@ Nicholas A. Ullman, MD, MSCI – University of Rochester Medical Center ### 970003###Author###R4 General Surgery Resident###University of Rochester Medical Center###
Author: Nicholas A. Ullman, MD, MSCI – University of Rochester Medical Center
### @@@ Paul R. Burchard, MD – University of Rochester Medical Center ### 1184658###Author###General Surgery Resident###University of Rochester Medical Center###
Author: Paul R. Burchard, MD – University of Rochester Medical Center
### @@@ Mary Georger, MS – University of Rochester Medical Center ### 1849893###Author###Tumor Immunology Lab###University of Rochester Medical Center###
Author: Mary Georger, MS – University of Rochester Medical Center
### @@@ Rachel Jewell, B.S. – University of Rochester Medical Center ### 1849904###Author###Lab Manager###University of Rochester Medical Center###
Author: Rachel Jewell, B.S. – University of Rochester Medical Center
### @@@ Brian Belt, JD – University of Rochester Medical Center ### 1849892###Author###Tumor Immunology Lab###University of Rochester Medical Center###
Author: Brian Belt, JD – University of Rochester Medical Center
### @@@ Ryan C. Fields, MD – Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine ### 937339###Author###Chief, Surgical Oncology; Professor of Surgery###Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine###
Author: Ryan C. Fields, MD – Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine
### @@@ Jacqueline Mudd, B.Sc. – Washington University in St. Louis ### 1850368###Author###Staff Scientist###Washington University in St. Louis###
Author: Jacqueline Mudd, B.Sc. – Washington University in St. Louis
### @@@ Luke Schoeniger, MD, PhD – University of Rochester Medical Center ### 1850693###Author###Professory of Surgery###University of Rochester Medical Center###
Author: Luke Schoeniger, MD, PhD – University of Rochester Medical Center
### @@@ Roberto Hernandez-Alejandro, MD – University of Rochester Medical Center ### 1850699###Author###Professory of Surgery###University of Rochester Medical Center###
Author: Roberto Hernandez-Alejandro, MD – University of Rochester Medical Center
### @@@ Elaine Gersz, BA – Vaccinex, Inc. ### 1850701###Author###Technician###Vaccinex, Inc.###
Author: Elaine Gersz, BA – Vaccinex, Inc.
### @@@ Crystal Mallow, n/a – Vaccinex, Inc. ### 1850606###Author###Investigator###Vaccinex, Inc.###
Author: Crystal Mallow, n/a – Vaccinex, Inc.
### @@@ Elizabeth Evans, PhD – Vaccinex, Inc. ### 1850611###Author###Investigator###Vaccinex, Inc.###
Author: Elizabeth Evans, PhD – Vaccinex, Inc.
### @@@ Terry Fisher, PhD – Vaccinex, Inc ### 1850612###Author###Investigator###Vaccinex, Inc###
Author: Terry Fisher, PhD – Vaccinex, Inc
### @@@ Maurice Zauderer, PhD – Vaccinex, Inc. ### 1850702###Author###CEO###Vaccinex, Inc.###
Author: Maurice Zauderer, PhD – Vaccinex, Inc.
### @@@ David Linehan, MD – University of Rochester Medical Center ### 937335###Author###Professor and Chair ###University of Rochester Medical Center###
Author: David Linehan, MD – University of Rochester Medical Center
###
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence

Deshka Foster, MD, PhD – Stanford University ### 1850681###Abstract Presenter###Resident###Stanford University###
Abstract Presenter: Deshka Foster, MD, PhD – Stanford University
### @@@ Deshka Foster, MD, PhD – Stanford University ### 1850681###First Author###Resident###Stanford University###
First Author: Deshka Foster, MD, PhD – Stanford University
### @@@ Daniel Delitto, Assistant Professor – Stanford University ### 1850682###Author###Surgeon###Stanford University###
Author: Daniel Delitto, Assistant Professor – Stanford University
### @@@ Michael Januszyk, MD, PhD – Stanford University ### 1850736###Author###Post-doctoral research fellow###Stanford University###
Author: Michael Januszyk, MD, PhD – Stanford University
### @@@ Kathryn Yost, PhD – Stanford University ### 1850737###Author###Post-doctoral research fellow###Stanford University###
Author: Kathryn Yost, PhD – Stanford University
### @@@ Michelle Griffin, MD PhD – Stanford University ### 1850678###Author###Post-doctoral fellow###Stanford University###
Author: Michelle Griffin, MD PhD – Stanford University
### @@@ Jason Guo, PhD – Stanford University ### 1850738###Author###Post-doctoral research fellow###Stanford University###
Author: Jason Guo, PhD – Stanford University
### @@@ Nicholas Guardino, n/a – Stanford University ### 1850680###Author###undergraduate student###Stanford University###
Author: Nicholas Guardino, n/a – Stanford University
### @@@ Andrea Delitto, PhD – Stanford University ### 1850683###Author###Technician###Stanford University###
Author: Andrea Delitto, PhD – Stanford University
### @@@ Malini Chinta, MD – Stanford University ### 1850739###Author###Medical student researcher###Stanford University###
Author: Malini Chinta, MD – Stanford University
### @@@ Austin Burcham, BS – Stanford University ### 1850740###Author###Undergraduate researcher###Stanford University###
Author: Austin Burcham, BS – Stanford University
### @@@ Alan Nguyen, BS – Stanford University ### 1850741###Author###Undergraduate researcher###Stanford University###
Author: Alan Nguyen, BS – Stanford University
### @@@ Khristian Bauer-Rowe, BS – Stanford University ### 1850742###Author###MD/PhD Student Researcher###Stanford University###
Author: Khristian Bauer-Rowe, BS – Stanford University
### @@@ Hunter Lindsay, n/a – BYU ### 1850679###Author###Undergraduate student###BYU###
Author: Hunter Lindsay, n/a – BYU
### @@@ Charlotte Berry, BS – Stanford University ### 1850743###Author###Medical student researcher###Stanford University###
Author: Charlotte Berry, BS – Stanford University
### @@@ Alexia Kim, BS – Stanford University ### 1850744###Author###Life Sciences Research Professional###Stanford University###
Author: Alexia Kim, BS – Stanford University
### @@@ Fatemeh Nosrati, BS – Stanford University ### 1850745###Author###Life Sciences Research Professional###Stanford University###
Author: Fatemeh Nosrati, BS – Stanford University
### @@@ Irene Wapnir, MD – Standford University School of Medicine ### 969525###Author###Professor of Surgery###Standford University School of Medicine###
Author: Irene Wapnir, MD – Standford University School of Medicine
### @@@ Howard Chang, MD, PhD – Stanford University ### 1850746###Author###Professor###Stanford University###
Author: Howard Chang, MD, PhD – Stanford University
### @@@ Jeffrey A. Norton, N/A, n/a – Stanford Unoversity ### 1850677###Author###Professor of Surgery###Stanford Unoversity###
Author: Jeffrey A. Norton, N/A, n/a – Stanford Unoversity
### @@@ Michael Longaker, MD PhD – Stanford University ### 1850684###Author###Professor of Surgery###Stanford University###
Author: Michael Longaker, MD PhD – Stanford University
###
4: Germline Genetic Mutations in a Prospective Multi-Center Cohort of 241 Phyllodes Tumors; Time to Expand Testing Criteria

Laura H. Rosenberger, MD, MS (she/her/hers) – Duke University Medical Center ### 970199###Abstract Presenter###Associate Professor of Surgery ###Duke University Medical Center###
Abstract Presenter: Laura H. Rosenberger, MD, MS (she/her/hers) – Duke University Medical Center
### she/her/hers @@@ Laura H. Rosenberger, MD, MS (she/her/hers) – Duke University Medical Center ### 970199###Author###Associate Professor of Surgery ###Duke University Medical Center###
Author: Laura H. Rosenberger, MD, MS (she/her/hers) – Duke University Medical Center
### she/her/hers @@@ Samantha M. Thomas, MS – Biostatistics and Bioinformatics, Duke University ### 1849711###Author###Biostatistician###Biostatistics and Bioinformatics, Duke University###
Author: Samantha M. Thomas, MS – Biostatistics and Bioinformatics, Duke University
### @@@ Tina J. Hieken, MD – Mayo Clinic ### 937357###Author###Professor of Surgery###Mayo Clinic###
Author: Tina J. Hieken, MD – Mayo Clinic
### @@@ Kristalyn K. Gallagher, DO (she/her/hers) – University of North Carolina at Chapel Hill ### 1144296###Author###Associate Professor of Surgery###University of North Carolina at Chapel Hill###
Author: Kristalyn K. Gallagher, DO (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ Heather B. Neuman, MD, MS – University of Wisconsin School of Medicine and Public Health ### 952870###Author###Associate Professor###University of Wisconsin School of Medicine and Public Health###
Author: Heather B. Neuman, MD, MS – University of Wisconsin School of Medicine and Public Health
### @@@ Anna Weiss, MD – Brigham and Women's Hospital ### 1184640###Author###Associate Surgeon###Brigham and Women's Hospital###
Author: Anna Weiss, MD – Brigham and Women's Hospital
### @@@ Tari A. King, MD, FSSO, FASCO (she/her/hers) – Brigham and Womens Hospital, Dana Farber/Brigham Cancer Center ### 1791617###Author###Chief, Division of Breast Surgery###Brigham and Womens Hospital, Dana Farber/Brigham Cancer Center###
Author: Tari A. King, MD, FSSO, FASCO (she/her/hers) – Brigham and Womens Hospital, Dana Farber/Brigham Cancer Center
### she/her/hers @@@ Jasmine Wong, MD – Department of Surgery, University of California, San Francisco ### 1850362###Author###Associate Professor###Department of Surgery, University of California, San Francisco###
Author: Jasmine Wong, MD – Department of Surgery, University of California, San Francisco
### @@@ Barry S. Tong, MS, MPH – University of California, San Francisco ### 1850363###Author###Genetic Counselor###University of California, San Francisco###
Author: Barry S. Tong, MS, MPH – University of California, San Francisco
### @@@ Amanda L. Nash, MD – Duke University School of Medicine ### 1530329###Author###Resident###Duke University School of Medicine###
Author: Amanda L. Nash, MD – Duke University School of Medicine
### @@@ Carolyn S. Menendez, MD – Department of Surgery, Duke University ### 1849712###Author###Assistant Professor###Department of Surgery, Duke University###
Author: Carolyn S. Menendez, MD – Department of Surgery, Duke University
### @@@ Shelley Hwang, MD MPH – Duke University ### 937373###Author###Vice Chair of Research, Chief of Breast Surgical Oncology###Duke University###
Author: Shelley Hwang, MD MPH – Duke University
### @@@ James W. Jakub, MD – Mayo Clinic ### 937495###Author###Division of Breast and Melanoma Surgical Oncology; Professor of Surgery###Mayo Clinic###
Author: James W. Jakub, MD – Mayo Clinic
### @@@ Jennifer K. Plichta, MD, MS – Duke University Medical Center ### 1184674###Author###Associate Professor of Surgery###Duke University Medical Center###
Author: Jennifer K. Plichta, MD, MS – Duke University Medical Center
###
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma

Tahsin M. Khan, MD – National Cancer Institute ### 1850976###Abstract Presenter###Surgical Oncology Research Fellow###National Cancer Institute###
Abstract Presenter: Tahsin M. Khan, MD – National Cancer Institute
### @@@ Tahsin M. Khan, MD – National Cancer Institute ### 1850976###First Author###Surgical Oncology Research Fellow###National Cancer Institute###
First Author: Tahsin M. Khan, MD – National Cancer Institute
### @@@ Reed I. Ayabe, MD – MD Anderson Cancer Center ### 1850916###Author###Complex General Surgical Oncology Fellow###MD Anderson Cancer Center###
Author: Reed I. Ayabe, MD – MD Anderson Cancer Center
### @@@ Pedro Torres-Ayuso, PhD – National Cancer Institute ### 1850977###Author###Post-doctoral Fellow###National Cancer Institute###
Author: Pedro Torres-Ayuso, PhD – National Cancer Institute
### @@@ Christina Robinson, BS – Laboratory Animal Sciences Program, National Cancer Institute ### 1850978###Author###Scientist###Laboratory Animal Sciences Program, National Cancer Institute###
Author: Christina Robinson, BS – Laboratory Animal Sciences Program, National Cancer Institute
### @@@ Amber Leila Sarvestani, MD – Surgical Oncology Program, Center for Cancer Research, National Cancer Institute ### 1534946###Author###Surgical Oncology Clinical Research Fellow###Surgical Oncology Program, Center for Cancer Research, National Cancer Institute###
Author: Amber Leila Sarvestani, MD – Surgical Oncology Program, Center for Cancer Research, National Cancer Institute
### @@@ Stephanie Lux, BS – National Institutes of Health, National Cancer Institute ### 1850854###Author###Post-Baccalaureate###National Institutes of Health, National Cancer Institute###
Author: Stephanie Lux, BS – National Institutes of Health, National Cancer Institute
### @@@ Emily Verbus, MD – National Cancer Institute ### 1850979###Author###Surgical Oncology Research Fellow###National Cancer Institute###
Author: Emily Verbus, MD – National Cancer Institute
### @@@ Alexander Rossi, MD – National Cancer Institute ### 1850980###Author###Surgical Oncology Research Fellow###National Cancer Institute###
Author: Alexander Rossi, MD – National Cancer Institute
### @@@ Shahyan Rehman, MD – National Cancer Institute ### 1850981###Author###MSRP Research Fellow###National Cancer Institute###
Author: Shahyan Rehman, MD – National Cancer Institute
### @@@ Cathleen Hannah, RN – National Institutes of Health, National Cancer Institute ### 1850919###Author###Research Nurse###National Institutes of Health, National Cancer Institute###
Author: Cathleen Hannah, RN – National Institutes of Health, National Cancer Institute
### @@@ Kathleen Smith, RN – National Cancer Institute ### 1850982###Author###Research Nurse###National Cancer Institute###
Author: Kathleen Smith, RN – National Cancer Institute
### @@@ Surajit Sinha, PhD – National Cancer Institute ### 1850957###Author###Post-doctoral fellow###National Cancer Institute###
Author: Surajit Sinha, PhD – National Cancer Institute
### @@@ Kirsten Remmert, PhD – National Cancer Institute | National Institutes of Health ### 1849931###Author###Staff Scientist###National Cancer Institute | National Institutes of Health###
Author: Kirsten Remmert, PhD – National Cancer Institute | National Institutes of Health
### @@@ Simone Difilippantonio, PhD – Laboratory Animal Sciences Program, National Cancer Institute ### 1850983###Author###Principal Scientist###Laboratory Animal Sciences Program, National Cancer Institute###
Author: Simone Difilippantonio, PhD – Laboratory Animal Sciences Program, National Cancer Institute
### @@@ Andrew M. Blakely, MD – Surgical Oncology Program, National Institutes of Health ### 1849920###Author###Program Director###Surgical Oncology Program, National Institutes of Health###
Author: Andrew M. Blakely, MD – Surgical Oncology Program, National Institutes of Health
### @@@ Jeremy L. Davis, MD – National Cancer Institute ### 969549###Author###Surgical Oncology###National Cancer Institute###
Author: Jeremy L. Davis, MD – National Cancer Institute
### @@@ Craig Thomas, PhD – National Center for Advancing Translational Sciences ### 1850984###Author###Leader, Division of Preclinical Innovation###National Center for Advancing Translational Sciences###
Author: Craig Thomas, PhD – National Center for Advancing Translational Sciences
### @@@ Michael B. Yaffe, MD, PhD – National Cancer Institute ### 1850986###Author###Director, Surgical Oncology Program###National Cancer Institute###
Author: Michael B. Yaffe, MD, PhD – National Cancer Institute
### @@@ John Brognard, PhD – National Cancer Institute ### 1850987###Author###Senior Investigator###National Cancer Institute###
Author: John Brognard, PhD – National Cancer Institute
### @@@ Jonathan M. Hernandez, MD – National Institutes of Health ### 972423###Author###Principal Investigator ###National Institutes of Health###
Author: Jonathan M. Hernandez, MD – National Institutes of Health
###
41: Defining the immune microenvironment surrounding pancreatic cancer using single cell RNA sequencing

Timothy L. Frankel, MD – University of Michigan ### 1850831###Abstract Presenter###Maude T. Lane Professor of Surgical Oncology###University of Michigan###
Abstract Presenter: Timothy L. Frankel, MD – University of Michigan
### @@@ Timothy L. Frankel, MD – University of Michigan ### 1850831###First Author###Maude T. Lane Professor of Surgical Oncology###University of Michigan###
First Author: Timothy L. Frankel, MD – University of Michigan
### @@@ Eileen Carpenter, MD, PhD – University of Michigan ### 1850832###Author###Assistant Professor###University of Michigan###
Author: Eileen Carpenter, MD, PhD – University of Michigan
### @@@ Padma Kadiyala, BS – University of Michigan ### 1850833###Author###Graduate Student###University of Michigan###
Author: Padma Kadiyala, BS – University of Michigan
### @@@ Ahmed Elhossiny, BPharm, MS – University of Michigan ### 1850834###Author###Graduate Student###University of Michigan###
Author: Ahmed Elhossiny, BPharm, MS – University of Michigan
### @@@ Jake McGue, BS – University of Michigan ### 1850835###Author###Research Technician###University of Michigan###
Author: Jake McGue, BS – University of Michigan
### @@@ Yaqing Zhang, PhD – University of Michigan ### 1850837###Author###Research Assistant Professor###University of Michigan###
Author: Yaqing Zhang, PhD – University of Michigan
### @@@ Brian D. Griffith, MD – University of Michigan ### 1850838###Author###General Surgery Resident###University of Michigan###
Author: Brian D. Griffith, MD – University of Michigan
### @@@ Jacob Edwards, BS – University of Michigan ### 1850839###Author###Research Technician###University of Michigan###
Author: Jacob Edwards, BS – University of Michigan
### @@@ Marina Pasca Di Magliano, PhD – University of MIchigan ### 1850836###Author###Professor of Surgery###University of MIchigan###
Author: Marina Pasca Di Magliano, PhD – University of MIchigan
###
42: Machine-learning based investigation of prognostic indicators for oncological outcome of pancreatic ductal adenocarcinoma

Jeremy Chang, MD MS – University of Iowa Hospitals and Clinics ### 1850542###Abstract Presenter###Resident###University of Iowa Hospitals and Clinics###
Abstract Presenter: Jeremy Chang, MD MS – University of Iowa Hospitals and Clinics
### @@@ Jeremy Chang, MD MS – University of Iowa Hospitals and Clinics ### 1850542###First Author###Resident###University of Iowa Hospitals and Clinics###
First Author: Jeremy Chang, MD MS – University of Iowa Hospitals and Clinics
### @@@ Yanan Liu, PhD – University of Iowa Hospitals and Clinics - 200 Hawkins DriveC52-P General HospitalIowa City, IA 52242UNITED STATES - Iowa City, IA ### 1850543###Author###Post Doc###University of Iowa Hospitals and Clinics - 200 Hawkins DriveC52-P General HospitalIowa City, IA 52242UNITED STATES - Iowa City, IA###
Author: Yanan Liu, PhD – University of Iowa Hospitals and Clinics - 200 Hawkins DriveC52-P General HospitalIowa City, IA 52242UNITED STATES - Iowa City, IA
### @@@ Stephanie Saey, n/a – University of Iowa Hospitals ### 1850544###Author###Medical Student###University of Iowa Hospitals###
Author: Stephanie Saey, n/a – University of Iowa Hospitals
### @@@ Kevin Chang, n/a – University of Iowa Hospitals and Clinics ### 1850545###Author###Medical Student###University of Iowa Hospitals and Clinics###
Author: Kevin Chang, n/a – University of Iowa Hospitals and Clinics
### @@@ Hannah Shrader, n/a – University of Iowa Hospitals and Clinics ### 1850546###Author###Research Assistant###University of Iowa Hospitals and Clinics###
Author: Hannah Shrader, n/a – University of Iowa Hospitals and Clinics
### @@@ Kelsey Steckly, n/a – University of Iowa Hospitals and Clinics ### 1850547###Author###Research Assistant###University of Iowa Hospitals and Clinics###
Author: Kelsey Steckly, n/a – University of Iowa Hospitals and Clinics
### @@@ Maheen Rajput, MD – University of Iowa Hospitals and Clinics ### 1850726###Author###Clinical Professor###University of Iowa Hospitals and Clinics###
Author: Maheen Rajput, MD – University of Iowa Hospitals and Clinics
### @@@ Milan Sonka, PhD – University of Iowa College of Engineering ### 1850727###Author###Professor###University of Iowa College of Engineering###
Author: Milan Sonka, PhD – University of Iowa College of Engineering
### @@@ Carlos HF Chan, MD, PhD – University of Iowa Hospitals and Clinics ### 915756###Author###Associate Professor of Surgery###University of Iowa Hospitals and Clinics###
Author: Carlos HF Chan, MD, PhD – University of Iowa Hospitals and Clinics
###
43: Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?

Roberto J. Vidri, MD, MPH (he/him/his) – University of Wisconsin School of Medicine and Public Health ### 1534942###Abstract Presenter###Fellow###University of Wisconsin School of Medicine and Public Health###
Abstract Presenter: Roberto J. Vidri, MD, MPH (he/him/his) – University of Wisconsin School of Medicine and Public Health
### he/him/his @@@ Roberto J. Vidri, MD, MPH (he/him/his) – University of Wisconsin School of Medicine and Public Health ### 1534942###First Author###Fellow###University of Wisconsin School of Medicine and Public Health###
First Author: Roberto J. Vidri, MD, MPH (he/him/his) – University of Wisconsin School of Medicine and Public Health
### he/him/his @@@ Patrick R. Varley, MD, MS – Division of Surgical Oncology, Department of Surgery, University of Wisconsin–Madison ### 1850728###Author###Assistant Professor###Division of Surgical Oncology, Department of Surgery, University of Wisconsin–Madison###
Author: Patrick R. Varley, MD, MS – Division of Surgical Oncology, Department of Surgery, University of Wisconsin–Madison
### @@@ Sean M. Ronnekleiv-Kelly, MD – University of Wisconsin School of Medicine and Public Health ### 1850894###Author###Assistant Professor###University of Wisconsin School of Medicine and Public Health###
Author: Sean M. Ronnekleiv-Kelly, MD – University of Wisconsin School of Medicine and Public Health
### @@@ Kelly J. Kaitlyn, MD – Department of Surgery, University of Wisconsin ### 1850457###Author###Associate Professor###Department of Surgery, University of Wisconsin###
Author: Kelly J. Kaitlyn, MD – Department of Surgery, University of Wisconsin
### @@@ Gregory C. Wilson, MD – University of Cincinnati College of Medicine, Department of Surgery ### 1850377###Author###Assistant Professor###University of Cincinnati College of Medicine, Department of Surgery###
Author: Gregory C. Wilson, MD – University of Cincinnati College of Medicine, Department of Surgery
### @@@ Syed Ahmad ### 1803898###Author#########
Author: Syed Ahmad
### @@@ Rebecca A. Snyder, MD, MPH (she/her/hers) – UT MD Anderson Cancer Center ### 970272###Author###Associate Professor of Surgery###UT MD Anderson Cancer Center###
Author: Rebecca A. Snyder, MD, MPH (she/her/hers) – UT MD Anderson Cancer Center
### she/her/hers @@@ Alexander A. Parikh, MD, MPH, FACS, FSSO (he/him/his) – UT Health San Antonio MD Anderson ### 1530031###Author###Professor of Surgery###UT Health San Antonio MD Anderson###
Author: Alexander A. Parikh, MD, MPH, FACS, FSSO (he/him/his) – UT Health San Antonio MD Anderson
### he/him/his @@@ Chet Hammill, MD, MCR – Washington University School of Medicine ### 894404###Author######Washington University School of Medicine###
Author: Chet Hammill, MD, MCR – Washington University School of Medicine
### @@@ Hong Jin Kim, MD – University of North Carolina at Chapel Hill ### 1214733###Author###Professor and Chief, Division of Surgical Oncology and Endocrine Surgery###University of North Carolina at Chapel Hill###
Author: Hong Jin Kim, MD – University of North Carolina at Chapel Hill
### @@@ Michael T. LeCompte, MD – University of North Carolina School of Medicine ### 1850896###Author###Assistant Professor###University of North Carolina School of Medicine###
Author: Michael T. LeCompte, MD – University of North Carolina School of Medicine
### @@@ David A. Kooby, MD – Emory University School of Medicine, Division of Surgical Oncology, Winship Cancer Institute ### 1850673###Author###Professor of Surgey###Emory University School of Medicine, Division of Surgical Oncology, Winship Cancer Institute###
Author: David A. Kooby, MD – Emory University School of Medicine, Division of Surgical Oncology, Winship Cancer Institute
### @@@ Mihir M. Shah, MD (he/him/his) – Emory University Winship Cancer Institute ### 1850674###Author###Assistant Professor of Surgery###Emory University Winship Cancer Institute###
Author: Mihir M. Shah, MD (he/him/his) – Emory University Winship Cancer Institute
### he/him/his @@@ Shishir K. Maithel, MD – Emory ### 917909###Author###Professor of Surgery###Emory###
Author: Shishir K. Maithel, MD – Emory
### @@@ Nipun B. Merchant, MD – University of Miami Miller School of Medicine ### 1849851###Author###Professor of Surgery###University of Miami Miller School of Medicine###
Author: Nipun B. Merchant, MD – University of Miami Miller School of Medicine
### @@@ Jashodeep Datta, MD – University of Miami ### 1849948###Author###Assistant Professor###University of Miami###
Author: Jashodeep Datta, MD – University of Miami
### @@@ Syed Nabeel Zafar, MD, MPH – University of Wisconsin-Madison ### 969955###Author###Assistant Professor of Surgery###University of Wisconsin-Madison###
Author: Syed Nabeel Zafar, MD, MPH – University of Wisconsin-Madison
### @@@ Sharon Weber, MD (she/her/hers) – UW Health/UW Madison ### 1213570###Author###Professor of Surgery###UW Health/UW Madison###
Author: Sharon Weber, MD (she/her/hers) – UW Health/UW Madison
### she/her/hers @@@ Daniel E. Abbott, MD – Division of Surgical Oncology, Department of Surgery, University of Wisconsin–Madison ### 1850376###Author###Professor###Division of Surgical Oncology, Department of Surgery, University of Wisconsin–Madison###
Author: Daniel E. Abbott, MD – Division of Surgical Oncology, Department of Surgery, University of Wisconsin–Madison
###
44: Pten deletion-induced murine model of cholangiocarcinoma: a pathologic and immune analysis

Yatee A. Dave, MD (she/her/hers) – University of Rochester Medical Center ### 1849903###Abstract Presenter###Resident Physician###University of Rochester Medical Center###
Abstract Presenter: Yatee A. Dave, MD (she/her/hers) – University of Rochester Medical Center
### she/her/hers @@@ Yatee A. Dave, MD (she/her/hers) – University of Rochester Medical Center ### 1849903###First Author###Resident Physician###University of Rochester Medical Center###
First Author: Yatee A. Dave, MD (she/her/hers) – University of Rochester Medical Center
### she/her/hers @@@ Paul R. Burchard, MD – University of Rochester Medical Center ### 1184658###Author###General Surgery Resident###University of Rochester Medical Center###
Author: Paul R. Burchard, MD – University of Rochester Medical Center
### @@@ Chelsea Marin, MD – University of Rochester Medical Center ### 1850710###Author###Resident Physician###University of Rochester Medical Center###
Author: Chelsea Marin, MD – University of Rochester Medical Center
### @@@ Mary Georger, MS – University of Rochester Medical Center ### 1849893###Author###Tumor Immunology Lab###University of Rochester Medical Center###
Author: Mary Georger, MS – University of Rochester Medical Center
### @@@ Rachel Jewell, B.S. – University of Rochester Medical Center ### 1849904###Author###Lab Manager###University of Rochester Medical Center###
Author: Rachel Jewell, B.S. – University of Rochester Medical Center
### @@@ Brian Belt, JD – University of Rochester Medical Center ### 1849892###Author###Tumor Immunology Lab###University of Rochester Medical Center###
Author: Brian Belt, JD – University of Rochester Medical Center
### @@@ David Linehan, MD – University of Rochester Medical Center ### 937335###Author###Professor and Chair ###University of Rochester Medical Center###
Author: David Linehan, MD – University of Rochester Medical Center
###
45: Differential Immune Signatures are Associated with Racial Disparities in Pancreatic Cancer

Zachary Gao, MD – Baylor College of Medicine ### 1850521###Abstract Presenter###Research Resident###Baylor College of Medicine###
Abstract Presenter: Zachary Gao, MD – Baylor College of Medicine
### @@@ Zachary Gao, MD – Baylor College of Medicine ### 1850521###First Author###Research Resident###Baylor College of Medicine###
First Author: Zachary Gao, MD – Baylor College of Medicine
### @@@ Zequn Sun, PhD – Northwestern University ### 1850523###Author###Biostatistician###Northwestern University###
Author: Zequn Sun, PhD – Northwestern University
### @@@ Derek Erstad, MD – Baylor College of Medicine ### 1850646###Author###Physician###Baylor College of Medicine###
Author: Derek Erstad, MD – Baylor College of Medicine
### @@@ Dongjun Chung, PhD – Ohio State University ### 1850524###Author###Biostatistician###Ohio State University###
Author: Dongjun Chung, PhD – Ohio State University
### @@@ William Fisher, MD – Baylor College of Medicine ### 1850647###Author###Physician###Baylor College of Medicine###
Author: William Fisher, MD – Baylor College of Medicine
### @@@ George Van Buren, MD – Baylor College of Medicine ### 1850526###Author###Physician###Baylor College of Medicine###
Author: George Van Buren, MD – Baylor College of Medicine
### @@@ David Lewin, MD – Medical University of South Carolina ### 1850527###Author###Physician###Medical University of South Carolina###
Author: David Lewin, MD – Medical University of South Carolina
### @@@ E. Ramsay Camp, MD, MSCR – Baylor College of Medicine ### 1499821###Author###Chief, Division of Surgical Oncology Olga Keith Wiess Chair of Surgery Michael E. DeBakey Department of Surgery ###Baylor College of Medicine###
Author: E. Ramsay Camp, MD, MSCR – Baylor College of Medicine
###
46: Pan-Lysyl Oxidase Inhibition Disrupts Macrophage Invasion and Renders Tumor-Associated Macrophages Susceptible to Cytotoxic Chemotherapy in Cholangiocarcinoma

Paul R. Burchard, MD – University of Rochester Medical Center ### 1184658###Abstract Presenter###General Surgery Resident###University of Rochester Medical Center###
Abstract Presenter: Paul R. Burchard, MD – University of Rochester Medical Center
### @@@ Paul R. Burchard, MD – University of Rochester Medical Center ### 1184658###First Author###General Surgery Resident###University of Rochester Medical Center###
First Author: Paul R. Burchard, MD – University of Rochester Medical Center
### @@@ Yatee A. Dave, MD (she/her/hers) – University of Rochester Medical Center ### 1849903###Author###Resident Physician###University of Rochester Medical Center###
Author: Yatee A. Dave, MD (she/her/hers) – University of Rochester Medical Center
### she/her/hers @@@ Luis I. Ruffolo, MD – University of Rochester Medical Center ### 969999###Author###Surgical Resident###University of Rochester Medical Center###
Author: Luis I. Ruffolo, MD – University of Rochester Medical Center
### @@@ Nicholas A. Ullman, MD, MSCI – University of Rochester Medical Center ### 970003###Author###R4 General Surgery Resident###University of Rochester Medical Center###
Author: Nicholas A. Ullman, MD, MSCI – University of Rochester Medical Center
### @@@ Chelsea Marin, MD – University of Rochester Medical Center ### 1850710###Author###Resident Physician###University of Rochester Medical Center###
Author: Chelsea Marin, MD – University of Rochester Medical Center
### @@@ Rachel Jewell, B.S. – University of Rochester Medical Center ### 1849904###Author###Lab Manager###University of Rochester Medical Center###
Author: Rachel Jewell, B.S. – University of Rochester Medical Center
### @@@ Mary Georger, MS – University of Rochester Medical Center ### 1849893###Author###Tumor Immunology Lab###University of Rochester Medical Center###
Author: Mary Georger, MS – University of Rochester Medical Center
### @@@ Brian Belt, JD – University of Rochester Medical Center ### 1849892###Author###Tumor Immunology Lab###University of Rochester Medical Center###
Author: Brian Belt, JD – University of Rochester Medical Center
### @@@ David Linehan, MD – University of Rochester Medical Center ### 937335###Author###Professor and Chair ###University of Rochester Medical Center###
Author: David Linehan, MD – University of Rochester Medical Center
### @@@ Roberto Hernandez-Alejandro, MD – University of Rochester Medical Center ### 1850699###Author###Professory of Surgery###University of Rochester Medical Center###
Author: Roberto Hernandez-Alejandro, MD – University of Rochester Medical Center
###
47: Surgical Microwave Ablation for Treatment of Hepatocellular Carcinoma: A Single Institution Review from 2006-2022

Ansley B. Ricker, MD (she/her/hers) – Atrium Health Carolinas Medical Center ### 1850920###Abstract Presenter###HPB Surgery Research Resident###Atrium Health Carolinas Medical Center###
Abstract Presenter: Ansley B. Ricker, MD (she/her/hers) – Atrium Health Carolinas Medical Center
### she/her/hers @@@ Ansley B. Ricker, MD (she/her/hers) – Atrium Health Carolinas Medical Center ### 1850920###First Author###HPB Surgery Research Resident###Atrium Health Carolinas Medical Center###
First Author: Ansley B. Ricker, MD (she/her/hers) – Atrium Health Carolinas Medical Center
### she/her/hers @@@ Matthew Strand, MD – Atrium Health Carolinas Medical Center ### 1850928###Author###HPB Surgery Research Fellow###Atrium Health Carolinas Medical Center###
Author: Matthew Strand, MD – Atrium Health Carolinas Medical Center
### @@@ Katheryn Peterson, BSPH – Atrium Health Carolinas Medical Center ### 1850921###Author###HPB Surgery Research Coordinator###Atrium Health Carolinas Medical Center###
Author: Katheryn Peterson, BSPH – Atrium Health Carolinas Medical Center
### @@@ Rohit Mantha, BS – Atrium Health Carolinas Medical Center ### 1850922###Author###HPB Surgery Research Associate###Atrium Health Carolinas Medical Center###
Author: Rohit Mantha, BS – Atrium Health Carolinas Medical Center
### @@@ Hannah Wang, PhD – Atrium Health Carolinas Medical Center ### 1850923###Author###HPB Surgery Senior Data Scientist###Atrium Health Carolinas Medical Center###
Author: Hannah Wang, PhD – Atrium Health Carolinas Medical Center
### @@@ Iain McKillop, PhD – Atrium Health Carolinas Medical Center ### 1850924###Author###HPB Surgery Research Professor & Director of Research###Atrium Health Carolinas Medical Center###
Author: Iain McKillop, PhD – Atrium Health Carolinas Medical Center
### @@@ Michael Beckman, MD – Atrium Health Carolinas Medical Center ### 1850930###Author###HPB Surgeon###Atrium Health Carolinas Medical Center###
Author: Michael Beckman, MD – Atrium Health Carolinas Medical Center
### @@@ Michael Driedger, MD – Atrium Health Carolinas Medical Center ### 1850929###Author###HPB Surgeon###Atrium Health Carolinas Medical Center###
Author: Michael Driedger, MD – Atrium Health Carolinas Medical Center
### @@@ Erin H. Baker, MD – Atrium Health ### 1139215###Author###Assistant Professor of Surgery###Atrium Health###
Author: Erin H. Baker, MD – Atrium Health
### @@@ John Martinie, MD – Atrium Health Carolinas Medical Center ### 1850925###Author###HPB Surgeon###Atrium Health Carolinas Medical Center###
Author: John Martinie, MD – Atrium Health Carolinas Medical Center
### @@@ Dionisios Vrochides, MD – Atrium Health Carolinas Medical Center ### 1850926###Author###HPB Surgeon###Atrium Health Carolinas Medical Center###
Author: Dionisios Vrochides, MD – Atrium Health Carolinas Medical Center
### @@@ David Iannitti, MD – Atrium Health Carolinas Medical Center ### 1850927###Author###HPB Surgeon###Atrium Health Carolinas Medical Center###
Author: David Iannitti, MD – Atrium Health Carolinas Medical Center
###
48: Machine Learning Derived Electronic Tumor Marker Mimics Prognostic Properties of CA19-9

Sam Thalji, MD – Medical College of Wisconsin ### 1184660###Abstract Presenter###Resident###Medical College of Wisconsin###
Abstract Presenter: Sam Thalji, MD – Medical College of Wisconsin
### @@@ Sam Thalji, MD – Medical College of Wisconsin ### 1184660###First Author###Resident###Medical College of Wisconsin###
First Author: Sam Thalji, MD – Medical College of Wisconsin
### @@@ Susan Tsai, MD, MHS – Medical College of Wisconsin ### 937445###Author###Professor###Medical College of Wisconsin###
Author: Susan Tsai, MD, MHS – Medical College of Wisconsin
### @@@ Mohammed Aldakkak, MD – Medical College of Wisconsin ### 1850885###Author###Instructor###Medical College of Wisconsin###
Author: Mohammed Aldakkak, MD – Medical College of Wisconsin
### @@@ Mouloud Belbahri, PhD – University of Montreal ### 1850886###Author###Machine Learning Scientist###University of Montreal###
Author: Mouloud Belbahri, PhD – University of Montreal
### @@@ Callisia Clarke, MD, MS (she/her/hers) – Medical College of Wisconsin ### 1795379###Author###Associate Professor of Surgery###Medical College of Wisconsin ###
Author: Callisia Clarke, MD, MS (she/her/hers) – Medical College of Wisconsin
### she/her/hers @@@ Kathleen K. Christians, MD – Medical College of Wisconsin, Department of Surgery, Division of Surgical Oncology ### 1850875###Author###Professor###Medical College of Wisconsin, Department of Surgery, Division of Surgical Oncology###
Author: Kathleen K. Christians, MD – Medical College of Wisconsin, Department of Surgery, Division of Surgical Oncology
### @@@ Ben George, MD – Medical College of Wisconsin ### 1850887###Author###Associate Professor###Medical College of Wisconsin###
Author: Ben George, MD – Medical College of Wisconsin
### @@@ Mandana Kamgar, MD, MPH – Medical College of Wisconsin ### 1850888###Author###Assistant Professor###Medical College of Wisconsin###
Author: Mandana Kamgar, MD, MPH – Medical College of Wisconsin
### @@@ Beth Erickson, MD – Medical College of Wisconsin ### 1850889###Author###Professor###Medical College of Wisconsin###
Author: Beth Erickson, MD – Medical College of Wisconsin
### @@@ William Hall, MD – Medical College of Wisconsin ### 1850890###Author###Associate Professor###Medical College of Wisconsin###
Author: William Hall, MD – Medical College of Wisconsin
### @@@ Paul Auer, PhD – Medical College of Wisconsin ### 1850891###Author###Professor###Medical College of Wisconsin###
Author: Paul Auer, PhD – Medical College of Wisconsin
### @@@ Bradley Taylor, MBA – Medical College of Wisconsin ### 1850892###Author###Chief Research Informatics Officer###Medical College of Wisconsin###
Author: Bradley Taylor, MBA – Medical College of Wisconsin
### @@@ Douglas Evans, MD – Medical College of Wisconsin ### 1529782###Author###Donald C. Ausman Family Foundation Professor of Surgery and Chair, Department of Surgery###Medical College of Wisconsin###
Author: Douglas Evans, MD – Medical College of Wisconsin
### @@@ Anai N. Kothari, MD, MS – Medical College of Wisconsin, Department of Surgery, Division of Surgical Oncology ### 1850481###Author###Assistant Professor###Medical College of Wisconsin, Department of Surgery, Division of Surgical Oncology###
Author: Anai N. Kothari, MD, MS – Medical College of Wisconsin, Department of Surgery, Division of Surgical Oncology
###
49: Stroma Selective Inhibition of TGFβ – Genomic Stratification As The Key to Overcoming Failed Clinical Translation in Pancreatic Cancer

Gilbert Z. Murimwa, MD – UT Southwestern ### 1186076###Abstract Presenter###Surgical Resident###UT Southwestern###
Abstract Presenter: Gilbert Z. Murimwa, MD – UT Southwestern
### @@@ Gilbert Z. Murimwa, MD – UT Southwestern ### 1186076###First Author###Surgical Resident###UT Southwestern###
First Author: Gilbert Z. Murimwa, MD – UT Southwestern
### @@@ Huocong Huang, M.D, Ph.D – UT Southwestern Medical Center, Dept of Surgery ### 1850622###Author###Assistant Professor###UT Southwestern Medical Center, Dept of Surgery###
Author: Huocong Huang, M.D, Ph.D – UT Southwestern Medical Center, Dept of Surgery
### @@@ Dina Alzhanova, Ph.D – UT Southwestern Medical Center, Dept of Surgery ### 1850958###Author###Senior Staff Scientist###UT Southwestern Medical Center, Dept of Surgery###
Author: Dina Alzhanova, Ph.D – UT Southwestern Medical Center, Dept of Surgery
### @@@ Rolf Brekken, Ph.D – UT Southwestern Medical Center, Dept of Surgery ### 1850621###Author###Professor, Deputy Director Hamon Center for Therapeutic Oncology Research###UT Southwestern Medical Center, Dept of Surgery###
Author: Rolf Brekken, Ph.D – UT Southwestern Medical Center, Dept of Surgery
###
5: Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection

Shruti Zaveri, MD MPH (she/her/hers) – MD Anderson Cancer Center ### 1850563###Abstract Presenter###Breast Surgical Oncology Fellow###MD Anderson Cancer Center###
Abstract Presenter: Shruti Zaveri, MD MPH (she/her/hers) – MD Anderson Cancer Center
### she/her/hers @@@ Shruti Zaveri, MD MPH (she/her/hers) – MD Anderson Cancer Center ### 1850563###Author###Breast Surgical Oncology Fellow###MD Anderson Cancer Center###
Author: Shruti Zaveri, MD MPH (she/her/hers) – MD Anderson Cancer Center
### she/her/hers @@@ Elizabeth FitzSullivan, MD – The University of Texas MD Anderson Cancer Center ### 894403###Author######The University of Texas MD Anderson Cancer Center###
Author: Elizabeth FitzSullivan, MD – The University of Texas MD Anderson Cancer Center
### @@@ Rosa Hwang, MD – The University of Texas MD Anderson Cancer Center ### 1527049###Author###Professor and Associate Medical Director for Breast Surgery###The University of Texas MD Anderson Cancer Center###
Author: Rosa Hwang, MD – The University of Texas MD Anderson Cancer Center
### @@@ Benjamin D. Smith, MD – The University of Texas MD Anderson Cancer Center ### 944428###Author###Professor###The University of Texas MD Anderson Cancer Center###
Author: Benjamin D. Smith, MD – The University of Texas MD Anderson Cancer Center
### @@@ Heather Lin, PhD – MD Anderson Cancer Center ### 1850564###Author###Statistician###MD Anderson Cancer Center###
Author: Heather Lin, PhD – MD Anderson Cancer Center
### @@@ Yu Shen, PhD – MD Anderson Cancer Center ### 1850565###Author###Statistician###MD Anderson Cancer Center###
Author: Yu Shen, PhD – MD Anderson Cancer Center
### @@@ Anthony Lucci, Jr., MD – The University of Texas MD Anderson Cancer Center ### 937367###Author###Professor###The University of Texas MD Anderson Cancer Center###
Author: Anthony Lucci, Jr., MD – The University of Texas MD Anderson Cancer Center
### @@@ Mediget Teshome, MD, MPH, FACS (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 894417###Author###Associate Professor###The University of Texas MD Anderson Cancer Center###
Author: Mediget Teshome, MD, MPH, FACS (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers @@@ Susie Sun, MD – MD Anderson Cancer Center ### 1850566###Author###Department of Breast Surgical Oncology###MD Anderson Cancer Center###
Author: Susie Sun, MD – MD Anderson Cancer Center
### @@@ Kelly K. Hunt, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 937327###Author###Chair, Department of Breast Surgical Oncology###The University of Texas MD Anderson Cancer Center###
Author: Kelly K. Hunt, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers @@@ Henry M. Kuerer, MD, PhD – The University of Texas MD Anderson Cancer Center ### 937372###Author###Professor, Breast Surgical Oncology; Executive Director, Breast Programs MD Anderson Cancer Network###The University of Texas MD Anderson Cancer Center###
Author: Henry M. Kuerer, MD, PhD – The University of Texas MD Anderson Cancer Center
###
50: Anti-Netrin-1 Therapy Inhibits Metastasis and Improves Survival in Pancreatic Cancer

Anthony S. Casabianca, MD – University of Rochester ### 970087###Abstract Presenter###General Surgery Resident###University of Rochester###
Abstract Presenter: Anthony S. Casabianca, MD – University of Rochester
### @@@ Crissy Dudgeon, PhD (she/her/hers) – Rutgers University ### 1850966###First Author###Research Scientist###Rutgers University###
First Author: Crissy Dudgeon, PhD (she/her/hers) – Rutgers University
### she/her/hers @@@ Chris Harris, PhD (he/him/his) – University of Rochester ### 1850967###Author###Research Assistant Professor###University of Rochester###
Author: Chris Harris, PhD (he/him/his) – University of Rochester
### he/him/his @@@ Igor Astsaturov, PhD (he/him/his) – Fox Chase Cancer Center ### 1850968###Author###associate professor###Fox Chase Cancer Center###
Author: Igor Astsaturov, PhD (he/him/his) – Fox Chase Cancer Center
### he/him/his @@@ Charline Ogier, PhD – Fox Chase Cancer Institute ### 1850970###Author###Post-Doctoral Research###Fox Chase Cancer Institute###
Author: Charline Ogier, PhD – Fox Chase Cancer Institute
### @@@ Jason Pitarresi, PhD – University of Massachusetts ### 1850971###Author###Assistant Professor###University of Massachusetts###
Author: Jason Pitarresi, PhD – University of Massachusetts
### @@@ Patric Mehlen, PhD – Université Claude Bernard Lyon ### 1850973###Author###Professor###Université Claude Bernard Lyon###
Author: Patric Mehlen, PhD – Université Claude Bernard Lyon
### @@@ Darren R. Carpizo, MD, PhD – University of Rochester ### 937333###Author###Professor and Chief, Division of Surgical Oncology###University of Rochester###
Author: Darren R. Carpizo, MD, PhD – University of Rochester
###
51: Response to neoadjuvant chemotherapy in invasive intraductal papillary mucinous cystic neoplasm compared to de novo pancreatic ductal adenocarcinoma

Alessandro Fogliati, MD (he/him/his) – Mayo Clinic ### 1850649###Abstract Presenter###Research fellow###Mayo Clinic###
Abstract Presenter: Alessandro Fogliati, MD (he/him/his) – Mayo Clinic
### he/him/his @@@ Alessandro Fogliati, MD (he/him/his) – Mayo Clinic ### 1850649###First Author###Research fellow###Mayo Clinic###
First Author: Alessandro Fogliati, MD (he/him/his) – Mayo Clinic
### he/him/his @@@ Andrea Zironda, MD – Mayo Clinic ### 1850676### Author###Research Fellow###Mayo Clinic###
Author: Andrea Zironda, MD – Mayo Clinic
### @@@ Guido Fiorentini, MD – Mayo Clinic ### 1850675###Author###HPB surgery Fellow###Mayo Clinic###
Author: Guido Fiorentini, MD – Mayo Clinic
### @@@ Amro M. Abdelrahman, MBBS MS (he/him/his) – Mayo Clinic ### 970196###Author###Research Fellow###Mayo Clinic###
Author: Amro M. Abdelrahman, MBBS MS (he/him/his) – Mayo Clinic
### he/him/his @@@ Susanne G. Warner, MD – Mayo Clinic ### 1553767###Author###Assistant Professor of Surgery###Mayo Clinic###
Author: Susanne G. Warner, MD – Mayo Clinic
### @@@ Cornelius A. Thiels, DO, MBA – Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic ### 1849801###Author###Assistant Professor###Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic###
Author: Cornelius A. Thiels, DO, MBA – Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic
### @@@ Rory L. Smoot, MD – Mayo Clinic, Department of Surgery and Department of Biochemistry and Molecular Biology ### 1849729###Author###Associate Professor of Surgery, Associate Professor of Biochemistry and Molecular Biology###Mayo Clinic, Department of Surgery and Department of Biochemistry and Molecular Biology###
Author: Rory L. Smoot, MD – Mayo Clinic, Department of Surgery and Department of Biochemistry and Molecular Biology
### @@@ Michael Kendrick, MD – Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic ### 1849798###Author###Professor###Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic###
Author: Michael Kendrick, MD – Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic
### @@@ Sean Cleary, MD – Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic ### 1849797###Author###Professor###Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic###
Author: Sean Cleary, MD – Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic
### @@@ Mark J. Truty, MD, MSc – Mayo Clinic Rochester ### 1416414###Author###Practice Chair###Mayo Clinic Rochester###
Author: Mark J. Truty, MD, MSc – Mayo Clinic Rochester
###
52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.

Jeremy Sharib, MD (he/him/his) – University of Washington ### 1850432###Abstract Presenter###Assistant Professor###University of Washington###
Abstract Presenter: Jeremy Sharib, MD (he/him/his) – University of Washington
### he/him/his @@@ Jeremy Sharib, MD (he/him/his) – University of Washington ### 1850432###First Author###Assistant Professor###University of Washington###
First Author: Jeremy Sharib, MD (he/him/his) – University of Washington
### he/him/his @@@ Annie Liu, MD PhD – Duke University Medical Center ### 1850431###Author###Resident###Duke University Medical Center###
Author: Annie Liu, MD PhD – Duke University Medical Center
### @@@ Sarah McIntyre, MD – New York University ### 1850433###Author###Resident###New York University###
Author: Sarah McIntyre, MD – New York University
### @@@ Kristen E. Rhodin, MD – Duke University Medical Center ### 1530206###Author###General Surgery Resident###Duke University Medical Center###
Author: Kristen E. Rhodin, MD – Duke University Medical Center
### @@@ Nancy E. Kemeny, MD – Memorial Sloan Kettering Cancer Center ### 1850439###Author###Attending###Memorial Sloan Kettering Cancer Center###
Author: Nancy E. Kemeny, MD – Memorial Sloan Kettering Cancer Center
### @@@ Andrea Cercek, MD – Memorial Sloan Kettering Cancer Center ### 1850438###Author###Associate Attending###Memorial Sloan Kettering Cancer Center###
Author: Andrea Cercek, MD – Memorial Sloan Kettering Cancer Center
### @@@ James J. Harding, MD – Memorial Sloan Kettering Cancer Center ### 1850445###Author###Assistant Attending###Memorial Sloan Kettering Cancer Center###
Author: James J. Harding, MD – Memorial Sloan Kettering Cancer Center
### @@@ Ghassan Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center ### 1214110###Author###Professor###Memorial Sloan Kettering Cancer Center###
Author: Ghassan Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center
### @@@ Kevin C. Soares, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850358###Author###Hepatobiliary Surgeon###Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: Kevin C. Soares, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
### @@@ Alice C. Wei, MD MSc FRCSC FACS (she/her/hers) – Memorial Sloan Kettering Cancer Center ### 937479###Author###Associate Attending Surgeon###Memorial Sloan Kettering Cancer Center###
Author: Alice C. Wei, MD MSc FRCSC FACS (she/her/hers) – Memorial Sloan Kettering Cancer Center
### she/her/hers @@@ Jeffrey A. Drebin, MD, PhD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850356###Author###Chair, Department of Surgery; Murray F. Brennan Chair in Surgery###Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: Jeffrey A. Drebin, MD, PhD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
### @@@ T. Peter Kingham, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850357###Author###Director of Global Cancer Disparities Initiatives###Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: T. Peter Kingham, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
### @@@ Michael I. D’Angelica, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850355###Author###Enid A. Haupt Chair in Surgery###Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: Michael I. D’Angelica, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
### @@@ Hope Uronis, MD, MHS – Duke University Medical Center ### 1850454###Author###Associate Professor of Medicine###Duke University Medical Center###
Author: Hope Uronis, MD, MHS – Duke University Medical Center
### @@@ John H. Strickler, MD – Duke University Medical Center ### 1850455###Author###Associate Professor of Medicine###Duke University Medical Center###
Author: John H. Strickler, MD – Duke University Medical Center
### @@@ Michael A. Morse, MD – Duke University Medical Center ### 1850456###Author###Professor of Medicine###Duke University Medical Center###
Author: Michael A. Morse, MD – Duke University Medical Center
### @@@ Sabino Zani, Jr., MD – Duke University Medical Center ### 1779328###Author###Associate Professor of Surgery###Duke University Medical Center###
Author: Sabino Zani, Jr., MD – Duke University Medical Center
### @@@ Peter Allen, MD – Duke University Medical Center ### 937324###Author###chief, surgical oncology###Duke University Medical Center###
Author: Peter Allen, MD – Duke University Medical Center
### @@@ William R. Jarnagin, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center ### 1850359###Author###Chief, Hepatobiliary Service; Leslie Blumgart Chair in Surgery###Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center###
Author: William R. Jarnagin, MD – Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
### @@@ Michael E. Lidsky, MD – Duke University ### 1213082###Author###Assistant Professor of Surgery###Duke University###
Author: Michael E. Lidsky, MD – Duke University
###
53: Surgical Outcomes of SWOG1801: Neoadjuvant/adjuvant versus adjuvant pembrolizumab for resectable stage III-IV melanoma

Michael C. Lowe, MD, MA, FACS, FSSO – Emory University School of Medicine ### 1169992###Abstract Presenter###Associate Professor of Surgery###Emory University School of Medicine###
Abstract Presenter: Michael C. Lowe, MD, MA, FACS, FSSO – Emory University School of Medicine
### @@@ John R. Hyngstrom, MD – Huntsman Cancer Institute, University of Utah Health ### 937477###First Author###Associate Professor, Surgical Oncology###Huntsman Cancer Institute, University of Utah Health###
First Author: John R. Hyngstrom, MD – Huntsman Cancer Institute, University of Utah Health
### @@@ Gerald P. Wright, MD, FACS – Spectrum Health ### 1850501###Author###Medical Director Cutaneous Oncology, Section Chief Breast Surgical Oncology, Assistant Professor###Spectrum Health###
Author: Gerald P. Wright, MD, FACS – Spectrum Health
### @@@ Megan Othus, PhD – University of Washington ### 1850500###Author###Professor###University of Washington###
Author: Megan Othus, PhD – University of Washington
### @@@ Elad Sharon, MD, MPH – National Cancer Institute, Bethesda, MD, USA ### 1850499###Author###Senior Investigator###National Cancer Institute, Bethesda, MD, USA###
Author: Elad Sharon, MD, MPH – National Cancer Institute, Bethesda, MD, USA
### @@@ John M. Kirkwood, MD – UPMC Hillman Cancer Center ### 1850817###Author###Professor of Medicine, Dermatology and Co-Director, Melanoma and Skin Cancer P###UPMC Hillman Cancer Center###
Author: John M. Kirkwood, MD – UPMC Hillman Cancer Center
### @@@ Antoni Ribas, MD, PhD – University of California Los Angeles, Los Angeles, CA, USA ### 1850497###Author###Professor of Medicine###University of California Los Angeles, Los Angeles, CA, USA###
Author: Antoni Ribas, MD, PhD – University of California Los Angeles, Los Angeles, CA, USA
### @@@ Sapna P. Patel, MD – MD Anderson Cancer Center, Houston, TX, USA ### 1850498###Author###Chair, SWOG Melanoma Committee; Associate Professor###MD Anderson Cancer Center, Houston, TX, USA###
Author: Sapna P. Patel, MD – MD Anderson Cancer Center, Houston, TX, USA
### @@@ Vernon K. Sondak, MD (he/him/his) – Moffitt Cancer Center ### 944416###Author###Chair, Department of Cutaneous Oncology###Moffitt Cancer Center###
Author: Vernon K. Sondak, MD (he/him/his) – Moffitt Cancer Center
### he/him/his
54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study

Charles H. Yoon, PhD, MD, FACS – Dana-Farber Brigham Cancer Center, Boston, MA, USA ### 1850804###Abstract Presenter###Director of Surgery for Cutaneous Oncology & Melanoma###Dana-Farber Brigham Cancer Center, Boston, MA, USA###
Abstract Presenter: Charles H. Yoon, PhD, MD, FACS – Dana-Farber Brigham Cancer Center, Boston, MA, USA
### @@@ Charles H. Yoon, PhD, MD, FACS – Dana-Farber Brigham Cancer Center, Boston, MA, USA ### 1850804###Author###Director of Surgery for Cutaneous Oncology & Melanoma###Dana-Farber Brigham Cancer Center, Boston, MA, USA###
Author: Charles H. Yoon, PhD, MD, FACS – Dana-Farber Brigham Cancer Center, Boston, MA, USA
### @@@ Merrick I. Ross, MD – The University of Texas MD Anderson Cancer Center ### 944423###Author###Professor of Surgery - Chief, Melanoma Section###The University of Texas MD Anderson Cancer Center###
Author: Merrick I. Ross, MD – The University of Texas MD Anderson Cancer Center
### @@@ Brian Gastman, MD – Cleveland Clinic Foundation, Cleveland, OH, USA ### 1850805###Author###Surgical Director, Melanoma & High-Risk Skin Cancer Program###Cleveland Clinic Foundation, Cleveland, OH, USA###
Author: Brian Gastman, MD – Cleveland Clinic Foundation, Cleveland, OH, USA
### @@@ Jason J. Luke, MD, FACP – Cancer Immunotherapeutics Center, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA ### 1850759###Author###Director and Associate Professor###Cancer Immunotherapeutics Center, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA###
Author: Jason J. Luke, MD, FACP – Cancer Immunotherapeutics Center, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA
### @@@ Paolo A. Ascierto, MD – Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Naples, Italy ### 1850806###Author###Director of the Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy###Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Naples, Italy###
Author: Paolo A. Ascierto, MD – Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Naples, Italy
### @@@ Georgina V. Long, AO, BSc PhD MBBS FRACP FAHMS – Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia ### 1850807###Author###Co-Medical Director###Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia###
Author: Georgina V. Long, AO, BSc PhD MBBS FRACP FAHMS – Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia
### @@@ Piotr Rutkowski, MD, PhD – Maria Skłodowska-Curie National Research Institute of Oncology ### 1850853###Author###Professor of Surgical Oncology###Maria Skłodowska-Curie National Research Institute of Oncology###
Author: Piotr Rutkowski, MD, PhD – Maria Skłodowska-Curie National Research Institute of Oncology
### @@@ Muhammad Khattak, PhD – Fiona Stanley Hospital and Edith Cowan University, Perth, WA, Australia ### 1850809###Author###Clinical Professor###Fiona Stanley Hospital and Edith Cowan University, Perth, WA, Australia###
Author: Muhammad Khattak, PhD – Fiona Stanley Hospital and Edith Cowan University, Perth, WA, Australia
### @@@ Michele Del Vecchio, MD, PhD – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 1850830###Author###Head, Unit of Melanoma Medical Oncology###Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###
Author: Michele Del Vecchio, MD, PhD – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### @@@ Luis de la Cruz Merino, PhD – Hospital Universitario Virgen Macarena, Seville, Spain ### 1850810###Author###Head of Department###Hospital Universitario Virgen Macarena, Seville, Spain###
Author: Luis de la Cruz Merino, PhD – Hospital Universitario Virgen Macarena, Seville, Spain
### @@@ Jacek Mackiewicz, PhD – Poznan University of Medical Sciences, Poznan, Poland ### 1850811###Author###Academician###Poznan University of Medical Sciences, Poznan, Poland###
Author: Jacek Mackiewicz, PhD – Poznan University of Medical Sciences, Poznan, Poland
### @@@ Vanna Chiarion-Sileni, MD – Veneto Institute of Oncology IOV-IRCCS, Veneto, Italy ### 1850812###Author###Head of Melanoma & Esophageal Oncology Unit###Veneto Institute of Oncology IOV-IRCCS, Veneto, Italy###
Author: Vanna Chiarion-Sileni, MD – Veneto Institute of Oncology IOV-IRCCS, Veneto, Italy
### @@@ Dirk Schadendorf, MD – Comprehensive Cancer Center, Universitaetsklinikum Essen & German Cancer Consortium, Essen, Germany ### 1850813###Author###Director of: Clinic for Dermatology###Comprehensive Cancer Center, Universitaetsklinikum Essen & German Cancer Consortium, Essen, Germany###
Author: Dirk Schadendorf, MD – Comprehensive Cancer Center, Universitaetsklinikum Essen & German Cancer Consortium, Essen, Germany
### @@@ Matteo S. Carlino, BMedSc MBBS FRACP PhD – Melanoma Institute Australia, The University of Sydney, Westmead and Blacktown Hospitals, Sydney, NSW, Australia ### 1850760###Author###Clinical Senior Lecturer Medicine###Melanoma Institute Australia, The University of Sydney, Westmead and Blacktown Hospitals, Sydney, NSW, Australia###
Author: Matteo S. Carlino, BMedSc MBBS FRACP PhD – Melanoma Institute Australia, The University of Sydney, Westmead and Blacktown Hospitals, Sydney, NSW, Australia
### @@@ Yujie Zhao, MD, PhD – Merck & Co., Inc., Rahway, NJ, USA ### 1850761###Author###Senior Scientist###Merck & Co., Inc., Rahway, NJ, USA###
Author: Yujie Zhao, MD, PhD – Merck & Co., Inc., Rahway, NJ, USA
### @@@ Mizuho Fukunaga-Kalabis, PhD – Merck & Co., Inc., Rahway, NJ, USA ### 1850814###Author###Oncology Senior Clinical Director###Merck & Co., Inc., Rahway, NJ, USA###
Author: Mizuho Fukunaga-Kalabis, PhD – Merck & Co., Inc., Rahway, NJ, USA
### @@@ Clemens Krepler, MD – Merck & Co., Inc., Rahway, NJ, USA ### 1850762###Author###Executive Director###Merck & Co., Inc., Rahway, NJ, USA###
Author: Clemens Krepler, MD – Merck & Co., Inc., Rahway, NJ, USA
### @@@ Alexander M. M. Eggermont, MD, PhD – University Medical Center Utrecht, Netherlands & Comprehensive Cancer Center Munich, Germany ### 1850763###Author###Chief Scientific Officer, Board of Directors###University Medical Center Utrecht, Netherlands & Comprehensive Cancer Center Munich, Germany###
Author: Alexander M. M. Eggermont, MD, PhD – University Medical Center Utrecht, Netherlands & Comprehensive Cancer Center Munich, Germany
### @@@ Jeffrey E. Gershenwald, MD – The University of Texas MD Anderson Cancer Center ### 944429###Author######The University of Texas MD Anderson Cancer Center###
Author: Jeffrey E. Gershenwald, MD – The University of Texas MD Anderson Cancer Center
### @@@ Vernon K. Sondak, MD (he/him/his) – Moffitt Cancer Center ### 944416###Author###Chair, Department of Cutaneous Oncology###Moffitt Cancer Center###
Author: Vernon K. Sondak, MD (he/him/his) – Moffitt Cancer Center
### he/him/his
55: Neoadjuvant Pepinemab in Combination with Nivolumab and/or Ipilimumab in Resectable Stage III Melanoma

Michael C. Lowe, MD, MA, FACS, FSSO – Emory University School of Medicine ### 1169992###Abstract Presenter###Associate Professor of Surgery###Emory University School of Medicine###
Abstract Presenter: Michael C. Lowe, MD, MA, FACS, FSSO – Emory University School of Medicine
### @@@ Michael C. Lowe, MD, MA, FACS, FSSO – Emory University School of Medicine ### 1169992###First Author###Associate Professor of Surgery###Emory University School of Medicine###
First Author: Michael C. Lowe, MD, MA, FACS, FSSO – Emory University School of Medicine
### @@@ Brian Olson, PhD – Emory University ### 1850604###Author###Assistant Professor###Emory University###
Author: Brian Olson, PhD – Emory University
### @@@ Melinda Yushak, MD, MPH – Emory University ### 1850605###Author###Assistant Professor###Emory University###
Author: Melinda Yushak, MD, MPH – Emory University
### @@@ Crystal Mallow, n/a – Vaccinex, Inc. ### 1850606###Author###Investigator###Vaccinex, Inc.###
Author: Crystal Mallow, n/a – Vaccinex, Inc.
### @@@ Christine Reilly, n/a – Vaccinex, Inc. ### 1850607###Author###Investigator###Vaccinex, Inc.###
Author: Christine Reilly, n/a – Vaccinex, Inc.
### @@@ Jacklyn Hammons, n/a – Emory University ### 1850608###Author###Research Specialist###Emory University###
Author: Jacklyn Hammons, n/a – Emory University
### @@@ Brian Burns, n/a – Emory University ### 1850609###Author###Investigator###Emory University###
Author: Brian Burns, n/a – Emory University
### @@@ Ali Mokhtari, MD – Emory University ### 1850610###Author###Pathology Resident###Emory University###
Author: Ali Mokhtari, MD – Emory University
### @@@ Doug Parker, MD – Emory University ### 1850613###Author###Associate Professor###Emory University###
Author: Doug Parker, MD – Emory University
### @@@ Terry Fisher, PhD – Vaccinex, Inc ### 1850612###Author###Investigator###Vaccinex, Inc###
Author: Terry Fisher, PhD – Vaccinex, Inc
### @@@ Elizabeth Evans, PhD – Vaccinex, Inc. ### 1850611###Author###Investigator###Vaccinex, Inc.###
Author: Elizabeth Evans, PhD – Vaccinex, Inc.
### @@@ Chrystal Paulos, PhD – Emory University ### 1850614###Author###Associate Professor###Emory University###
Author: Chrystal Paulos, PhD – Emory University
### @@@ Keith A. Delman, MD (he/him/his) – Emory University ### 937328###Author###Chief of Surgery, Grady Memorial Hospital and Associate Chair, Dept of Surgery, Emory University School of Medicine###Emory University###
Author: Keith A. Delman, MD (he/him/his) – Emory University
### he/him/his @@@ Gregory Lesinski, PhD – Emory University ### 1850615###Author###Professor###Emory University###
Author: Gregory Lesinski, PhD – Emory University
###
56: International Validation Study of the Melanoma Institute Australia Sentinel Node Metastasis Risk Nomogram

Serigne Lo, MSc, PhD – Melanoma Institute Australia; The University of Sydney ### 1849888###First Author###A/prof###Melanoma Institute Australia; The University of Sydney###
First Author: Serigne Lo, MSc, PhD – Melanoma Institute Australia; The University of Sydney
### @@@ Caroline Gjorup, MD, PhD, FEBOPRAS – Melanoma Institute Australia; The University of Sydney ### 1850623###Author###Fellow###Melanoma Institute Australia; The University of Sydney###
Author: Caroline Gjorup, MD, PhD, FEBOPRAS – Melanoma Institute Australia; The University of Sydney
### @@@ Annette Hougaard Chakera, MD, PhD – Department of Plastic Surgery, Herlev University Hospital, Denmark ### 1850624###Author###Consultant plastic surgeon###Department of Plastic Surgery, Herlev University Hospital, Denmark###
Author: Annette Hougaard Chakera, MD, PhD – Department of Plastic Surgery, Herlev University Hospital, Denmark
### @@@ Lisbet Rosenkrantz Hölmich, MD, dr.med. – Department of Plastic Surgery, Herlev University Hospital, University of Copenhagen ### 1850625###Author###Professor###Department of Plastic Surgery, Herlev University Hospital, University of Copenhagen###
Author: Lisbet Rosenkrantz Hölmich, MD, dr.med. – Department of Plastic Surgery, Herlev University Hospital, University of Copenhagen
### @@@ Marc D. Moncrieff, MD FRCS(Plast.) – Norfolk & Norwich University Hospital ### 944415###Author###Professor of Plastic and Reconstructive Surgery###Norfolk & Norwich University Hospital###
Author: Marc D. Moncrieff, MD FRCS(Plast.) – Norfolk & Norwich University Hospital
### @@@ Alistair Ross, MD, FRCS – Department of Plastic Surgery Guy's and St Thomas' NHS Foundation Trust London, United Kingdom ### 1850627###Author###Consultant plastic surgeon###Department of Plastic Surgery Guy's and St Thomas' NHS Foundation Trust London, United Kingdom###
Author: Alistair Ross, MD, FRCS – Department of Plastic Surgery Guy's and St Thomas' NHS Foundation Trust London, United Kingdom
### @@@ Oliver Cassell, MB ChB, FRCS (Ed), FRCS (Plast), MS – Oxford University Hospitals NHS Foundation Trust, UK ### 1850628###Author###Consultant plastic surgeon###Oxford University Hospitals NHS Foundation Trust, UK###
Author: Oliver Cassell, MB ChB, FRCS (Ed), FRCS (Plast), MS – Oxford University Hospitals NHS Foundation Trust, UK
### @@@ Jiawen Ma, MD – Melanoma Institute Australia ### 1850703###Author###Dr###Melanoma Institute Australia###
Author: Jiawen Ma, MD – Melanoma Institute Australia
### @@@ Roger Olofsson Bagge, MD, PhD – Department of Surgery, Sahlgrenska University Hospital, Sweden ### 1850704###Author###A/prof###Department of Surgery, Sahlgrenska University Hospital, Sweden###
Author: Roger Olofsson Bagge, MD, PhD – Department of Surgery, Sahlgrenska University Hospital, Sweden
### @@@ Eduardo Bertolli, MD, PhD – Hospital A. C. Camargo Cancer Center, São Paulo, Brazil ### 1850708###Author###Surgical Oncologist###Hospital A. C. Camargo Cancer Center, São Paulo, Brazil###
Author: Eduardo Bertolli, MD, PhD – Hospital A. C. Camargo Cancer Center, São Paulo, Brazil
### @@@ Cimarron Sharon, MD – Hospital of the University of Pennsylvania, US ### 1850715###Author###Dr.###Hospital of the University of Pennsylvania, US###
Author: Cimarron Sharon, MD – Hospital of the University of Pennsylvania, US
### @@@ Giorgos Karakousis, MD – Hospital of the University of Pennsylvania ### 915770###Author###Professor of Surgery###Hospital of the University of Pennsylvania###
Author: Giorgos Karakousis, MD – Hospital of the University of Pennsylvania
### @@@ Mohammed Kashani-Sabet, MD – California Pacific Medical Center, San Francisco, CA ### 1850721###Author###Dr.###California Pacific Medical Center, San Francisco, CA###
Author: Mohammed Kashani-Sabet, MD – California Pacific Medical Center, San Francisco, CA
### @@@ George Adigbli, MRCS, DPhil – Nuffield Dept. of Surgical Sciences, University of Oxford ### 1850735###Author###Academic Clinical Fellow & Specialty Registrar in Plastic Surgery###Nuffield Dept. of Surgical Sciences, University of Oxford###
Author: George Adigbli, MRCS, DPhil – Nuffield Dept. of Surgical Sciences, University of Oxford
### @@@ Richard Scolyer, BMedSci, MBBS, MD, FRCPA, FRCPath, FAHMS – Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, ### 1849947###Author###Professor###Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney,###
Author: Richard Scolyer, BMedSci, MBBS, MD, FRCPA, FRCPath, FAHMS – Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney,
### @@@ John Thompson, MD – Melanoma Institute Australia, The University of Sydney ### 944391###Author###Emeritus Professor Melanoma and Surgical Oncology###Melanoma Institute Australia, The University of Sydney###
Author: John Thompson, MD – Melanoma Institute Australia, The University of Sydney
### @@@ Alexander H. Varey, MBChB MRCS(Eng) FRACS FRCS(Plast) PhD (he/him/his) – Melanoma Institute Australia; Department of Plastic Surgery, Westmead Hospital; Faculty of Medicine and Health, The University of Sydney ### 1849887###Abstract Presenter###A/Prof###Melanoma Institute Australia; Department of Plastic Surgery, Westmead Hospital; Faculty of Medicine and Health, The University of Sydney###
Abstract Presenter: Alexander H. Varey, MBChB MRCS(Eng) FRACS FRCS(Plast) PhD (he/him/his) – Melanoma Institute Australia; Department of Plastic Surgery, Westmead Hospital; Faculty of Medicine and Health, The University of Sydney
### he/him/his
57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations

Vernon K. Sondak, MD (he/him/his) – Moffitt Cancer Center ### 944416###Abstract Presenter###Chair, Department of Cutaneous Oncology###Moffitt Cancer Center###
Abstract Presenter: Vernon K. Sondak, MD (he/him/his) – Moffitt Cancer Center
### he/him/his @@@ Vernon K. Sondak, MD (he/him/his) – Moffitt Cancer Center ### 944416###First Author###Chair, Department of Cutaneous Oncology###Moffitt Cancer Center###
First Author: Vernon K. Sondak, MD (he/him/his) – Moffitt Cancer Center
### he/him/his @@@ Shay L. Bellasea, MS – SWOG Statistics and Data Management Center and Fred Hutchinson Cancer Research Center, Seattle, WA, USA ### 1850841###Author###Biostatistician###SWOG Statistics and Data Management Center and Fred Hutchinson Cancer Research Center, Seattle, WA, USA###
Author: Shay L. Bellasea, MS – SWOG Statistics and Data Management Center and Fred Hutchinson Cancer Research Center, Seattle, WA, USA
### @@@ John R. Hyngstrom, MD – Huntsman Cancer Institute, University of Utah Health ### 937477###Author###Associate Professor, Surgical Oncology###Huntsman Cancer Institute, University of Utah Health###
Author: John R. Hyngstrom, MD – Huntsman Cancer Institute, University of Utah Health
### @@@ Carlo M. Contreras, MD – The Ohio State University ### 970287###Author###Associate Professor, Section Head of Melanoma/Sarcoma###The Ohio State University###
Author: Carlo M. Contreras, MD – The Ohio State University
### @@@ Alicia M. Terando, MD (she/her/hers) – Huntington Hospital Cancer Center, an Affiliate of Cedars Sinai Cancer ### 937406###Author###Regional Director of Surgical Oncology###Huntington Hospital Cancer Center, an Affiliate of Cedars Sinai Cancer###
Author: Alicia M. Terando, MD (she/her/hers) – Huntington Hospital Cancer Center, an Affiliate of Cedars Sinai Cancer
### she/her/hers @@@ Michael A. Harrington, MD, MPH – USF Morsani College of Medicine, Tampa, FL, USA ### 1850843###Author###Associate Professor of Surgery, Department of Plastic Surgery###USF Morsani College of Medicine, Tampa, FL, USA###
Author: Michael A. Harrington, MD, MPH – USF Morsani College of Medicine, Tampa, FL, USA
### @@@ Marcos M. Monroe, MD – Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA ### 1850844###Author###Associate Professor, Otolaryngology-Head and Neck Surgery###Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA###
Author: Marcos M. Monroe, MD – Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA
### @@@ David Wada, MD – Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA ### 1850877###Author###Associate Professor, Department of Dermatology###Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA###
Author: David Wada, MD – Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA
### @@@ Joseph A. Plaza, MD – Ohio State University Wexner Medical Center, Columbus, OH, USA ### 1850878###Author###Director of Dermatopathology, Professor of Pathology and Dermatology###Ohio State University Wexner Medical Center, Columbus, OH, USA###
Author: Joseph A. Plaza, MD – Ohio State University Wexner Medical Center, Columbus, OH, USA
### @@@ Zeynep Eroglu, MD – Moffitt Cancer Center, Tampa, FL, USA ### 1850879###Author###Associate Member, Department of Cutaneous Oncology###Moffitt Cancer Center, Tampa, FL, USA###
Author: Zeynep Eroglu, MD – Moffitt Cancer Center, Tampa, FL, USA
### @@@ Siwen Hu-Lieskovan, MD, PhD – Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA ### 1850880###Author###Associate Professor, Department of Medicine###Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA###
Author: Siwen Hu-Lieskovan, MD, PhD – Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA
### @@@ Gino K. In, MD, MPH – University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA ### 1850413###Author###Assistant Professor of Medicine and Dermatology###University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA###
Author: Gino K. In, MD, MPH – University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA
### @@@ Alexandra P. Ikeguchi, MD – Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA ### 1850881###Author###Assistant Professor of Medicine, Division of Hematology/Oncology###Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA###
Author: Alexandra P. Ikeguchi, MD – Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
### @@@ Elad Sharon, MD, MPH – National Cancer Institute, Bethesda, MD, USA ### 1850499###Author###Senior Investigator###National Cancer Institute, Bethesda, MD, USA###
Author: Elad Sharon, MD, MPH – National Cancer Institute, Bethesda, MD, USA
### @@@ Michael C. Wu, PhD – SWOG Statistics and Data Management Center and Fred Hutchinson Cancer Research Center, Seattle, WA, USA ### 1850882###Author###Biostatistician###SWOG Statistics and Data Management Center and Fred Hutchinson Cancer Research Center, Seattle, WA, USA###
Author: Michael C. Wu, PhD – SWOG Statistics and Data Management Center and Fred Hutchinson Cancer Research Center, Seattle, WA, USA
### @@@ James Moon, MS – SWOG Statistics and Data Management Center and Fred Hutchinson Cancer Research Center, Seattle, WA, USA ### 1850883###Author###Biostatistician###SWOG Statistics and Data Management Center and Fred Hutchinson Cancer Research Center, Seattle, WA, USA###
Author: James Moon, MS – SWOG Statistics and Data Management Center and Fred Hutchinson Cancer Research Center, Seattle, WA, USA
### @@@ Antoni Ribas, MD, PhD – University of California Los Angeles, Los Angeles, CA, USA ### 1850497###Author###Professor of Medicine###University of California Los Angeles, Los Angeles, CA, USA###
Author: Antoni Ribas, MD, PhD – University of California Los Angeles, Los Angeles, CA, USA
### @@@ Sapna P. Patel, MD – MD Anderson Cancer Center, Houston, TX, USA ### 1850498###Author###Chair, SWOG Melanoma Committee; Associate Professor###MD Anderson Cancer Center, Houston, TX, USA###
Author: Sapna P. Patel, MD – MD Anderson Cancer Center, Houston, TX, USA
### @@@ William Carson, III, MD – Ohio State University James Cancer Hospital, Columbus, OH, USA ### 1849773###Author###Professor, Division of Surgical Oncology###Ohio State University James Cancer Hospital, Columbus, OH, USA###
Author: William Carson, III, MD – Ohio State University James Cancer Hospital, Columbus, OH, USA
### @@@ Kari L. Kendra, MD, PhD – Ohio State University James Cancer Hospital, Columbus, OH, USA ### 1850842###Author###Professor, Division of Medical Oncology, Department of Medicine###Ohio State University James Cancer Hospital, Columbus, OH, USA###
Author: Kari L. Kendra, MD, PhD – Ohio State University James Cancer Hospital, Columbus, OH, USA
###
58: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?

Kristen E. Rhodin, MD – Duke University Medical Center ### 1530206###Abstract Presenter###General Surgery Resident###Duke University Medical Center###
Abstract Presenter: Kristen E. Rhodin, MD – Duke University Medical Center
### @@@ Kristen E. Rhodin, MD – Duke University Medical Center ### 1530206###First Author###General Surgery Resident###Duke University Medical Center###
First Author: Kristen E. Rhodin, MD – Duke University Medical Center
### @@@ Sin-Ho Jung, PhD – Duke University ### 1850346###Author###Professor of Biostatistics and Bioinformatics###Duke University###
Author: Sin-Ho Jung, PhD – Duke University
### @@@ Kelly Elleson, MS, MD – Moffitt Cancer Center ### 1534861###Author###Breast Surgical Oncology Fellow ###Moffitt Cancer Center###
Author: Kelly Elleson, MS, MD – Moffitt Cancer Center
### @@@ Danielle DePalo, MD – Moffitt Cancer Center ### 1849705###Author###Research Fellow###Moffitt Cancer Center###
Author: Danielle DePalo, MD – Moffitt Cancer Center
### @@@ Richard Straker, MD – Hospital of the University of Pennsylvania ### 1850347###Author###General Surgery Resident###Hospital of the University of Pennsylvania###
Author: Richard Straker, MD – Hospital of the University of Pennsylvania
### @@@ Sophia McKinley, MD – Memorial Sloan Kettering Cancer Center ### 1850348###Author###Complex General Surgical Oncology Fellow###Memorial Sloan Kettering Cancer Center###
Author: Sophia McKinley, MD – Memorial Sloan Kettering Cancer Center
### @@@ Kate Beekman – University of South Florida ### 1850349###Author###Medical Student###University of South Florida###
Author: Kate Beekman – University of South Florida
### @@@ Lily Parker (she/her/hers) – University of South Florida ### 1850350###Author###Medical Student###University of South Florida###
Author: Lily Parker (she/her/hers) – University of South Florida
### she/her/hers @@@ Suephy Chen, MD, MS – Duke University Medical Center ### 1850351###Author###Professor of Dermatology###Duke University Medical Center###
Author: Suephy Chen, MD, MS – Duke University Medical Center
### @@@ April Salama, MD – Duke University Medical Center ### 1850352###Author###Associate Professor of Medicine###Duke University Medical Center###
Author: April Salama, MD – Duke University Medical Center
### @@@ Matthew K. Iyer, MD, PhD – Duke University Medical Center ### 1850353###Author###Complex General Surgical Oncology Fellow###Duke University Medical Center###
Author: Matthew K. Iyer, MD, PhD – Duke University Medical Center
### @@@ Edmund Bartlett, MD – Memorial Sloan Kettering Cancer Center ### 944412###Author###Assistant Attending, Gastric and Mixed Tumor Service###Memorial Sloan Kettering Cancer Center###
Author: Edmund Bartlett, MD – Memorial Sloan Kettering Cancer Center
### @@@ Giorgos Karakousis, MD – Hospital of the University of Pennsylvania ### 915770###Author###Professor of Surgery###Hospital of the University of Pennsylvania###
Author: Giorgos Karakousis, MD – Hospital of the University of Pennsylvania
### @@@ Jonathan S. Zager, MD – H. Lee Moffitt Cancer Center ### 917915###Author###Chief Academic Officer, Director of Regional Therapies, Senior member and Professor of Surgery###H. Lee Moffitt Cancer Center###
Author: Jonathan S. Zager, MD – H. Lee Moffitt Cancer Center
### @@@ Doug Tyler, MD, MSHCT – University of Texas Medical Branch ### 1795367###Author###Professor and Chairman, Department of Surgery###University of Texas Medical Branch###
Author: Doug Tyler, MD, MSHCT – University of Texas Medical Branch
### @@@ Georgia Beasley, MD, MHSc (she/her/hers) – Duke University ### 938016###Author###Associate Professor of Surgery, Associate Professor of Medicine, Co-director Duke Melanoma Program###Duke University###
Author: Georgia Beasley, MD, MHSc (she/her/hers) – Duke University
### she/her/hers
59: Validating the Use of Surrogate Endpoints to Assess the Survival Outcomes of Melanoma Patients in Clinical Trials

Marc D. Moncrieff, MD FRCS(Plast.) – Norfolk & Norwich University Hospital ### 944415###Abstract Presenter###Professor of Plastic and Reconstructive Surgery###Norfolk & Norwich University Hospital###
Abstract Presenter: Marc D. Moncrieff, MD FRCS(Plast.) – Norfolk & Norwich University Hospital
### @@@ Marc D. Moncrieff, MD FRCS(Plast.) – Norfolk & Norwich University Hospital ### 944415###First Author###Professor of Plastic and Reconstructive Surgery###Norfolk & Norwich University Hospital###
First Author: Marc D. Moncrieff, MD FRCS(Plast.) – Norfolk & Norwich University Hospital
### @@@ Serigne Lo, MSc, PhD – Melanoma Institute Australia; The University of Sydney ### 1849888###Author###A/prof###Melanoma Institute Australia; The University of Sydney###
Author: Serigne Lo, MSc, PhD – Melanoma Institute Australia; The University of Sydney
### @@@ Robyn Saw, MBBS, FRACS, MS – Melanoma Institute Australia, Royal Prince Alfred Hospital, University of Sydney ### 1850619###Author###A/prof###Melanoma Institute Australia, Royal Prince Alfred Hospital, University of Sydney###
Author: Robyn Saw, MBBS, FRACS, MS – Melanoma Institute Australia, Royal Prince Alfred Hospital, University of Sydney
### @@@ Kerwin Shannon, MBBS, FRACS – Melanoma Institute of Australia, University of Sydney, Sydney, Australia ### 1850617###Author###Surgeon###Melanoma Institute of Australia, University of Sydney, Sydney, Australia###
Author: Kerwin Shannon, MBBS, FRACS – Melanoma Institute of Australia, University of Sydney, Sydney, Australia
### @@@ Andrew Spillane, MD FRACS BM BS – Melanoma Institute Australia, ### 1850618###Author###Professor###Melanoma Institute Australia,###
Author: Andrew Spillane, MD FRACS BM BS – Melanoma Institute Australia,
### @@@ Jonathan Stretch, D.Phil (Oxon) FRACS, AM – Melanoma Institute Australia, Royal North Shore Hospital ### 1850620###Author###A/prof###Melanoma Institute Australia, Royal North Shore Hospital###
Author: Jonathan Stretch, D.Phil (Oxon) FRACS, AM – Melanoma Institute Australia, Royal North Shore Hospital
### @@@ Martin Heaton, MD FRCS(Plast.) – Norfolk & Norwich University Hospital Foundation NHS Trust ### 1850344###Author###Consultant Plastic & Reconstructive Surgeon###Norfolk & Norwich University Hospital Foundation NHS Trust###
Author: Martin Heaton, MD FRCS(Plast.) – Norfolk & Norwich University Hospital Foundation NHS Trust
### @@@ Andrew Snelling, FRCS(Plast.) – Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK ### 1850345###Author###Consultant Plastic & Reconstructive Surgeon###Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK###
Author: Andrew Snelling, FRCS(Plast.) – Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK
### @@@ Sydney Ch'ng, PhD, AFRCS – Melanoma Institute Australia ### 1850748###Author###A/ Prof Plastic and Reconstructive Surgeon###Melanoma Institute Australia###
Author: Sydney Ch'ng, PhD, AFRCS – Melanoma Institute Australia
### @@@ Omgo E. Nieweg, MD, PhD – Melanoma Institute Australia ### 944414###Author###Senior surgeon###Melanoma Institute Australia###
Author: Omgo E. Nieweg, MD, PhD – Melanoma Institute Australia
### @@@ John Thompson, MD – Melanoma Institute Australia, The University of Sydney ### 944391###Author###Emeritus Professor Melanoma and Surgical Oncology###Melanoma Institute Australia, The University of Sydney###
Author: John Thompson, MD – Melanoma Institute Australia, The University of Sydney
###
6: Population-based survival outcomes of pure vs mixed invasive Lobular Breast Carcinoma in Ontario, Canada

David W. Lim, MDCM, MEd, PhD – Women's College Research Institute, Women's College Hospital & University of Toronto Department of Surgery ### 1184695###Abstract Presenter###Surgeon-Scientist & Assistant Professor###Women's College Research Institute, Women's College Hospital & University of Toronto Department of Surgery###
Abstract Presenter: David W. Lim, MDCM, MEd, PhD – Women's College Research Institute, Women's College Hospital & University of Toronto Department of Surgery
### @@@ David W. Lim, MDCM, MEd, PhD – Women's College Research Institute, Women's College Hospital & University of Toronto Department of Surgery ### 1184695###Author###Surgeon-Scientist & Assistant Professor###Women's College Research Institute, Women's College Hospital & University of Toronto Department of Surgery###
Author: David W. Lim, MDCM, MEd, PhD – Women's College Research Institute, Women's College Hospital & University of Toronto Department of Surgery
### @@@ Vasily Giannakeas, PhD – Women's College Research Institute ### 1850985###Author###PhD candidate###Women's College Research Institute###
Author: Vasily Giannakeas, PhD – Women's College Research Institute
### @@@ Steven Narod, MD – Women's College Research Institute ### 1850988###Author###Senior Scientist###Women's College Research Institute###
Author: Steven Narod, MD – Women's College Research Institute
### @@@ Kelly Metcalfe, RN PhD – Women's College Research Institute ### 1850989###Author###Senior Scientist###Women's College Research Institute###
Author: Kelly Metcalfe, RN PhD – Women's College Research Institute
###
60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers

Georgia Beasley, MD, MHSc (she/her/hers) – Duke University ### 938016###Abstract Presenter###Associate Professor of Surgery, Associate Professor of Medicine, Co-director Duke Melanoma Program###Duke University###
Abstract Presenter: Georgia Beasley, MD, MHSc (she/her/hers) – Duke University
### she/her/hers @@@ Georgia Beasley, MD, MHSc (she/her/hers) – Duke University ### 938016###First Author###Associate Professor of Surgery, Associate Professor of Medicine, Co-director Duke Melanoma Program###Duke University###
First Author: Georgia Beasley, MD, MHSc (she/her/hers) – Duke University
### she/her/hers @@@ Ari M. VanderWalde, MD, MPH, FACP – West Cancer Center and Research Institute ### 1850406###Author###Research Faculty###West Cancer Center and Research Institute###
Author: Ari M. VanderWalde, MD, MPH, FACP – West Cancer Center and Research Institute
### @@@ Tawnya L. Bowles, MD – Intermountain Medical Center ### 937420###Author###Medical Director for Melanoma Services###Intermountain Medical Center###
Author: Tawnya L. Bowles, MD – Intermountain Medical Center
### @@@ Joseph J. Sacco, PhD, MBChB, MSc, MRCP – Clatterbridge Cancer Centre and University of Liverpool ### 1850407###Author###Consultant in Medical Oncology###Clatterbridge Cancer Centre and University of Liverpool###
Author: Joseph J. Sacco, PhD, MBChB, MSc, MRCP – Clatterbridge Cancer Centre and University of Liverpool
### @@@ Jiaxin Niu, MD, PhD – Banner MD Anderson Cancer Center ### 1850408###Author###Medical Oncologist###Banner MD Anderson Cancer Center###
Author: Jiaxin Niu, MD, PhD – Banner MD Anderson Cancer Center
### @@@ Katy K. Tsai, MD – Helen Diller Family Comprehensive Cancer Center Cutaneous Oncology ### 1850409###Author###Assistant Clinical Professor###Helen Diller Family Comprehensive Cancer Center Cutaneous Oncology###
Author: Katy K. Tsai, MD – Helen Diller Family Comprehensive Cancer Center Cutaneous Oncology
### @@@ Jason A. Chesney, MD, PhD – University of Louisville, Louisville, KY, USA ### 1850373###Author###Professor of Medicine###University of Louisville, Louisville, KY, USA###
Author: Jason A. Chesney, MD, PhD – University of Louisville, Louisville, KY, USA
### @@@ Bartosz Chmielowski, MD – University of California Los Angeles ### 1850410###Author###Oncologist###University of California Los Angeles###
Author: Bartosz Chmielowski, MD – University of California Los Angeles
### @@@ Adel Samson, PhD – University of Leeds ### 1850411###Author###Clinical Associate Professor###University of Leeds###
Author: Adel Samson, PhD – University of Leeds
### @@@ Terence Duane Rhodes, MD – Intermountain Medical Center ### 1850412###Author###Oncologist###Intermountain Medical Center###
Author: Terence Duane Rhodes, MD – Intermountain Medical Center
### @@@ Gino K. In, MD, MPH – University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA ### 1850413###Author###Assistant Professor of Medicine and Dermatology###University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA###
Author: Gino K. In, MD, MPH – University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA
### @@@ Anna C. Pavlick, DO – Weill Cornell Medical College ### 1850414###Author###Director of Melanoma and Cutaneous Oncology###Weill Cornell Medical College###
Author: Anna C. Pavlick, DO – Weill Cornell Medical College
### @@@ Trisha M. Wise-Draper, MD, PhD – University of Cincinnati ### 1850415###Author###Associate Professor of Medicine###University of Cincinnati###
Author: Trisha M. Wise-Draper, MD, PhD – University of Cincinnati
### @@@ Miguel F. Sanmamed, MD, PhD – Clínica Universidad de Navarra ### 1850416###Author###Medical Oncologist###Clínica Universidad de Navarra###
Author: Miguel F. Sanmamed, MD, PhD – Clínica Universidad de Navarra
### @@@ Jeannie Hou, MD – Replimune Inc. ### 1850425###Author###Vice President, Clinical Development###Replimune Inc.###
Author: Jeannie Hou, MD – Replimune Inc.
### @@@ Mark R. Middleton, MD, PhD – Churchill Hospital ### 1850426###Author###Professor; Consultant Medical Oncologist###Churchill Hospital###
Author: Mark R. Middleton, MD, PhD – Churchill Hospital
### @@@ Kevin Harrington, PhD, BSc, MBBS, MRCP, FRCP, FRCR – Royal Marsden NHS Foundation Trust, The Institute of Cancer Research ### 1850427###Author###Head of the Division of Radiology and Imaging; Professor###Royal Marsden NHS Foundation Trust, The Institute of Cancer Research###
Author: Kevin Harrington, PhD, BSc, MBBS, MRCP, FRCP, FRCR – Royal Marsden NHS Foundation Trust, The Institute of Cancer Research
### @@@ Céleste Lebbe, MD, PhD – Université de Paris and CIC AP-HP Hôpital Saint Louis ### 1850428###Author###Professor###Université de Paris and CIC AP-HP Hôpital Saint Louis###
Author: Céleste Lebbe, MD, PhD – Université de Paris and CIC AP-HP Hôpital Saint Louis
### @@@ Judith Michels, MD, PhD – Institut Gustave Roussy ### 1850429###Author###Medical Oncologist###Institut Gustave Roussy###
Author: Judith Michels, MD, PhD – Institut Gustave Roussy
### @@@ Mohammed M. Milhem, MBBS – Holden Comprehensive Cancer Center ### 1850430###Author###Director, Melanoma Program###Holden Comprehensive Cancer Center###
Author: Mohammed M. Milhem, MBBS – Holden Comprehensive Cancer Center
###
61: Smoking imparts shorter disease specific survival in patients with primary cutaneous melanoma

Katherine Jackson, MD – St. John's Cancer Institute ### 1850591###Abstract Presenter###Surgical Oncology Fellow###St. John's Cancer Institute###
Abstract Presenter: Katherine Jackson, MD – St. John's Cancer Institute
### @@@ Katherine Jackson, MD – St. John's Cancer Institute ### 1850591###First Author###Surgical Oncology Fellow###St. John's Cancer Institute###
First Author: Katherine Jackson, MD – St. John's Cancer Institute
### @@@ Peter Jones, MD – St John's Cancer Institute ### 1850593###Author###Former Faculty###St John's Cancer Institute###
Author: Peter Jones, MD – St John's Cancer Institute
### @@@ Laura Fluke, DO, FACS – Providence Saint John's Cancer Institute ### 1850592###Author###Surgical Oncology Fellow###Providence Saint John's Cancer Institute###
Author: Laura Fluke, DO, FACS – Providence Saint John's Cancer Institute
### @@@ Trevan Fischer, MD – Saint John's Cancer Institute, Donald L Morton CGSO Fellowship ### 1849882###Author###Assistant Program Director###Saint John's Cancer Institute, Donald L Morton CGSO Fellowship###
Author: Trevan Fischer, MD – Saint John's Cancer Institute, Donald L Morton CGSO Fellowship
### @@@ Stacey Stern, MS – Saint John's Cancer Institute ### 1849883###Author###Data Manager###Saint John's Cancer Institute###
Author: Stacey Stern, MS – Saint John's Cancer Institute
### @@@ John Thompson, MD – Melanoma Institute Australia, The University of Sydney ### 944391###Author###Emeritus Professor Melanoma and Surgical Oncology###Melanoma Institute Australia, The University of Sydney###
Author: John Thompson, MD – Melanoma Institute Australia, The University of Sydney
### @@@ Alistair Cochran, MD – University of California Los Angeles ### 944418###Author######University of California Los Angeles###
Author: Alistair Cochran, MD – University of California Los Angeles
### @@@ Mark B. Faries, MD (he/him/his) – The Angeles Clinic and Research Institute/ Cedars-Sinai Medical Center ### 944392###Author###Professor of Surgery ###The Angeles Clinic and Research Institute/ Cedars-Sinai Medical Center###
Author: Mark B. Faries, MD (he/him/his) – The Angeles Clinic and Research Institute/ Cedars-Sinai Medical Center
### he/him/his @@@ Dave Hoon, PhD – St John's Cancer Institute ### 1850594###Author###Professor, Director of Dept. of Translational Molecular Medicine###St John's Cancer Institute###
Author: Dave Hoon, PhD – St John's Cancer Institute
### @@@ Leland Foshag, MD – St John's Cancer Institute ### 1850595###Author###Fellowship Program Director###St John's Cancer Institute###
Author: Leland Foshag, MD – St John's Cancer Institute
###
62: Validation of Invasive Area for Predicting Sentinel Node Status and Survival in Melanoma

Sophie E. Orme, MChem MBBS (she/her/hers) – Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK ### 1850381###Abstract Presenter###Academic Foundation Doctor###Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK###
Abstract Presenter: Sophie E. Orme, MChem MBBS (she/her/hers) – Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK
### she/her/hers @@@ Sophie E. Orme, MChem MBBS (she/her/hers) – Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK ### 1850381###First Author###Academic Foundation Doctor###Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK###
First Author: Sophie E. Orme, MChem MBBS (she/her/hers) – Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK
### she/her/hers @@@ Mark Bamford, FRCPath – University Hospitals of Leicester NHS Trust, Leicester, UK ### 1850382###Author###Consultant Histopathologist###University Hospitals of Leicester NHS Trust, Leicester, UK###
Author: Mark Bamford, FRCPath – University Hospitals of Leicester NHS Trust, Leicester, UK
### @@@ Marie O’Riordan, FRCPath – University Hospitals of Leicester NHS Trust, Leicester, UK ### 1850383###Author###Consultant Histopathologist###University Hospitals of Leicester NHS Trust, Leicester, UK###
Author: Marie O’Riordan, FRCPath – University Hospitals of Leicester NHS Trust, Leicester, UK
### @@@ Philip D. Da Forno, MD FRCPath – University Hospitals of Leicester NHS Trust, Leicester, UK ### 1850384###Author###Consultant Histopathologist###University Hospitals of Leicester NHS Trust, Leicester, UK###
Author: Philip D. Da Forno, MD FRCPath – University Hospitals of Leicester NHS Trust, Leicester, UK
### @@@ Andrew Snelling, FRCS(Plast.) – Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK ### 1850345###Author###Consultant Plastic & Reconstructive Surgeon###Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK###
Author: Andrew Snelling, FRCS(Plast.) – Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK
### @@@ Martin Heaton, MD FRCS(Plast.) – Norfolk & Norwich University Hospital Foundation NHS Trust ### 1850344###Author###Consultant Plastic & Reconstructive Surgeon###Norfolk & Norwich University Hospital Foundation NHS Trust###
Author: Martin Heaton, MD FRCS(Plast.) – Norfolk & Norwich University Hospital Foundation NHS Trust
### @@@ Rachael Stanley, PhD – Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK ### 1850386###Author###Biorepository Manager###Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK###
Author: Rachael Stanley, PhD – Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK
### @@@ Roxanne Brunton-Sim, n/a – Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK ### 1850387###Author###Research Consent Lead###Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK###
Author: Roxanne Brunton-Sim, n/a – Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK
### @@@ Marc D. Moncrieff, MD FRCS(Plast.) – Norfolk & Norwich University Hospital ### 944415###Author###Professor of Plastic and Reconstructive Surgery###Norfolk & Norwich University Hospital###
Author: Marc D. Moncrieff, MD FRCS(Plast.) – Norfolk & Norwich University Hospital
### @@@ Gerald Saldanha, PhD FRCPath – University Hospitals of Leicester NHS Trust, Leicester, UK ### 1850388###Author###Consultant Histopathologist###University Hospitals of Leicester NHS Trust, Leicester, UK###
Author: Gerald Saldanha, PhD FRCPath – University Hospitals of Leicester NHS Trust, Leicester, UK
###
63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)

Brian Gastman, MD – Cleveland Clinic Foundation, Cleveland, OH, USA ### 1850805###Abstract Presenter###Surgical Director, Melanoma & High-Risk Skin Cancer Program###Cleveland Clinic Foundation, Cleveland, OH, USA###
Abstract Presenter: Brian Gastman, MD – Cleveland Clinic Foundation, Cleveland, OH, USA
### @@@ Brian Gastman, MD – Cleveland Clinic Foundation, Cleveland, OH, USA ### 1850805###First Author###Surgical Director, Melanoma & High-Risk Skin Cancer Program###Cleveland Clinic Foundation, Cleveland, OH, USA###
First Author: Brian Gastman, MD – Cleveland Clinic Foundation, Cleveland, OH, USA
### @@@ Georgina V. Long, AO, BSc PhD MBBS FRACP FAHMS – Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia ### 1850807###Author###Co-Medical Director###Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia###
Author: Georgina V. Long, AO, BSc PhD MBBS FRACP FAHMS – Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia
### @@@ John M. Kirkwood, MD – UPMC Hillman Cancer Center ### 1850817###Author###Professor of Medicine, Dermatology and Co-Director, Melanoma and Skin Cancer P###UPMC Hillman Cancer Center###
Author: John M. Kirkwood, MD – UPMC Hillman Cancer Center
### @@@ Christoph Hoeller, MD, PhD – Medizinische Universität Wien ### 1850818###Author###Professor of Dermatology and Head of the Skin Cancer Center###Medizinische Universität Wien###
Author: Christoph Hoeller, MD, PhD – Medizinische Universität Wien
### @@@ Jeffrey Weber, MD, PhD – NYU Langone Medical Center ### 1850819###Author###Deputy director of the Perlmutter Cancer Center###NYU Langone Medical Center###
Author: Jeffrey Weber, MD, PhD – NYU Langone Medical Center
### @@@ Jean-Jacques Grob, MD, PhD – Hôpital de la Timone ### 1850820###Author###Professor of Dermatology###Hôpital de la Timone###
Author: Jean-Jacques Grob, MD, PhD – Hôpital de la Timone
### @@@ Peter Mohr, MD – Elbe Klinikum Buxtehude ### 1850821###Author###Dermatology Specialist###Elbe Klinikum Buxtehude###
Author: Peter Mohr, MD – Elbe Klinikum Buxtehude
### @@@ Stephan Grabbe, MD – University of Mainz Medical Center ### 1850822###Author###Managing Director of Dermatology###University of Mainz Medical Center###
Author: Stephan Grabbe, MD – University of Mainz Medical Center
### @@@ Caroline Dutriaux, MD – Hôpital Saint André ### 1850823###Author###Melanoma Specialist###Hôpital Saint André###
Author: Caroline Dutriaux, MD – Hôpital Saint André
### @@@ Vanna Chiarion-Sileni, MD – Veneto Institute of Oncology IOV-IRCCS, Veneto, Italy ### 1850812###Author###Head of Melanoma & Esophageal Oncology Unit###Veneto Institute of Oncology IOV-IRCCS, Veneto, Italy###
Author: Vanna Chiarion-Sileni, MD – Veneto Institute of Oncology IOV-IRCCS, Veneto, Italy
### @@@ Jacek Mackiewicz, PhD – Poznan University of Medical Sciences, Poznan, Poland ### 1850811###Author###Academician###Poznan University of Medical Sciences, Poznan, Poland###
Author: Jacek Mackiewicz, PhD – Poznan University of Medical Sciences, Poznan, Poland
### @@@ Piotr Rutkowski, MD, PhD – Maria Skłodowska-Curie National Research Institute of Oncology ### 1850853###Author###Professor of Surgical Oncology###Maria Skłodowska-Curie National Research Institute of Oncology###
Author: Piotr Rutkowski, MD, PhD – Maria Skłodowska-Curie National Research Institute of Oncology
### @@@ Petr Arenberger, DrSc., MBA – Charles University Third Faculty of Medicine and University Hospital of Královské Vinohrady ### 1850825###Author###Professor and Chairman at the Department of Dermatovenereology###Charles University Third Faculty of Medicine and University Hospital of Královské Vinohrady###
Author: Petr Arenberger, DrSc., MBA – Charles University Third Faculty of Medicine and University Hospital of Královské Vinohrady
### @@@ Gaelle Quereux, MD – Nantes University Hospital ### 1850826###Author###Dermatologist and Venerologist###Nantes University Hospital###
Author: Gaelle Quereux, MD – Nantes University Hospital
### @@@ Tarek Meniawy, MBBS FRACP PhD – 15Sir Charles Gairdner Hospital ### 1850827###Author###Medical Oncologist###15Sir Charles Gairdner Hospital###
Author: Tarek Meniawy, MBBS FRACP PhD – 15Sir Charles Gairdner Hospital
### @@@ Paolo A. Ascierto, MD – Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Naples, Italy ### 1850806###Author###Director of the Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy###Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Naples, Italy###
Author: Paolo A. Ascierto, MD – Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Naples, Italy
### @@@ Alexander van Akkooi, MD, PhD – Melanoma Institute Australia, Faculty of Medicine and Health, University of Sydney and Royal Prince Alfred Hospital ### 1850616###Author###A/prof###Melanoma Institute Australia, Faculty of Medicine and Health, University of Sydney and Royal Prince Alfred Hospital###
Author: Alexander van Akkooi, MD, PhD – Melanoma Institute Australia, Faculty of Medicine and Health, University of Sydney and Royal Prince Alfred Hospital
### @@@ Piyush Durani, MD – Bristol Myers Squibb ### 1850828###Author###Director, Global Oncology Clinical Development###Bristol Myers Squibb###
Author: Piyush Durani, MD – Bristol Myers Squibb
### @@@ Federico Campigotto, MS – Bristol Myers Squibb ### 1850829###Author###Statistician###Bristol Myers Squibb###
Author: Federico Campigotto, MS – Bristol Myers Squibb
### @@@ Michele Del Vecchio, MD, PhD – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 1850830###Author###Head, Unit of Melanoma Medical Oncology###Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###
Author: Michele Del Vecchio, MD, PhD – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
###
64: Lifileucel TIL Cell Therapy in Patients With Advanced Melanoma After Progression on Immune Checkpoint Inhibitors (ICI) and Targeted Therapy: Tumor Tissue Procurement Data from the C-144-01 Study

Michael E. Egger, MD, MPH – Unversity of Louisville ### 969528###Abstract Presenter###Associate Professor###Unversity of Louisville###
Abstract Presenter: Michael E. Egger, MD, MPH – Unversity of Louisville
### @@@ Michael E. Egger, MD, MPH – Unversity of Louisville ### 969528###First Author###Associate Professor###Unversity of Louisville###
First Author: Michael E. Egger, MD, MPH – Unversity of Louisville
### @@@ Martin McCarter, MD – University of Colorado School of Medicine ### 1547279###Author###Professor of Surgery###University of Colorado School of Medicine###
Author: Martin McCarter, MD – University of Colorado School of Medicine
### @@@ Kelly Olino, MD (she/her/hers) – Yale School of Medicine ### 969524###Author###Assistant Professor of Surgical Oncology###Yale School of Medicine###
Author: Kelly Olino, MD (she/her/hers) – Yale School of Medicine
### she/her/hers @@@ Nikhil Khushalani, MD – H. Lee Moffitt Cancer Center, Tampa, FL, USA ### 1850372###Author###Vice Chair for the Department of Cutaneous Oncology###H. Lee Moffitt Cancer Center, Tampa, FL, USA###
Author: Nikhil Khushalani, MD – H. Lee Moffitt Cancer Center, Tampa, FL, USA
### @@@ Jason A. Chesney, MD, PhD – University of Louisville, Louisville, KY, USA ### 1850373###Author###Professor of Medicine###University of Louisville, Louisville, KY, USA###
Author: Jason A. Chesney, MD, PhD – University of Louisville, Louisville, KY, USA
### @@@ Theresa Medina, MD – University of Colorado Cancer Center – Anschutz Medical Campus, Aurora, CO, USA ### 1850528###Author###Assistant Professor, Medicine-Medical Oncology###University of Colorado Cancer Center – Anschutz Medical Campus, Aurora, CO, USA###
Author: Theresa Medina, MD – University of Colorado Cancer Center – Anschutz Medical Campus, Aurora, CO, USA
### @@@ Harriet Kluger, MD – Yale University School of Medicine, Smilow Cancer Center, New Haven Hospital, NewHaven, CT, USA ### 1850529###Author###Professor of Medicine (Oncology) and of Dermatology###Yale University School of Medicine, Smilow Cancer Center, New Haven Hospital, NewHaven, CT, USA###
Author: Harriet Kluger, MD – Yale University School of Medicine, Smilow Cancer Center, New Haven Hospital, NewHaven, CT, USA
### @@@ Friedrich Graf Finckenstein, MD – Iovance Biotherapeutics, Inc., San Carlos, CA, USA ### 1850530###Author###Chief Medical Officer###Iovance Biotherapeutics, Inc., San Carlos, CA, USA###
Author: Friedrich Graf Finckenstein, MD – Iovance Biotherapeutics, Inc., San Carlos, CA, USA
### @@@ Parameswaran Hari, MD – Iovance Biotherapeutics, Inc., San Carlos, CA, USA ### 1850531###Author###Senior Vice President###Iovance Biotherapeutics, Inc., San Carlos, CA, USA###
Author: Parameswaran Hari, MD – Iovance Biotherapeutics, Inc., San Carlos, CA, USA
### @@@ Madan Jagasia, MBBS, MD – Iovance Biotherapeutics, Inc., San Carlos, CA, USA ### 1850533###Author###Executive Vice President###Iovance Biotherapeutics, Inc., San Carlos, CA, USA###
Author: Madan Jagasia, MBBS, MD – Iovance Biotherapeutics, Inc., San Carlos, CA, USA
### @@@ Xiao Wu, PhD – Iovance Biotherapeutics, Inc., San Carlos, CA, USA ### 1850534###Author###Executive Director, Biostatistics###Iovance Biotherapeutics, Inc., San Carlos, CA, USA###
Author: Xiao Wu, PhD – Iovance Biotherapeutics, Inc., San Carlos, CA, USA
### @@@ Wen Shi, MD, PhD – Iovance Biotherapeutics, Inc., San Carlos, CA, USA ### 1850535###Author###Vice President, Clinical Science###Iovance Biotherapeutics, Inc., San Carlos, CA, USA###
Author: Wen Shi, MD, PhD – Iovance Biotherapeutics, Inc., San Carlos, CA, USA
### @@@ Amod Sarnaik, MD – H. Lee Moffitt Cancer Center, Tampa, FL, USA ### 1850536###Author###Associate Professor of Cutaneous Oncology and Immunology###H. Lee Moffitt Cancer Center, Tampa, FL, USA###
Author: Amod Sarnaik, MD – H. Lee Moffitt Cancer Center, Tampa, FL, USA
###
65: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH Sensitive Imaging Agent: Topline Results from a Phase 2 Study

Patrick Wagner, MD – Allegheny Health Network ### 1849809###Abstract Presenter###Director, AHN Cancer Institute Division of Complex General Surgical Oncology###Allegheny Health Network###
Abstract Presenter: Patrick Wagner, MD – Allegheny Health Network
### @@@ Patrick Wagner, MD – Allegheny Health Network ### 1849809###Author###Director, AHN Cancer Institute Division of Complex General Surgical Oncology###Allegheny Health Network###
Author: Patrick Wagner, MD – Allegheny Health Network
### @@@ Edward A. Levine, MD – Wake Forest University ### 1795517###Author###Chief, Surgical Oncology###Wake Forest University###
Author: Edward A. Levine, MD – Wake Forest University
### @@@ Alex C. Kim, MD, PhD – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute ### 1529408###Author###Assistant Professor of Surgery###The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute###
Author: Alex C. Kim, MD, PhD – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute
### @@@ Perry Shen, MD – Atrium Health Wake Forest Baptist ### 1850480###Author###Professor###Atrium Health Wake Forest Baptist###
Author: Perry Shen, MD – Atrium Health Wake Forest Baptist
### @@@ Nicole Fleming, MD – MD Anderson Cancer Center ### 1850634###Author###Associate Professor###MD Anderson Cancer Center###
Author: Nicole Fleming, MD – MD Anderson Cancer Center
### @@@ Shannon Westin, MD, MPH – MD Anderson Cancer Center ### 1850635###Author###Professor###MD Anderson Cancer Center###
Author: Shannon Westin, MD, MPH – MD Anderson Cancer Center
### @@@ Madeline Olson, PhD – OncoNano Medicine ### 1850482###Author###Clinical Scientist###OncoNano Medicine###
Author: Madeline Olson, PhD – OncoNano Medicine
### @@@ Brian Madajewski, PhD – OncoNano Medicine ### 1850636###Author###Associate Director, Clinical Development###OncoNano Medicine###
Author: Brian Madajewski, PhD – OncoNano Medicine
### @@@ Brian Ostrander, MS – OncoNano Medicine ### 1850637###Author###Vice President, Head of Clinical Operations###OncoNano Medicine###
Author: Brian Ostrander, MS – OncoNano Medicine
### @@@ Kartik Krishnan, MD, PhD – OncoNano Medicine ### 1850638###Author###Chief Medical Officer###OncoNano Medicine###
Author: Kartik Krishnan, MD, PhD – OncoNano Medicine
### @@@ Baran Sumer, MD – UT Southwestern Medical Center ### 1850639###Author###Professor###UT Southwestern Medical Center###
Author: Baran Sumer, MD – UT Southwestern Medical Center
### @@@ Tian Zhao, PhD – OncoNano Medicine ### 1850640###Author###Vice President, Research and Development###OncoNano Medicine###
Author: Tian Zhao, PhD – OncoNano Medicine
### @@@ Jinming Gao, MD – Allegheny Health Network ### 1850641###Author###Chair, AHN Cancer Institute###Allegheny Health Network###
Author: Jinming Gao, MD – Allegheny Health Network
### @@@ David L. Bartlett, MD – Allegheny Health Network Cancer Institute ### 917897###Author###System Chair###Allegheny Health Network Cancer Institute###
Author: David L. Bartlett, MD – Allegheny Health Network Cancer Institute
###
66: Utilizing Organoids to Study Perfusate Selection in Appendiceal Cancer Patients Undergoing Repeat HIPEC

Richard A. Erali, MD MPH – Wake Forest Baptist Health ### 918100###Abstract Presenter###General Surgery Resident###Wake Forest Baptist Health###
Abstract Presenter: Richard A. Erali, MD MPH – Wake Forest Baptist Health
### @@@ Richard A. Erali, MD MPH – Wake Forest Baptist Health ### 918100###First Author###General Surgery Resident###Wake Forest Baptist Health###
First Author: Richard A. Erali, MD MPH – Wake Forest Baptist Health
### @@@ Steven D. Forsythe, MSc – Wake Forest School of Medicine ### 915761###Author###Graduate Student###Wake Forest School of Medicine###
Author: Steven D. Forsythe, MSc – Wake Forest School of Medicine
### @@@ Daniel Gironda, MS – Wake Forest University ### 1850974###Author###Graduate Research Student###Wake Forest University###
Author: Daniel Gironda, MS – Wake Forest University
### @@@ Nadeem Wajih, PhD – Wake Forest University ### 1850969###Author###Research Assistant###Wake Forest University###
Author: Nadeem Wajih, PhD – Wake Forest University
### @@@ Chris W. Mangieri, MD – Tripler Army Medical Center ### 1850975###Author###Chief of Surgical Oncology###Tripler Army Medical Center###
Author: Chris W. Mangieri, MD – Tripler Army Medical Center
### @@@ Perry Shen, MD – Atrium Health Wake Forest Baptist ### 1850480###Author###Professor###Atrium Health Wake Forest Baptist###
Author: Perry Shen, MD – Atrium Health Wake Forest Baptist
### @@@ Edward A. Levine, MD – Wake Forest University ### 1795517###Author###Chief, Surgical Oncology###Wake Forest University###
Author: Edward A. Levine, MD – Wake Forest University
### @@@ Shay Soker, PhD – Wake Forest University ### 1850972###Author###Professor###Wake Forest University###
Author: Shay Soker, PhD – Wake Forest University
### @@@ Konstantinos I. Votanopoulos, MD, PhD – Wake Forest University ### 922517###Author###Professor Surgical Oncology; Director, Wake Forest Organoid Research Center (WFORCE)###Wake Forest University ###
Author: Konstantinos I. Votanopoulos, MD, PhD – Wake Forest University
###
67: Molecular mechanism of colorectal peritoneal metastasis: an interesting TWIST

Manoj H. Palavalli, MD (he/him/his) – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute ### 1850695###Abstract Presenter###Research Assistant ###The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute###
Abstract Presenter: Manoj H. Palavalli, MD (he/him/his) – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute
### he/him/his @@@ Manoj H. Palavalli, MD (he/him/his) – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute ### 1850695###First Author###Research Assistant ###The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute###
First Author: Manoj H. Palavalli, MD (he/him/his) – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute
### he/him/his @@@ Mozaffarul Islam, PhD – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute ### 1850696###Author###Research Scientist###The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute###
Author: Mozaffarul Islam, PhD – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute
### @@@ Christopher T. Aquina, MD, MPH – AdventHealth Orlando ### 1530277###Author###Assistant Professor###AdventHealth Orlando###
Author: Christopher T. Aquina, MD, MPH – AdventHealth Orlando
### @@@ Samantha Ruff, MD – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute ### 1849932###Author###Fellow###The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute###
Author: Samantha Ruff, MD – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute
### @@@ Gyulnara Kasumova, MD – Ohio State University/ James Cancer Hospital ### 1530326###Author###GCSO Fellow###Ohio State University/ James Cancer Hospital###
Author: Gyulnara Kasumova, MD – Ohio State University/ James Cancer Hospital
### @@@ Andrew Koempel, n/a – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute ### 1850697###Author###Undergraduate Research Assistant###The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute###
Author: Andrew Koempel, n/a – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute
### @@@ Jing Wen, MS – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute ### 1850698###Author###Research Assistant###The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute###
Author: Jing Wen, MS – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute
### @@@ Oliver S. Eng, MD (he/him/his) – University of California, Irvine ### 1849737###Author###Associate Professor of Surgery###University of California, Irvine###
Author: Oliver S. Eng, MD (he/him/his) – University of California, Irvine
### he/him/his @@@ Mohamed Adam, MD – University of California - San Francisco Medical Center ### 1849933###Author###Assistant Professor of Surgery###University of California - San Francisco Medical Center###
Author: Mohamed Adam, MD – University of California - San Francisco Medical Center
### @@@ Jordan M. Cloyd, MD – The Ohio State University ### 915758###Author###Assistant Professor###The Ohio State University###
Author: Jordan M. Cloyd, MD – The Ohio State University
### @@@ Aslam Ejaz, MD, MPH – The Ohio State University ### 1502392###Author###Assistant Professor of Surgery###The Ohio State University###
Author: Aslam Ejaz, MD, MPH – The Ohio State University
### @@@ Joal D. Beane, MD – The Ohio State University Wexner Medical Center- Division of Surgical Oncology ### 1849833###Author###Assistant Professor###The Ohio State University Wexner Medical Center- Division of Surgical Oncology###
Author: Joal D. Beane, MD – The Ohio State University Wexner Medical Center- Division of Surgical Oncology
### @@@ Alex C. Kim, MD, PhD – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute ### 1529408###Author###Assistant Professor of Surgery###The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute###
Author: Alex C. Kim, MD, PhD – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute
###
68: Assessing the Mucolytic and Cytotoxic Activity of Bromelain in Appendiceal Cancer Organoids

Richard A. Erali, MD MPH – Wake Forest Baptist Health ### 918100###Abstract Presenter###General Surgery Resident###Wake Forest Baptist Health###
Abstract Presenter: Richard A. Erali, MD MPH – Wake Forest Baptist Health
### @@@ Richard A. Erali, MD MPH – Wake Forest Baptist Health ### 918100###First Author###General Surgery Resident###Wake Forest Baptist Health###
First Author: Richard A. Erali, MD MPH – Wake Forest Baptist Health
### @@@ Nadeem Wajih, PhD – Wake Forest University ### 1850969###Author###Research Assistant###Wake Forest University###
Author: Nadeem Wajih, PhD – Wake Forest University
### @@@ Steven D. Forsythe, MSc – Wake Forest School of Medicine ### 915761###Author###Graduate Student###Wake Forest School of Medicine###
Author: Steven D. Forsythe, MSc – Wake Forest School of Medicine
### @@@ Perry Shen, MD – Atrium Health Wake Forest Baptist ### 1850480###Author###Professor###Atrium Health Wake Forest Baptist###
Author: Perry Shen, MD – Atrium Health Wake Forest Baptist
### @@@ Edward A. Levine, MD – Wake Forest University ### 1795517###Author###Chief, Surgical Oncology###Wake Forest University###
Author: Edward A. Levine, MD – Wake Forest University
### @@@ Shay Soker, PhD – Wake Forest University ### 1850972###Author###Professor###Wake Forest University###
Author: Shay Soker, PhD – Wake Forest University
### @@@ David L. Morris, FRCS, FRCSE, MD, PhD, FRACS (he/him/his) – St George Hospital ### 1795365###Author###Professor of Surgery###St George Hospital###
Author: David L. Morris, FRCS, FRCSE, MD, PhD, FRACS (he/him/his) – St George Hospital
### he/him/his @@@ Konstantinos I. Votanopoulos, MD, PhD – Wake Forest University ### 922517###Author###Professor Surgical Oncology; Director, Wake Forest Organoid Research Center (WFORCE)###Wake Forest University ###
Author: Konstantinos I. Votanopoulos, MD, PhD – Wake Forest University
###
69: Peritoneal fluid cytokine analysis reveals targets for regional immunotherapy in carcinomatosis

Chelsea Knotts, MD – Allegheny Health Network ### 1849804###Abstract Presenter###Surgical Oncology Fellow###Allegheny Health Network###
Abstract Presenter: Chelsea Knotts, MD – Allegheny Health Network
### @@@ Chelsea Knotts, MD – Allegheny Health Network ### 1849804###First Author###Surgical Oncology Fellow###Allegheny Health Network###
First Author: Chelsea Knotts, MD – Allegheny Health Network
### @@@ Vera Donnenberg, PhD – University of Pittsburgh Medical Center ### 1850597###Author###Scientist###University of Pittsburgh Medical Center###
Author: Vera Donnenberg, PhD – University of Pittsburgh Medical Center
### @@@ Christian Cruz Pico, MD – Allegheny Health Network Cancer Institute ### 1850599###Author###Fellow###Allegheny Health Network Cancer Institute###
Author: Christian Cruz Pico, MD – Allegheny Health Network Cancer Institute
### @@@ Suzanne Schiffman, MD – Allegheny Health Network Cancer Institute ### 1850600###Author###Attending Surgeon###Allegheny Health Network Cancer Institute###
Author: Suzanne Schiffman, MD – Allegheny Health Network Cancer Institute
### @@@ William Nelson, MD – Allegheny Health Network ### 1850601###Author###Attending Surgeon###Allegheny Health Network###
Author: William Nelson, MD – Allegheny Health Network
### @@@ Kirsten Newhams, MD – Allegheny Health Network ### 1850602###Author###Attending Surgeon###Allegheny Health Network###
Author: Kirsten Newhams, MD – Allegheny Health Network
### @@@ Casey J. Allen, MD – Allegheny Health Network ### 969950###Author###Assistant Professor, Division of Surgical Oncology###Allegheny Health Network###
Author: Casey J. Allen, MD – Allegheny Health Network
### @@@ Albert Donnenberg, PhD – University of Pittsburgh Medical Center ### 1850598###Author###Scientist###University of Pittsburgh Medical Center###
Author: Albert Donnenberg, PhD – University of Pittsburgh Medical Center
### @@@ David L. Bartlett, MD – Allegheny Health Network Cancer Institute ### 917897###Author###System Chair###Allegheny Health Network Cancer Institute###
Author: David L. Bartlett, MD – Allegheny Health Network Cancer Institute
### @@@ Patrick Wagner, MD – Allegheny Health Network ### 1849809###Author###Director, AHN Cancer Institute Division of Complex General Surgical Oncology###Allegheny Health Network###
Author: Patrick Wagner, MD – Allegheny Health Network
###
7: Multicenter clinical trial for omission of breast surgery in invasive cancer following neoadjuvant systemic therapy: Longitudinal patient reported outcomes and decisional comfort planned analyses

Helen M. Johnson, MD (she/her/hers) – MD Anderson Cancer Center ### 1850446###Abstract Presenter###Breast Surgical Oncology Fellow###MD Anderson Cancer Center###
Abstract Presenter: Helen M. Johnson, MD (she/her/hers) – MD Anderson Cancer Center
### she/her/hers @@@ Emilia Diego, MD – University of Pittsburgh ### 1047219###Author###Chief, Section of Breast Surgery###University of Pittsburgh###
Author: Emilia Diego, MD – University of Pittsburgh
### @@@ Savitri Krishnamurthy, MD – MD Anderson Cancer Center ### 1850447###Author###Department of Pathology###MD Anderson Cancer Center###
Author: Savitri Krishnamurthy, MD – MD Anderson Cancer Center
### @@@ Wei Yang, MBBS MHM – MD Anderson Cancer Center ### 1850448###Author###Department of Breast Imaging###MD Anderson Cancer Center###
Author: Wei Yang, MBBS MHM – MD Anderson Cancer Center
### @@@ Benjamin D. Smith, MD – The University of Texas MD Anderson Cancer Center ### 944428###Author###Professor###The University of Texas MD Anderson Cancer Center###
Author: Benjamin D. Smith, MD – The University of Texas MD Anderson Cancer Center
### @@@ Vincente Valero, MD – MD Anderson Cancer Center ### 1850449###Author###Department of Breast Medical Oncology###MD Anderson Cancer Center###
Author: Vincente Valero, MD – MD Anderson Cancer Center
### @@@ Anthony Lucci, Jr., MD – The University of Texas MD Anderson Cancer Center ### 937367###Author###Professor###The University of Texas MD Anderson Cancer Center###
Author: Anthony Lucci, Jr., MD – The University of Texas MD Anderson Cancer Center
### @@@ Simona Shaitelman, MD EdM – MD Anderson Cancer Center ### 1850450###Author###Department of Radiation Oncology###MD Anderson Cancer Center###
Author: Simona Shaitelman, MD EdM – MD Anderson Cancer Center
### @@@ Melissa Mitchell, MD PhD – MD Anderson Cancer Center ### 1850451###Author###Department of Radiation Oncology###MD Anderson Cancer Center###
Author: Melissa Mitchell, MD PhD – MD Anderson Cancer Center
### @@@ Judy C. Boughey, MD, FACS, FSSO (she/her/hers) – Mayo Clinic ### 937371###Author###Professor of Surgery, W.H. Odell Professor in Individualized Medicine, Chair-Division of Breast and Melanoma Surgical Oncology, Department of Surgery###Mayo Clinic###
Author: Judy C. Boughey, MD, FACS, FSSO (she/her/hers) – Mayo Clinic
### she/her/hers @@@ Richard L. White, MD – Atrium Health-Levine Cancer Institute ### 1184643###Author###Chief, Division of Surgical Oncology###Atrium Health-Levine Cancer Institute###
Author: Richard L. White, MD – Atrium Health-Levine Cancer Institute
### @@@ Gaiane Rauch, MD PhD – MD Anderson Cancer Center ### 1850452###Author###Department of Breast Imaging###MD Anderson Cancer Center###
Author: Gaiane Rauch, MD PhD – MD Anderson Cancer Center
### @@@ Henry M. Kuerer, MD, PhD – The University of Texas MD Anderson Cancer Center ### 937372###Author###Professor, Breast Surgical Oncology; Executive Director, Breast Programs MD Anderson Cancer Network###The University of Texas MD Anderson Cancer Center###
Author: Henry M. Kuerer, MD, PhD – The University of Texas MD Anderson Cancer Center
###
70: Oncologic outcomes of cytoreductive surgery and HIPEC for highly selected patients with pancreatic ductal adenocarcinoma

Hallbera Gudmundsdottir, MD – Department of Surgery, Mayo Clinic ### 1849795###Abstract Presenter###Resident###Department of Surgery, Mayo Clinic###
Abstract Presenter: Hallbera Gudmundsdottir, MD – Department of Surgery, Mayo Clinic
### @@@ Hallbera Gudmundsdottir, MD – Department of Surgery, Mayo Clinic ### 1849795###First Author###Resident###Department of Surgery, Mayo Clinic###
First Author: Hallbera Gudmundsdottir, MD – Department of Surgery, Mayo Clinic
### @@@ Jennifer Yonkus, MD – Mayo Clinic ### 1530217###Author###General Surgery Resident###Mayo Clinic###
Author: Jennifer Yonkus, MD – Mayo Clinic
### @@@ Cornelius A. Thiels, DO, MBA – Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic ### 1849801###Author###Assistant Professor###Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic###
Author: Cornelius A. Thiels, DO, MBA – Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic
### @@@ Susanne G. Warner, MD – Mayo Clinic ### 1553767###Author###Assistant Professor of Surgery###Mayo Clinic###
Author: Susanne G. Warner, MD – Mayo Clinic
### @@@ Sean Cleary, MD – Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic ### 1849797###Author###Professor###Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic###
Author: Sean Cleary, MD – Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic
### @@@ Michael Kendrick, MD – Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic ### 1849798###Author###Professor###Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic###
Author: Michael Kendrick, MD – Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic
### @@@ Mark J. Truty, MD, MSc – Mayo Clinic Rochester ### 1416414###Author###Practice Chair###Mayo Clinic Rochester###
Author: Mark J. Truty, MD, MSc – Mayo Clinic Rochester
### @@@ Travis E. Grotz, MD – Mayo Clinic ### 1214721###Author###Assistant Professor###Mayo Clinic###
Author: Travis E. Grotz, MD – Mayo Clinic
###
71: Intra-and interpatient drug response heterogeneity exist in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastrointestinal cancers

Shannon N. Radomski, MD (she/her/hers) – Department of Surgery, Johns Hopkins Hospital ### 1850375###Abstract Presenter###Resident###Department of Surgery, Johns Hopkins Hospital###
Abstract Presenter: Shannon N. Radomski, MD (she/her/hers) – Department of Surgery, Johns Hopkins Hospital
### she/her/hers @@@ Shannon N. Radomski, MD (she/her/hers) – Department of Surgery, Johns Hopkins Hospital ### 1850375###First Author###Resident###Department of Surgery, Johns Hopkins Hospital###
First Author: Shannon N. Radomski, MD (she/her/hers) – Department of Surgery, Johns Hopkins Hospital
### she/her/hers @@@ Matthew Dunworth, BS – Department of Cell Biology, School of Medicine, Johns Hopkins University ### 1850378###Author###Graduate Student###Department of Cell Biology, School of Medicine, Johns Hopkins University###
Author: Matthew Dunworth, BS – Department of Cell Biology, School of Medicine, Johns Hopkins University
### @@@ Junior J. West, PhD – Department of Cell Biology, School of Medicine, Johns Hopkins University ### 1850379###Author###Postdoctoral Fellow###Department of Cell Biology, School of Medicine, Johns Hopkins University###
Author: Junior J. West, PhD – Department of Cell Biology, School of Medicine, Johns Hopkins University
### @@@ Jonathan B. Greer, MD – Johns Hopkins University School of Medicine ### 915765###Author###Assistant Professor of Surgery and Oncology###Johns Hopkins University School of Medicine###
Author: Jonathan B. Greer, MD – Johns Hopkins University School of Medicine
### @@@ Fabian M. Johnston, MD, MHS – Johns Hopkins University ### 917904###Author###Associate Professor of Surgery###Johns Hopkins University###
Author: Fabian M. Johnston, MD, MHS – Johns Hopkins University
### @@@ Andrew Ewald, PhD – Department of Cell Biology, School of Medicine, Johns Hopkins University ### 1850380###Author###Professor###Department of Cell Biology, School of Medicine, Johns Hopkins University###
Author: Andrew Ewald, PhD – Department of Cell Biology, School of Medicine, Johns Hopkins University
###
72: Cost Analysis and Financial Implications of Cytoreductive Surgery and HIPEC: a US Single Center Experience

Andres A. Abreu, MD (he/him/his) – UT Southwestern Medical Center ### 1850136###Abstract Presenter###Postdoctoral Researcher###UT Southwestern Medical Center###
Abstract Presenter: Andres A. Abreu, MD (he/him/his) – UT Southwestern Medical Center
### he/him/his @@@ Andres A. Abreu, MD (he/him/his) – UT Southwestern Medical Center ### 1850136###First Author###Postdoctoral Researcher###UT Southwestern Medical Center###
First Author: Andres A. Abreu, MD (he/him/his) – UT Southwestern Medical Center
### he/him/his @@@ Emile Farah, MD – UT Southwestern Medical Center ### 1850133###Author###Postdoctoral Research Fellow###UT Southwestern Medical Center###
Author: Emile Farah, MD – UT Southwestern Medical Center
### @@@ Collin Coble, n/a – UTSW ### 1850933###Author###Management Analyst###UTSW###
Author: Collin Coble, n/a – UTSW
### @@@ Benjamin Rail, n/a – UT Southwestern Medical Center ### 1850138###Author###Medical Student###UT Southwestern Medical Center###
Author: Benjamin Rail, n/a – UT Southwestern Medical Center
### @@@ Rodrigo E. Alterio, MD – University of Texas Southwestern Medical Center ### 1850515###Author###Resident###University of Texas Southwestern Medical Center###
Author: Rodrigo E. Alterio, MD – University of Texas Southwestern Medical Center
### @@@ Shweta Sridhar, n/a – UTSW ### 1850935###Author###Medical Student###UTSW###
Author: Shweta Sridhar, n/a – UTSW
### @@@ Yoma Ogbevire, n/a – UTSW ### 1850936###Author###Medical Student###UTSW###
Author: Yoma Ogbevire, n/a – UTSW
### @@@ Robert Nix, MBA – UTSW ### 1850934###Author###Surgery Department Administrator###UTSW###
Author: Robert Nix, MBA – UTSW
### @@@ Fallon Ngo, D.O. – UTSW ### 1850937###Author###Assistant Professor###UTSW###
Author: Fallon Ngo, D.O. – UTSW
### @@@ Anupama Wadwah, M.D. – UTSW ### 1850938###Author###Professor of Anesthesiology###UTSW###
Author: Anupama Wadwah, M.D. – UTSW
### @@@ Mathew M. Augustine, M.D. – UTSW ### 1850932###Author###Assistant Professor###UTSW###
Author: Mathew M. Augustine, M.D. – UTSW
### @@@ Sam C. Wang, MD – UT Southwestern Medical Center ### 969956###Author###Associate Professor###UT Southwestern Medical Center###
Author: Sam C. Wang, MD – UT Southwestern Medical Center
### @@@ Giorgos Karakousis, MD – Hospital of the University of Pennsylvania ### 915770###Author###Professor of Surgery###Hospital of the University of Pennsylvania###
Author: Giorgos Karakousis, MD – Hospital of the University of Pennsylvania
### @@@ Adam Yopp, MD – UT Southwestern Medical Center ### 937334###Author###Chief, Division of Surgical Oncology###UT Southwestern Medical Center###
Author: Adam Yopp, MD – UT Southwestern Medical Center
### @@@ Herbert J. Zeh, III, MD – UT Southwestern Medical Center ### 952880###Author###Chair of Surgery###UT Southwestern Medical Center###
Author: Herbert J. Zeh, III, MD – UT Southwestern Medical Center
### @@@ Patricio M. Polanco, MD – University of Texas Southwestern Medical Center ### 937411###Author###MD###University of Texas Southwestern Medical Center###
Author: Patricio M. Polanco, MD – University of Texas Southwestern Medical Center
###
73: Predicting Early Recurrence to optimize Patient Selection for Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy in High-Grade Appendiceal Mucinous Carcinoma Peritonei

Ahmed B. Hamed, MD – University of Pittsburgh ### 1850066###Abstract Presenter###Post-doctoral associate###University of Pittsburgh###
Abstract Presenter: Ahmed B. Hamed, MD – University of Pittsburgh
### @@@ Ahmed B. Hamed, MD – University of Pittsburgh ### 1850066###First Author###Post-doctoral associate###University of Pittsburgh###
First Author: Ahmed B. Hamed, MD – University of Pittsburgh
### @@@ Joshua Derby, BA – University of Pittsburgh Medical Center ### 1849703###Author###Data Coordinator and Analyst###University of Pittsburgh Medical Center###
Author: Joshua Derby, BA – University of Pittsburgh Medical Center
### @@@ Matthew Holtzman, MD – University of Pittsburgh Medical Center ### 1849704###Author###Assistant Professor of Surgery###University of Pittsburgh Medical Center###
Author: Matthew Holtzman, MD – University of Pittsburgh Medical Center
### @@@ Melanie Ongchin, MD – University of Pittsburgh Medical Center ### 915783###Author###Assistant Professor of Surgery###University of Pittsburgh Medical Center###
Author: Melanie Ongchin, MD – University of Pittsburgh Medical Center
### @@@ David L. Bartlett, MD – Allegheny Health Network Cancer Institute ### 917897###Author###System Chair###Allegheny Health Network Cancer Institute###
Author: David L. Bartlett, MD – Allegheny Health Network Cancer Institute
### @@@ James F. Pingpank, Jr., MD – University of Pittsburgh ### 937467###Author###Associate Professor###University of Pittsburgh###
Author: James F. Pingpank, Jr., MD – University of Pittsburgh
### @@@ Reetesh Pai, MD – University of Pittsburgh Medical Center ### 1850067###Author###Professor of Pathology###University of Pittsburgh Medical Center###
Author: Reetesh Pai, MD – University of Pittsburgh Medical Center
### @@@ Aatur Singhi, MD, PhD – University of Pittsburgh Medical Center ### 937362###Author######University of Pittsburgh Medical Center###
Author: Aatur Singhi, MD, PhD – University of Pittsburgh Medical Center
### @@@ Mohammad Haroon A. Choudry, MD – University of Pittsburgh School of Medicine ### 915757###Author###Associate Professor of Surgery###University of Pittsburgh School of Medicine###
Author: Mohammad Haroon A. Choudry, MD – University of Pittsburgh School of Medicine
###
74: Interim Results of a Phase II Trial of Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Patients with Extremity Sarcoma

Edmund Bartlett, MD – Memorial Sloan Kettering Cancer Center ### 944412###Abstract Presenter###Assistant Attending, Gastric and Mixed Tumor Service###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Edmund Bartlett, MD – Memorial Sloan Kettering Cancer Center
### @@@ Edmund Bartlett, MD – Memorial Sloan Kettering Cancer Center ### 944412###First Author###Assistant Attending, Gastric and Mixed Tumor Service###Memorial Sloan Kettering Cancer Center###
First Author: Edmund Bartlett, MD – Memorial Sloan Kettering Cancer Center
### @@@ Sandra D'Angelo, MD – Department of Medicine ### 1850489###Author###Associate attending###Department of Medicine###
Author: Sandra D'Angelo, MD – Department of Medicine
### @@@ Ciara Kelly, MD – Department of Medicine ### 1850490###Author###Assistant Attending###Department of Medicine###
Author: Ciara Kelly, MD – Department of Medicine
### @@@ Evan Rosenbaum, MD – Department of Medicine ### 1850491###Author###Assistant Attending###Department of Medicine###
Author: Evan Rosenbaum, MD – Department of Medicine
### @@@ Sujana Movva, MD – Department of Medicine ### 1850492###Author###Assistant Attending###Department of Medicine###
Author: Sujana Movva, MD – Department of Medicine
### @@@ Joseph Erinjeri, MD – Department of Radiology ### 1850493###Author###Attending###Department of Radiology###
Author: Joseph Erinjeri, MD – Department of Radiology
### @@@ Charles Fisher, BA – Department of Anesthesia ### 1850494###Author###Chief Anesthetist###Department of Anesthesia###
Author: Charles Fisher, BA – Department of Anesthesia
### @@@ Samuel Singer, MD – Memorial Sloan Kettering Cancer Center ### 1529501###Author###Director MSK Sarcoma Center###Memorial Sloan Kettering Cancer Center###
Author: Samuel Singer, MD – Memorial Sloan Kettering Cancer Center
### @@@ Cristina Antonescu, MD, PhD – Department of Pathology ### 1850495###Author###Attending###Department of Pathology###
Author: Cristina Antonescu, MD, PhD – Department of Pathology
### @@@ Charlotte E. Ariyan, MD, PhD – Memorial Sloan Kettering Cancer Center ### 937462###Author###Associate Attending, Gastric & Mixed Tumor Service###Memorial Sloan Kettering Cancer Center###
Author: Charlotte E. Ariyan, MD, PhD – Memorial Sloan Kettering Cancer Center
###
75: T cell Inducible Costimulator (ICOS) blockade increases the efficacy of imatinib in Gastrointestinal Stromal Tumor (GIST)

Katherine J. Tardy, MD – University of Pennsylvania ### 1850840###Abstract Presenter###Post-Doctoral Research Fellow###University of Pennsylvania###
Abstract Presenter: Katherine J. Tardy, MD – University of Pennsylvania
### @@@ Katherine J. Tardy, MD – University of Pennsylvania ### 1850840###First Author###Post-Doctoral Research Fellow###University of Pennsylvania###
First Author: Katherine J. Tardy, MD – University of Pennsylvania
### @@@ Andrew Tieniber, MD – University of Pennsylvania ### 1530270###Author###General Surgery Resident ###University of Pennsylvania###
Author: Andrew Tieniber, MD – University of Pennsylvania
### @@@ Hyunjee V. Kwak, MD – University of Pennsylvania ### 1850845###Author###Postdoctoral Research Fellow###University of Pennsylvania###
Author: Hyunjee V. Kwak, MD – University of Pennsylvania
### @@@ Kevin Do, BS – University of Pennsylvania ### 1850847###Author###Laboratory Technician###University of Pennsylvania###
Author: Kevin Do, BS – University of Pennsylvania
### @@@ Laura Wang, BS – University of Pennsylvania ### 1850846###Author###Laboratory Technician###University of Pennsylvania###
Author: Laura Wang, BS – University of Pennsylvania
### @@@ Shan Zeng, PhD – University of Pennsylvania ### 1850848###Author###Senior Scientist###University of Pennsylvania###
Author: Shan Zeng, PhD – University of Pennsylvania
### @@@ Ferdinando Rossi, PhD – University of Pennsylvania ### 1850849###Author###Senior Scientist###University of Pennsylvania###
Author: Ferdinando Rossi, PhD – University of Pennsylvania
### @@@ Ronald P. DeMatteo, MD, FACS (he/him/his) – The Hospital of the University of Pennsylvania ### 1262633###Author###Chair, Department of Surgery###The Hospital of the University of Pennsylvania###
Author: Ronald P. DeMatteo, MD, FACS (he/him/his) – The Hospital of the University of Pennsylvania
### he/him/his
76: Single nuclei RNAseq Reveals Dedifferentiation States from Human ICCs to GIST

Ashwyn K. Sharma, MD (he/him/his) – UC San Diego ### 1850947###Abstract Presenter###Resident Physician###UC San Diego###
Abstract Presenter: Ashwyn K. Sharma, MD (he/him/his) – UC San Diego
### he/him/his @@@ Ashwyn K. Sharma, MD (he/him/his) – UC San Diego ### 1850947###First Author###Resident Physician###UC San Diego###
First Author: Ashwyn K. Sharma, MD (he/him/his) – UC San Diego
### he/him/his @@@ John Jun, B.S. – UC San Diego ### 1850948###Author###Bioinformatics Scientist###UC San Diego###
Author: John Jun, B.S. – UC San Diego
### @@@ Alexander T. Wenzel, B.S. – UC San Diego ### 1850949###Author###PhD Candidate###UC San Diego###
Author: Alexander T. Wenzel, B.S. – UC San Diego
### @@@ Chih-Min Tang, PhD – UC San Diego ### 1850951###Author###Staff Research Associate###UC San Diego###
Author: Chih-Min Tang, PhD – UC San Diego
### @@@ Diwakar Guragain, PhD – UC San Diego ### 1850950###Author###Postdoctoral Employee###UC San Diego###
Author: Diwakar Guragain, PhD – UC San Diego
### @@@ Jill P. Mesirov, PhD – UC San Diego ### 1850952###Author###Professor of Medicine###UC San Diego###
Author: Jill P. Mesirov, PhD – UC San Diego
### @@@ Jason Sicklick, MD (he/him/his) – Moores Cancer Center | UC San Diego Health ### 1795514###Author###Professor of Surgery and Pharmacology###Moores Cancer Center | UC San Diego Health ###
Author: Jason Sicklick, MD (he/him/his) – Moores Cancer Center | UC San Diego Health
### he/him/his
77: Current Patterns of Care and Outcomes for Dermatofibrosarcoma Protuberans: An International Multi-institutional Collaborative

Leah K. Winer, MD – Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, USA ### 1850779###Abstract Presenter###Complex General Surgical Oncology Fellow###Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, USA###
Abstract Presenter: Leah K. Winer, MD – Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, USA
### @@@ Leah K. Winer, MD – Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, USA ### 1850779###First Author###Complex General Surgical Oncology Fellow###Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, USA###
First Author: Leah K. Winer, MD – Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, USA
### @@@ Rita Akumuo, MD – Department of General Surgery, Temple University Hospital, Philadelphia, USA ### 1850780###Author###General Surgery Resident###Department of General Surgery, Temple University Hospital, Philadelphia, USA###
Author: Rita Akumuo, MD – Department of General Surgery, Temple University Hospital, Philadelphia, USA
### @@@ Elizabeth Handorf, PhD – Division of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, USA ### 1850781###Author###Associate Professor###Division of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, USA###
Author: Elizabeth Handorf, PhD – Division of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, USA
### @@@ Stephanie Greco, MD, FACS – Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, USA ### 1850782###Author###Assistant Professor###Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, USA###
Author: Stephanie Greco, MD, FACS – Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, USA
### @@@ Alex Bartholomew, MD (he/him/his) – Duke University Medical Center ### 1849697###Author###General Surgery Resident###Duke University Medical Center###
Author: Alex Bartholomew, MD (he/him/his) – Duke University Medical Center
### he/him/his @@@ Dan Blazer, III, MD – Duke University Medical Center ### 1214700###Author###Associate Professor of Surgery###Duke University Medical Center###
Author: Dan Blazer, III, MD – Duke University Medical Center
### @@@ Lucie Gabrielova, MD – Department of Surgery, Masaryk Memorial Cancer Institute, Brno, Zluty kopec, Czech Republic ### 1850783###Author###Assistant Professor###Department of Surgery, Masaryk Memorial Cancer Institute, Brno, Zluty kopec, Czech Republic###
Author: Lucie Gabrielova, MD – Department of Surgery, Masaryk Memorial Cancer Institute, Brno, Zluty kopec, Czech Republic
### @@@ Dagmar A. Krakorova, MD, PhD – Department of Surgery, Masaryk Memorial Cancer Institute, Brno, Zluty kopec, Czech Republic ### 1850784###Author###Assistant Professor###Department of Surgery, Masaryk Memorial Cancer Institute, Brno, Zluty kopec, Czech Republic###
Author: Dagmar A. Krakorova, MD, PhD – Department of Surgery, Masaryk Memorial Cancer Institute, Brno, Zluty kopec, Czech Republic
### @@@ Ericka Bernard-Bedard, n/a – Division of Surgical Oncology, Ottawa Hospital, Ottawa, Canada ### 1850802###Author###Assistant Professor###Division of Surgical Oncology, Ottawa Hospital, Ottawa, Canada###
Author: Ericka Bernard-Bedard, n/a – Division of Surgical Oncology, Ottawa Hospital, Ottawa, Canada
### @@@ Carolyn Nessim, MD, MSc, FRCSC, FACS (she/her/hers) – The Ottawa Hospital, University of Ottawa, Ottawa Hospital Research Institute ### 1795369###Author###Surgical Oncologist, Associate Professor, Clinician Investigator, CGSO Program Director###The Ottawa Hospital, University of Ottawa, Ottawa Hospital Research Institute###
Author: Carolyn Nessim, MD, MSc, FRCSC, FACS (she/her/hers) – The Ottawa Hospital, University of Ottawa, Ottawa Hospital Research Institute
### she/her/hers @@@ Attila Kollár, MD – Department of Medical Oncology, Inselspital University Hospital Bern, Freiburgstrasse, Switzerland ### 1850786###Author###Consultant###Department of Medical Oncology, Inselspital University Hospital Bern, Freiburgstrasse, Switzerland###
Author: Attila Kollár, MD – Department of Medical Oncology, Inselspital University Hospital Bern, Freiburgstrasse, Switzerland
### @@@ Radu Olariu, MD PhD – Department of Plastic and Hand Surgery, Inselspital University Hospital Bern, Freiburgstrasse, Switzerland ### 1850787###Author###Deputy Head of Department###Department of Plastic and Hand Surgery, Inselspital University Hospital Bern, Freiburgstrasse, Switzerland###
Author: Radu Olariu, MD PhD – Department of Plastic and Hand Surgery, Inselspital University Hospital Bern, Freiburgstrasse, Switzerland
### @@@ Romi Cencelj-Arnez, MD – Institute of Oncology ### 1850468###Author###Surgical Oncologist###Institute of Oncology###
Author: Romi Cencelj-Arnez, MD – Institute of Oncology
### @@@ Daphne Hompes, MD, PhD – Department of Surgical Oncology, University Hospitals Leuven, Leuven, Belgium ### 1850791###Author###Professor###Department of Surgical Oncology, University Hospitals Leuven, Leuven, Belgium###
Author: Daphne Hompes, MD, PhD – Department of Surgical Oncology, University Hospitals Leuven, Leuven, Belgium
### @@@ Sam Ford, n/a – University Hospital Birmingham NHS Foundation Trust ### 1849925###Author###Surgical Oncologist###University Hospital Birmingham NHS Foundation Trust###
Author: Sam Ford, n/a – University Hospital Birmingham NHS Foundation Trust
### @@@ Kenneth Cardona, MD – Winship Cancer Institute, Emory University ### 937449###Author###Patricia R. Reynolds Professor of Sarcoma, Associate Chief of Surgery EUH Midtown; Lead, Sarcoma Working Group, Winship Cancer Institute###Winship Cancer Institute, Emory University###
Author: Kenneth Cardona, MD – Winship Cancer Institute, Emory University
### @@@ Kenji Sato, MD – Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan ### 1850789###Author###Assistant Professor###Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan###
Author: Kenji Sato, MD – Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan
### @@@ Shintaro Iwata, MD – Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan ### 1850790###Author###Assistant Professor###Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan###
Author: Shintaro Iwata, MD – Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan
### @@@ Jeffrey M. Farma, MD – Fox Chase Cancer Center ### 894402###Author###Interim Chair of Surgery, Professor of Surgical Oncology###Fox Chase Cancer Center###
Author: Jeffrey M. Farma, MD – Fox Chase Cancer Center
### @@@ Anthony M. VIllano, MD – Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, USA ### 1850801###Author###Clinical Instructor###Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, USA###
Author: Anthony M. VIllano, MD – Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, USA
###
78: Detection of Circulating Tumor DNA Predicts Recurrence in Soft Tissue Sarcomas

Beatrice J. Sun, MD – Stanford University School of Medicine ### 1850374###Abstract Presenter###Resident###Stanford University School of Medicine###
Abstract Presenter: Beatrice J. Sun, MD – Stanford University School of Medicine
### @@@ Beatrice J. Sun, MD – Stanford University School of Medicine ### 1850374###First Author###Resident###Stanford University School of Medicine###
First Author: Beatrice J. Sun, MD – Stanford University School of Medicine
### @@@ Amy Y. Li, MD (she/her/hers) – Stanford University School of Medicine ### 1850603###Author###Resident###Stanford University School of Medicine###
Author: Amy Y. Li, MD (she/her/hers) – Stanford University School of Medicine
### she/her/hers @@@ Wilson Alobuia, MD – Stanford University School of Medicine ### 1850485###Author###Resident###Stanford University School of Medicine###
Author: Wilson Alobuia, MD – Stanford University School of Medicine
### @@@ Dong Hur, BS – Stanford University School of Medicine ### 1850486###Author###Medical Student###Stanford University School of Medicine###
Author: Dong Hur, BS – Stanford University School of Medicine
### @@@ Sara K. Daniel, MD (she/her/hers) – Stanford University School of Medicine ### 1850532###Author###CGSO Fellow###Stanford University School of Medicine###
Author: Sara K. Daniel, MD (she/her/hers) – Stanford University School of Medicine
### she/her/hers @@@ Amanda R. Kirane, MD, PhD-c, FACS, FSSO (she/her/hers) – Stanford University ### 1534976###Author###Assistant Professor###Stanford University###
Author: Amanda R. Kirane, MD, PhD-c, FACS, FSSO (she/her/hers) – Stanford University
### she/her/hers @@@ George Poultsides, MD (he/him/his) – Stanford University ### 1214754###Author###Chief, Section of Surgical Oncology; Professor of Surgery###Stanford University###
Author: George Poultsides, MD (he/him/his) – Stanford University
### he/him/his @@@ Byrne Lee, MD (he/him/his) – Stanford University School of Medicine ### 1214742###Author###Clinical Professor of Surgery###Stanford University School of Medicine###
Author: Byrne Lee, MD (he/him/his) – Stanford University School of Medicine
### he/him/his
79: Dysregulation of Mitochondrial Dynamics via Dynamin-Related Protein 1 Implicated in Dedifferentiated Liposarcoma

Kyle D. Klingbeil, MD MS – UCLA Health ### 1850795###Abstract Presenter###General Surgery Resident###UCLA Health###
Abstract Presenter: Kyle D. Klingbeil, MD MS – UCLA Health
### @@@ Kyle D. Klingbeil, MD MS – UCLA Health ### 1850795###First Author###General Surgery Resident###UCLA Health###
First Author: Kyle D. Klingbeil, MD MS – UCLA Health
### @@@ Chris Frias, MS – UCLA Health ### 1850796###Author###Research Associate###UCLA Health###
Author: Chris Frias, MS – UCLA Health
### @@@ Sarah M. Dry, MD – UCLA Health ### 1850799###Author###Department Chair, Pathology and Laboratory Medicine###UCLA Health###
Author: Sarah M. Dry, MD – UCLA Health
### @@@ Joseph G. Crompton, MD PhD – UCLA Health ### 1850798###Author###Assistant Professor, Division of Surgical Oncology###UCLA Health###
Author: Joseph G. Crompton, MD PhD – UCLA Health
### @@@ Fritz C. Eilber, MD – UCLA Health ### 1850797###Author###Professor of Surgery, Division of Surgical Oncology###UCLA Health###
Author: Fritz C. Eilber, MD – UCLA Health
### @@@ David B. Shackelford, PhD – UCLA Health ### 1850800###Author###Associate Professor, Division of Pulmonary and Critical Care Medicine###UCLA Health###
Author: David B. Shackelford, PhD – UCLA Health
### @@@ Brian Kadera, MD (he/him/his) – University of California, Los Angeles ### 1795516###Author###Assistant Professor of Surgery###University of California, Los Angeles###
Author: Brian Kadera, MD (he/him/his) – University of California, Los Angeles
### he/him/his
8: De-escalation of Post-Mastectomy Irradiation in Hormone Receptor-Positive Breast Cancer with One to Three Positive Nodes

Gili G. Halfteck, MD, PhD (she/her/hers) – University of Texas Medical Branch ### 1850541###Abstract Presenter###Breast Surgical Oncology Fellow###University of Texas Medical Branch###
Abstract Presenter: Gili G. Halfteck, MD, PhD (she/her/hers) – University of Texas Medical Branch
### she/her/hers @@@ Gili G. Halfteck, MD, PhD (she/her/hers) – University of Texas Medical Branch ### 1850541###Author###Breast Surgical Oncology Fellow###University of Texas Medical Branch###
Author: Gili G. Halfteck, MD, PhD (she/her/hers) – University of Texas Medical Branch
### she/her/hers @@@ Efstathia Polychronopoulou, MsC – University of Texas Medical Branch ### 1850859###Author###statistician###University of Texas Medical Branch###
Author: Efstathia Polychronopoulou, MsC – University of Texas Medical Branch
### @@@ Waqar Haque, MD – University of Texas medical Branch ### 1850860###Author###Radiation Oncologist###University of Texas medical Branch###
Author: Waqar Haque, MD – University of Texas medical Branch
### @@@ Roi Weiser, MD – University of Texas Medical Branch ### 969970###Author###Fellow###University of Texas Medical Branch###
Author: Roi Weiser, MD – University of Texas Medical Branch
### @@@ Sandra S. Hatch, MD – University of Texas Medical Branch ### 1850861###Author###Chief of Radiation Oncology###University of Texas Medical Branch###
Author: Sandra S. Hatch, MD – University of Texas Medical Branch
### @@@ Suzanne Klimberg, MD PhD MSHCT MAMSE – UTMB, MDACC ### 1795507###Author###Professor ###UTMB, MDACC###
Author: Suzanne Klimberg, MD PhD MSHCT MAMSE – UTMB, MDACC
###
80: Disparities in Socioeconomic Mediation of Racial Segregation in Hepatopancreaticobiliary Cancer

Muhammad Musaab Munir, MBBS – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center ### 1850857###Author###Research Fellow###Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center###
Author: Muhammad Musaab Munir, MBBS – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
### @@@ Selamawit Woldesenbet, MSc, PhD – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center ### 1850858###Author###Biostatistician###Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center###
Author: Selamawit Woldesenbet, MSc, PhD – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
### @@@ Yutaka Endo, MD, PhD – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center ### 1850707###Author###Research Scholar###Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center###
Author: Yutaka Endo, MD, PhD – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
### @@@ Henrique Araujo Lima, MD – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center ### 1850705###Author###Research Scholar###Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center###
Author: Henrique Araujo Lima, MD – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
### @@@ Lovette Azap, n/a – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center ### 1850862###Author###Medical Student###Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center###
Author: Lovette Azap, n/a – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
### @@@ Zorays Moazzam, MD – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center ### 1849935###Author###Research Scholar###Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center###
Author: Zorays Moazzam, MD – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
### @@@ Jordan M. Cloyd, MD – The Ohio State University ### 915758###Author###Assistant Professor###The Ohio State University###
Author: Jordan M. Cloyd, MD – The Ohio State University
### @@@ Joal D. Beane, MD – The Ohio State University Wexner Medical Center- Division of Surgical Oncology ### 1849833###Author###Assistant Professor###The Ohio State University Wexner Medical Center- Division of Surgical Oncology###
Author: Joal D. Beane, MD – The Ohio State University Wexner Medical Center- Division of Surgical Oncology
### @@@ Alex C. Kim, MD, PhD – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute ### 1529408###Author###Assistant Professor of Surgery###The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute###
Author: Alex C. Kim, MD, PhD – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute
### @@@ Aslam Ejaz, MD, MPH – The Ohio State University ### 1502392###Author###Assistant Professor of Surgery###The Ohio State University###
Author: Aslam Ejaz, MD, MPH – The Ohio State University
### @@@ Timothy M. Pawlik, MD, PhD – The Ohio State University Wexner Medical Center ### 937481### Author###Chair of Surgery###The Ohio State University Wexner Medical Center###
Author: Timothy M. Pawlik, MD, PhD – The Ohio State University Wexner Medical Center
### @@@ Muhammad Musaab Munir, MBBS – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center ### 1850857###Abstract Presenter###Research Fellow###Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center###
Abstract Presenter: Muhammad Musaab Munir, MBBS – Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
###
81: Racial and socioeconomic disparities in colorectal cancer screening during the COVID-19 pandemic

Laura Fluke, DO, FACS – Providence Saint John's Cancer Institute ### 1850592###Abstract Presenter###Surgical Oncology Fellow###Providence Saint John's Cancer Institute###
Abstract Presenter: Laura Fluke, DO, FACS – Providence Saint John's Cancer Institute
### @@@ Laura Fluke, DO, FACS – Providence Saint John's Cancer Institute ### 1850592###First Author###Surgical Oncology Fellow###Providence Saint John's Cancer Institute###
First Author: Laura Fluke, DO, FACS – Providence Saint John's Cancer Institute
### @@@ Jessica Weiss, MD – Providence Saint John's Cancer Institute ### 1850915###Author###Surgical Oncology Fellow###Providence Saint John's Cancer Institute###
Author: Jessica Weiss, MD – Providence Saint John's Cancer Institute
### @@@ Shu-Ching Chang, PhD (she/her/hers) – Providence Health and Services ### 1850084###Author###Senior Biostatistician###Providence Health and Services###
Author: Shu-Ching Chang, PhD (she/her/hers) – Providence Health and Services
### she/her/hers @@@ Staci Wendt, PhD – Providence Saint John's Cancer Institute ### 1850942###Author###Senior Clinical Research Scientist###Providence Saint John's Cancer Institute###
Author: Staci Wendt, PhD – Providence Saint John's Cancer Institute
### @@@ Roshanthi Weerasinghe, MPH – Providence Saint John's Cancer Institute ### 1850944###Author###Director Clinical Research###Providence Saint John's Cancer Institute###
Author: Roshanthi Weerasinghe, MPH – Providence Saint John's Cancer Institute
### @@@ Ann Vita, n/a – Providence Saint John's Cancer Institute ### 1850945###Author###Clinical Data Engineer###Providence Saint John's Cancer Institute###
Author: Ann Vita, n/a – Providence Saint John's Cancer Institute
### @@@ Anton Bilchik, MD PhD MBA FACS – Providence Saint John's Cancer Institute ### 1850816###Author###Professor of Surgery###Providence Saint John's Cancer Institute###
Author: Anton Bilchik, MD PhD MBA FACS – Providence Saint John's Cancer Institute
###
82: Socioeconomic Disparities in the Treatment and Survival of Extremity Soft Tissue Sarcoma

Hayley M. Dunlop, MPH (she/her/hers) – The Ohio State University College of Medicine ### 1850666###Abstract Presenter###Medical Student###The Ohio State University College of Medicine###
Abstract Presenter: Hayley M. Dunlop, MPH (she/her/hers) – The Ohio State University College of Medicine
### she/her/hers @@@ Hayley M. Dunlop, MPH (she/her/hers) – The Ohio State University College of Medicine ### 1850666###First Author###Medical Student###The Ohio State University College of Medicine###
First Author: Hayley M. Dunlop, MPH (she/her/hers) – The Ohio State University College of Medicine
### she/her/hers @@@ Bence Bende, n/a – The Ohio State University ### 1850667###Author###Undergraduate Research Assistant###The Ohio State University###
Author: Bence Bende, n/a – The Ohio State University
### @@@ Alex C. Kim, MD, PhD – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute ### 1529408###Author###Assistant Professor of Surgery###The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute###
Author: Alex C. Kim, MD, PhD – The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute
### @@@ James Fisher, PhD – The Ohio State University College of Public Health ### 1850668###Author###Adjunct Associate Professor of Epidemiology###The Ohio State University College of Public Health###
Author: James Fisher, PhD – The Ohio State University College of Public Health
### @@@ Valerie Grignol, MD – The Ohio State University ### 937494###Author###Associate Professor of Surgery###The Ohio State University###
Author: Valerie Grignol, MD – The Ohio State University
### @@@ Carlo M. Contreras, MD – The Ohio State University ### 970287###Author###Associate Professor, Section Head of Melanoma/Sarcoma###The Ohio State University###
Author: Carlo M. Contreras, MD – The Ohio State University
### @@@ Nicci Owusu-Brackett, MD – The Ohio State University ### 1530244###Author###Complex General Surgical Oncology Fellow###The Ohio State University###
Author: Nicci Owusu-Brackett, MD – The Ohio State University
### @@@ Timothy M. Pawlik, MD, PhD – The Ohio State University Wexner Medical Center ### 937481###Author###Chair of Surgery###The Ohio State University Wexner Medical Center###
Author: Timothy M. Pawlik, MD, PhD – The Ohio State University Wexner Medical Center
### @@@ Joel Mayerson, MD – The James Cancer Hospital and Solove Research Institute ### 1850868###Author###Chief of Musculoskeletal Oncology###The James Cancer Hospital and Solove Research Institute###
Author: Joel Mayerson, MD – The James Cancer Hospital and Solove Research Institute
### @@@ Raphael Pollock, MD PhD – The Ohio State University Wexner Medical Center- Division of Surgical Oncology ### 1849832###Author###Professor of Surgery, Director James Comprehensive Cancer Center###The Ohio State University Wexner Medical Center- Division of Surgical Oncology###
Author: Raphael Pollock, MD PhD – The Ohio State University Wexner Medical Center- Division of Surgical Oncology
### @@@ Joal D. Beane, MD – The Ohio State University Wexner Medical Center- Division of Surgical Oncology ### 1849833###Author###Assistant Professor###The Ohio State University Wexner Medical Center- Division of Surgical Oncology###
Author: Joal D. Beane, MD – The Ohio State University Wexner Medical Center- Division of Surgical Oncology
###
83: Adherence to and outcomes of extended venous thromboembolism prophylaxis after complex gastrointestinal cancer surgery

Michail Mavros, MD (he/him/his) – University of Arkansas for Medical Sciences ### 1850785###Abstract Presenter###Assistant Professor of Surgery###University of Arkansas for Medical Sciences###
Abstract Presenter: Michail Mavros, MD (he/him/his) – University of Arkansas for Medical Sciences
### he/him/his @@@ Michail Mavros, MD (he/him/his) – University of Arkansas for Medical Sciences ### 1850785###Author###Assistant Professor of Surgery###University of Arkansas for Medical Sciences###
Author: Michail Mavros, MD (he/him/his) – University of Arkansas for Medical Sciences
### he/him/his @@@ Lauren Johnson, MD – University of Arkansas for Medical Sciences ### 1850794###Author###General Surgery resident###University of Arkansas for Medical Sciences###
Author: Lauren Johnson, MD – University of Arkansas for Medical Sciences
### @@@ Sonia Orcutt, MD – University of Arkansas for Medical Sciences ### 1850788###Author###Assistant Professor of Surgery###University of Arkansas for Medical Sciences###
Author: Sonia Orcutt, MD – University of Arkansas for Medical Sciences
### @@@ Cheng Peng, MPA, MS, PhD – University of Arkansas for Medical Sciences ### 1850792###Author###Assistant Research Professor, Division of Pharmaceutical Evaluation and Policy###University of Arkansas for Medical Sciences###
Author: Cheng Peng, MPA, MS, PhD – University of Arkansas for Medical Sciences
### @@@ Bradley Martin, PharmD, PhD – University of Arkansas for Medical Sciences ### 1850793###Author###Professor###University of Arkansas for Medical Sciences###
Author: Bradley Martin, PharmD, PhD – University of Arkansas for Medical Sciences
###
84: The association between familiarity of the surgeon-anesthesiologist dyad and post-operative patient outcomes for complex gastrointestinal cancer surgery: a population-based study.

Julie Hallet, MD MSc FRCSC FSSO (she/her/hers) – University of Toronto; Odette Cancer Centre - Sunnybrook Health Sciences Centre ### 969516###Abstract Presenter###Associate Professor of Surgery###University of Toronto; Odette Cancer Centre - Sunnybrook Health Sciences Centre###
Abstract Presenter: Julie Hallet, MD MSc FRCSC FSSO (she/her/hers) – University of Toronto; Odette Cancer Centre - Sunnybrook Health Sciences Centre
### she/her/hers @@@ Julie Hallet, MD MSc FRCSC FSSO (she/her/hers) – University of Toronto; Odette Cancer Centre - Sunnybrook Health Sciences Centre ### 969516###First Author###Associate Professor of Surgery###University of Toronto; Odette Cancer Centre - Sunnybrook Health Sciences Centre###
First Author: Julie Hallet, MD MSc FRCSC FSSO (she/her/hers) – University of Toronto; Odette Cancer Centre - Sunnybrook Health Sciences Centre
### she/her/hers @@@ Rinku Sutradhar, PhD – University of Toronto ### 1850330###Author###Professor###University of Toronto###
Author: Rinku Sutradhar, PhD – University of Toronto
### @@@ Angela Jerath, MD PhD – University of Toronto ### 1850331###Author###Associate Professor###University of Toronto###
Author: Angela Jerath, MD PhD – University of Toronto
### @@@ Pablo Perez d'Empaire, MD – University of Toronto ### 1850332###Author###Assistant Professor###University of Toronto###
Author: Pablo Perez d'Empaire, MD – University of Toronto
### @@@ Francois Carrier, MD MSc – CHUM ### 1850333###Author###Anesthesiologist###CHUM###
Author: Francois Carrier, MD MSc – CHUM
### @@@ Alexis Turgeon, MD MSc – CHU de québec ### 1850334###Author###Anesthesiologist###CHU de québec###
Author: Alexis Turgeon, MD MSc – CHU de québec
### @@@ Daniel McIssac ### 1803892###Author#########
Author: Daniel McIssac
### @@@ chris Idestrup, MD MSc – University of Toronto ### 1850336###Author###Anesthesiologist###University of Toronto###
Author: chris Idestrup, MD MSc – University of Toronto
### @@@ Gianni Lorello, MD MSc – University of Toronto ### 1850337###Author###Anesthesiologist###University of Toronto###
Author: Gianni Lorello, MD MSc – University of Toronto
### @@@ Alana Flexman, MD – UBC ### 1850338###Author###Anesthesiologist###UBC###
Author: Alana Flexman, MD – UBC
### @@@ biniam Kidane, MD MSc – University of Manitoba ### 1850339###Author###Surgeon###University of Manitoba###
Author: biniam Kidane, MD MSc – University of Manitoba
### @@@ Wing Chan, MPH – IC/ES ### 1850340###Author###Analyst###IC/ES###
Author: Wing Chan, MPH – IC/ES
### @@@ Yosuf Kaliwal, MPH – ICES ### 1850341###Author###analyst###ICES###
Author: Yosuf Kaliwal, MPH – ICES
### @@@ Victoria Barabash, MSc – Sunnybrook research institute ### 1850342###Author###Research coordinator###Sunnybrook research institute###
Author: Victoria Barabash, MSc – Sunnybrook research institute
### @@@ Gursharan Sohi, MD(c) – Sunnybrook Research Institute ### 970176###Author###Medical Student###Sunnybrook Research Institute###
Author: Gursharan Sohi, MD(c) – Sunnybrook Research Institute
### @@@ Antoine Eskander, MD ScM – University of Toronto ### 1850343###Author###Assistant Professor###University of Toronto###
Author: Antoine Eskander, MD ScM – University of Toronto
###
85: Impact of Incident Hospital-Acquired Geriatric Syndromes on Short-term Outcomes following Gastrointestinal Cancer Resection

Alexa D. Melucci, MD, MS (she/her/hers) – University of Rochester Medical Center ### 1186193###Abstract Presenter###Resident###University of Rochester Medical Center###
Abstract Presenter: Alexa D. Melucci, MD, MS (she/her/hers) – University of Rochester Medical Center
### she/her/hers @@@ Alexa D. Melucci, MD, MS (she/her/hers) – University of Rochester Medical Center ### 1186193###First Author###Resident###University of Rochester Medical Center###
First Author: Alexa D. Melucci, MD, MS (she/her/hers) – University of Rochester Medical Center
### she/her/hers @@@ Christopher T. Aquina, MD, MPH – AdventHealth Orlando ### 1530277###Author###Assistant Professor###AdventHealth Orlando###
Author: Christopher T. Aquina, MD, MPH – AdventHealth Orlando
### @@@ Anthony Loria, MD – University of Rochester Medical Center ### 1850560###Author###Resident###University of Rochester Medical Center###
Author: Anthony Loria, MD – University of Rochester Medical Center
### @@@ Gabriela McDonald, BS – University of Rochester Medical Center ### 1850884###Author###Medical Student###University of Rochester Medical Center###
Author: Gabriela McDonald, BS – University of Rochester Medical Center
### @@@ Aqsa Ghaffar, BA – University of Rochester Medical Center ### 1850561###Author###Medical Student###University of Rochester Medical Center###
Author: Aqsa Ghaffar, BA – University of Rochester Medical Center
### @@@ Erika Ramsdale, MD – University of Rochester Medical Center ### 1849870###Author###Associate Professor Department of Medicine###University of Rochester Medical Center###
Author: Erika Ramsdale, MD – University of Rochester Medical Center
### @@@ Larissa Temple, MSc MD (she/her/hers) – University of Rochester, New York New York ### 1807432###Author###Chief Colorectal Surgery, Professor Surgery and Oncology###University of Rochester, New York New York###
Author: Larissa Temple, MSc MD (she/her/hers) – University of Rochester, New York New York
### she/her/hers @@@ Fergal J. Fleming, MD, MPH, FRCSI, FACS – University of Rochester Medical Center ### 1850562###Author###Associate Professor Department of Surgery###University of Rochester Medical Center###
Author: Fergal J. Fleming, MD, MPH, FRCSI, FACS – University of Rochester Medical Center
###
86: Identifying Characteristics of High-Performing Hospital Networks for Major Cancer Surgery

Sara L. Schaefer, MD – University of Michigan ### 1850855###Abstract Presenter###Surgical Resident###University of Michigan###
Abstract Presenter: Sara L. Schaefer, MD – University of Michigan
### @@@ Sara L. Schaefer, MD – University of Michigan ### 1850855###First Author###Surgical Resident###University of Michigan###
First Author: Sara L. Schaefer, MD – University of Michigan
### @@@ Adrian Diaz, MD (he/him/his) – The Ohio State University ### 1850016###Author###Clinical Housestaff###The Ohio State University###
Author: Adrian Diaz, MD (he/him/his) – The Ohio State University
### he/him/his @@@ Usha Nuliyalu, MPH – University of Michigan ### 1850018###Author###Senior Statistician###University of Michigan###
Author: Usha Nuliyalu, MPH – University of Michigan
### @@@ Andrew Ibrahim, MD MPH – University of Michigan ### 1850020###Author###Professor###University of Michigan###
Author: Andrew Ibrahim, MD MPH – University of Michigan
### @@@ Hari Nathan, MD, PhD, FACS, FSSO (he/him/his) – University of Michigan ### 937428###Author###Associate Professor of Surgery and Chief, Division of Hepato-Pancreato-Biliary Surgery###University of Michigan###
Author: Hari Nathan, MD, PhD, FACS, FSSO (he/him/his) – University of Michigan
### he/him/his
87: Identifying Optimal Surgical Timing Relative to SARS-CoV-2 Infection Using COVID-19 Severity in Cancer Patients

Nathaniel B. Verhagen, BS – Medical College of Wisconsin ### 1850869###Abstract Presenter###Medical Student###Medical College of Wisconsin###
Abstract Presenter: Nathaniel B. Verhagen, BS – Medical College of Wisconsin
### @@@ Nathaniel B. Verhagen, BS – Medical College of Wisconsin ### 1850869###First Author###Medical Student###Medical College of Wisconsin###
First Author: Nathaniel B. Verhagen, BS – Medical College of Wisconsin
### @@@ Nicolas K. Koerber, BS – Medical College of Wisconsin ### 1850870###Author###Medical Student###Medical College of Wisconsin###
Author: Nicolas K. Koerber, BS – Medical College of Wisconsin
### @@@ Salma A. Sheriff, BS – Medical College of Wisconsin ### 1850567###Author###Clinical Research Coordinator###Medical College of Wisconsin###
Author: Salma A. Sheriff, BS – Medical College of Wisconsin
### @@@ Aniko Szabo, PhD – Medical College of Wisconsin, Department of Biostatistics ### 1850871###Author###Professor###Medical College of Wisconsin, Department of Biostatistics###
Author: Aniko Szabo, PhD – Medical College of Wisconsin, Department of Biostatistics
### @@@ Callisia Clarke, MD, MS (she/her/hers) – Medical College of Wisconsin ### 1795379###Author###Associate Professor of Surgery###Medical College of Wisconsin ###
Author: Callisia Clarke, MD, MS (she/her/hers) – Medical College of Wisconsin
### she/her/hers @@@ Ugwuji N. Maduekwe, MD, MPH – Medical College of Wisconsin, Department of Surgery, Division of Surgical Oncology ### 1850872###Author###Associate Professor###Medical College of Wisconsin, Department of Surgery, Division of Surgical Oncology###
Author: Ugwuji N. Maduekwe, MD, MPH – Medical College of Wisconsin, Department of Surgery, Division of Surgical Oncology
### @@@ Njeri Wainaina, MD – Medical College of Wisconsin, Department of Internal Medicine ### 1850873###Author###Associate Professor, Vice Chair###Medical College of Wisconsin, Department of Internal Medicine###
Author: Njeri Wainaina, MD – Medical College of Wisconsin, Department of Internal Medicine
### @@@ Kathryn K. Lauer, MD – Medical College of Wisconsin, Department of Anesthesiology ### 1850874###Author###Professor, Vice Chair###Medical College of Wisconsin, Department of Anesthesiology###
Author: Kathryn K. Lauer, MD – Medical College of Wisconsin, Department of Anesthesiology
### @@@ Kathleen K. Christians, MD – Medical College of Wisconsin, Department of Surgery, Division of Surgical Oncology ### 1850875###Author###Professor###Medical College of Wisconsin, Department of Surgery, Division of Surgical Oncology###
Author: Kathleen K. Christians, MD – Medical College of Wisconsin, Department of Surgery, Division of Surgical Oncology
### @@@ Jon Gould, MD, MBA – Medical College of Wisconsin, Department of General Surgery ### 1850876###Author###Professor###Medical College of Wisconsin, Department of General Surgery###
Author: Jon Gould, MD, MBA – Medical College of Wisconsin, Department of General Surgery
### @@@ Anai N. Kothari, MD, MS – Medical College of Wisconsin, Department of Surgery, Division of Surgical Oncology ### 1850481###Author###Assistant Professor###Medical College of Wisconsin, Department of Surgery, Division of Surgical Oncology###
Author: Anai N. Kothari, MD, MS – Medical College of Wisconsin, Department of Surgery, Division of Surgical Oncology
###
88: Optimal Radiation Dose Intensity: Low- vs. High-Dose in the Neo-Adjuvant Treatment of Locally Advanced Esophageal Cancer

Nicholas S. Caminiti, MD – University of Louisville ### 1850522###Abstract Presenter###Surgical Resident###University of Louisville###
Abstract Presenter: Nicholas S. Caminiti, MD – University of Louisville
### @@@ Nicholas S. Caminiti, MD – University of Louisville ### 1850522###First Author###Surgical Resident###University of Louisville###
First Author: Nicholas S. Caminiti, MD – University of Louisville
### @@@ Prejesh Philips, MD – University of Louisville ### 1529650###Author###Associate Professor###University of Louisville###
Author: Prejesh Philips, MD – University of Louisville
### @@@ Michael E. Egger, MD, MPH – Unversity of Louisville ### 969528###Author###Associate Professor###Unversity of Louisville###
Author: Michael E. Egger, MD, MPH – Unversity of Louisville
### @@@ Charles Scoggins, MD, MDA – University of Louisville ### 1850525###Author###Surgical Oncologist###University of Louisville###
Author: Charles Scoggins, MD, MDA – University of Louisville
### @@@ Robert CG Martin, II, MD,PhD – University of Louisville School of Medicine, Department of Surgery ### 969995###Author###Professor of Surgery###University of Louisville School of Medicine, Department of Surgery###
Author: Robert CG Martin, II, MD,PhD – University of Louisville School of Medicine, Department of Surgery
###
89: Variation in Postoperative Outcomes Across CMS Hospital Star Ratings for complex Cancer Surgery

Adrian Diaz, MD (he/him/his) – The Ohio State University ### 1850016###Abstract Presenter###Clinical Housestaff###The Ohio State University###
Abstract Presenter: Adrian Diaz, MD (he/him/his) – The Ohio State University
### he/him/his @@@ Adrian Diaz, MD (he/him/his) – The Ohio State University ### 1850016###First Author###Clinical Housestaff###The Ohio State University###
First Author: Adrian Diaz, MD (he/him/his) – The Ohio State University
### he/him/his @@@ Usha Nuliyalu, MPH – University of Michigan ### 1850018###Author###Senior Statistician###University of Michigan###
Author: Usha Nuliyalu, MPH – University of Michigan
### @@@ Nick Kunneth, MPH – University of Michigan ### 1850815###Author###Statistician###University of Michigan###
Author: Nick Kunneth, MPH – University of Michigan
### @@@ Justin Dimick, MD MPH – University of Michigan ### 1850019###Author###Professor###University of Michigan###
Author: Justin Dimick, MD MPH – University of Michigan
### @@@ Andrew Ibrahim, MD MPH – University of Michigan ### 1850020###Author###Professor###University of Michigan###
Author: Andrew Ibrahim, MD MPH – University of Michigan
### @@@ Hari Nathan, MD, PhD, FACS, FSSO (he/him/his) – University of Michigan ### 937428###Author###Associate Professor of Surgery and Chief, Division of Hepato-Pancreato-Biliary Surgery###University of Michigan###
Author: Hari Nathan, MD, PhD, FACS, FSSO (he/him/his) – University of Michigan
### he/him/his
9: Breast cancer-related lymphedema and its relationship to major landmark trials in surgical oncology and radiation oncology

Robert M. Pride, MD – Dana Farber Cancer Institute/Brigham & Women's Hospital/Massachusetts General Hospital ### 1850685###Abstract Presenter###Breast Surgical Oncology Fellow###Dana Farber Cancer Institute/Brigham & Women's Hospital/Massachusetts General Hospital###
Abstract Presenter: Robert M. Pride, MD – Dana Farber Cancer Institute/Brigham & Women's Hospital/Massachusetts General Hospital
### @@@ Robert M. Pride, MD – Dana Farber Cancer Institute/Brigham & Women's Hospital/Massachusetts General Hospital ### 1850685###Author###Breast Surgical Oncology Fellow###Dana Farber Cancer Institute/Brigham & Women's Hospital/Massachusetts General Hospital###
Author: Robert M. Pride, MD – Dana Farber Cancer Institute/Brigham & Women's Hospital/Massachusetts General Hospital
### @@@ Michelle C. Specht, MD – Massachusetts General Hospital ### 1850686###Author###Breast Surgical Oncologist###Massachusetts General Hospital###
Author: Michelle C. Specht, MD – Massachusetts General Hospital
### @@@ George Naoum, MD MMSCI – Northwestern University Memorial Hospital ### 1850687###Author###Radiation Oncology Resident###Northwestern University Memorial Hospital###
Author: George Naoum, MD MMSCI – Northwestern University Memorial Hospital
### @@@ Brooke C. Juhel, n/a – Massachusetts General Hospital ### 1850688###Author###Clinical Research Coordinator###Massachusetts General Hospital###
Author: Brooke C. Juhel, n/a – Massachusetts General Hospital
### @@@ Cheryl L. Brunelle, PT MS CCS CLT – Massachusetts General Hospital ### 1850689###Author###Physical Therapy Clinical Specialist###Massachusetts General Hospital###
Author: Cheryl L. Brunelle, PT MS CCS CLT – Massachusetts General Hospital
### @@@ Amy M. Shui, n/a – Massachusetts General Hospital ### 1850690###Author###Statistician###Massachusetts General Hospital###
Author: Amy M. Shui, n/a – Massachusetts General Hospital
### @@@ Charity C. Glass, MD MPP – Dana-Farber Cancer Institute/ Brigham & Women's Hospital/ Massachusetts General Hospital ### 1850510###Author###Fellow###Dana-Farber Cancer Institute/ Brigham & Women's Hospital/ Massachusetts General Hospital###
Author: Charity C. Glass, MD MPP – Dana-Farber Cancer Institute/ Brigham & Women's Hospital/ Massachusetts General Hospital
### @@@ Alphonse G. Taghian, MD PHD – Massachusetts General Hospital ### 1850691###Author###Radiation Oncologist###Massachusetts General Hospital###
Author: Alphonse G. Taghian, MD PHD – Massachusetts General Hospital
###
90: Obesity and Gastric Cancer Aggressiveness – a New Link

Shelly Loewenstein, PhD – Tel-Aviv Sourasky Medical Center and Tel-Aviv University ### 1534907### Author###Senior researcher###Tel-Aviv Sourasky Medical Center and Tel-Aviv University###
Author: Shelly Loewenstein, PhD – Tel-Aviv Sourasky Medical Center and Tel-Aviv University
### @@@ Adi Rubin, Msc – Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel ### 1850469### Author###MSc Student, Surgical Oncology Research Laboratory###Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel###
Author: Adi Rubin, Msc – Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel
### @@@ Guy Lahat, MD (he/him/his) – Tel Aviv Sourasky Medical Center, Tel Aviv, Israel ### 1849774###Abstract Presenter###Head Surgery Division###Tel Aviv Sourasky Medical Center, Tel Aviv, Israel###
Abstract Presenter: Guy Lahat, MD (he/him/his) – Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
### he/him/his @@@ Adi Rubin, Msc – Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel ### 1850469###First Author###MSc Student, Surgical Oncology Research Laboratory###Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel###
First Author: Adi Rubin, Msc – Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel
### @@@ Adi Friedman – Tel-Aviv Sourasky Medical Center ### 1871355###Author######Tel-Aviv Sourasky Medical Center###
Author: Adi Friedman – Tel-Aviv Sourasky Medical Center
### @@@ Eran Nizri, MD, PhD – Tel-Aviv Sourasky Medical Center ### 969944###Author###Head of Unit###Tel-Aviv Sourasky Medical Center###
Author: Eran Nizri, MD, PhD – Tel-Aviv Sourasky Medical Center
### @@@ Nir Lubezky, MD – Tel-Aviv Sourasky Medical Center ### 1871358###Author######Tel-Aviv Sourasky Medical Center###
Author: Nir Lubezky, MD – Tel-Aviv Sourasky Medical Center
###
91: CD40 activation has direct tumor effects in gastrointestinal stromal tumor (GIST)

Hyunjee V. Kwak, MD – University of Pennsylvania ### 1850845###Abstract Presenter###Postdoctoral Research Fellow###University of Pennsylvania###
Abstract Presenter: Hyunjee V. Kwak, MD – University of Pennsylvania
### @@@ Hyunjee V. Kwak, MD – University of Pennsylvania ### 1850845###First Author###Postdoctoral Research Fellow###University of Pennsylvania###
First Author: Hyunjee V. Kwak, MD – University of Pennsylvania
### @@@ Katherine J. Tardy, MD – University of Pennsylvania ### 1850840###Author###Post-Doctoral Research Fellow###University of Pennsylvania###
Author: Katherine J. Tardy, MD – University of Pennsylvania
### @@@ Laura Wang, BS – University of Pennsylvania ### 1850846###Author###Laboratory Technician###University of Pennsylvania###
Author: Laura Wang, BS – University of Pennsylvania
### @@@ Kevin Do, BS – University of Pennsylvania ### 1850847###Author###Laboratory Technician###University of Pennsylvania###
Author: Kevin Do, BS – University of Pennsylvania
### @@@ Shan Zeng, PhD – University of Pennsylvania ### 1850848###Author###Senior Scientist###University of Pennsylvania###
Author: Shan Zeng, PhD – University of Pennsylvania
### @@@ Ferdinando Rossi, PhD – University of Pennsylvania ### 1850849###Author###Senior Scientist###University of Pennsylvania###
Author: Ferdinando Rossi, PhD – University of Pennsylvania
### @@@ Ronald P. DeMatteo, MD, FACS (he/him/his) – The Hospital of the University of Pennsylvania ### 1262633###Author###Chair, Department of Surgery###The Hospital of the University of Pennsylvania###
Author: Ronald P. DeMatteo, MD, FACS (he/him/his) – The Hospital of the University of Pennsylvania
### he/him/his
92: Long-term outcomes of proximal gastrectomy for upper third advanced gastric and Siewert type II esophagogastric junction cancers in comparison with total gastrectomy: a propensity-score matched analysis

Do Joong Park, MD, PhD – Seoul National University Hospital ### 969509###Abstract Presenter###Professor###Seoul National University Hospital###
Abstract Presenter: Do Joong Park, MD, PhD – Seoul National University Hospital
### @@@ Do Joong Park, MD, PhD – Seoul National University Hospital ### 969509###First Author###Professor###Seoul National University Hospital###
First Author: Do Joong Park, MD, PhD – Seoul National University Hospital
### @@@ Yoon Soo Chae, MD – Seoul National University Hospital ### 1850470###Author###Doctor###Seoul National University Hospital###
Author: Yoon Soo Chae, MD – Seoul National University Hospital
### @@@ Jeesun Kim, MD – Seoul National University Hospital ### 1850471###Author###Doctor###Seoul National University Hospital###
Author: Jeesun Kim, MD – Seoul National University Hospital
### @@@ Yo-Seok Cho, MD – Seoul National University Hospital ### 1850472###Author###Doctor###Seoul National University Hospital###
Author: Yo-Seok Cho, MD – Seoul National University Hospital
### @@@ Seong-Ho Kong, MD, PhD – Seoul National University Hospital ### 1850473###Author###Professor###Seoul National University Hospital###
Author: Seong-Ho Kong, MD, PhD – Seoul National University Hospital
### @@@ Hyuk-Joon Lee, MD, PhD – Seoul National University Hospital ### 1850474###Author###Professor###Seoul National University Hospital###
Author: Hyuk-Joon Lee, MD, PhD – Seoul National University Hospital
### @@@ Han-Kwang Yang, MD, PhD – Seoul National University Hospital ### 937485###Author######Seoul National University Hospital###
Author: Han-Kwang Yang, MD, PhD – Seoul National University Hospital
###
93: Effectiveness of Sentinel Lymph Node Mapping in Gastric Cancer

Miseker E. Abate, MD, MPH – Memorial Sloan Kettering Cancer Center ### 1534908###Abstract Presenter###Research Fellow###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Miseker E. Abate, MD, MPH – Memorial Sloan Kettering Cancer Center
### @@@ Miseker E. Abate, MD, MPH – Memorial Sloan Kettering Cancer Center ### 1534908###First Author###Research Fellow###Memorial Sloan Kettering Cancer Center###
First Author: Miseker E. Abate, MD, MPH – Memorial Sloan Kettering Cancer Center
### @@@ Harrison M. Drebin, BA – Memorial Sloan Kettering Cancer Center ### 1849749###Author###Research Coordinator###Memorial Sloan Kettering Cancer Center###
Author: Harrison M. Drebin, BA – Memorial Sloan Kettering Cancer Center
### @@@ Teng Fei, PhD – Memorial Sloan Kettering Cancer Center ### 1849750###Author###Biostatistician###Memorial Sloan Kettering Cancer Center###
Author: Teng Fei, PhD – Memorial Sloan Kettering Cancer Center
### @@@ Katherine Poruk, MD – The Mayo Clinic - Jacksonville ### 1850464###Author###Surgical Oncology###The Mayo Clinic - Jacksonville###
Author: Katherine Poruk, MD – The Mayo Clinic - Jacksonville
### @@@ Madalyn Neuwirth, MD – Memorial Sloan Kettering Cancer Center ### 1850465###Author###Surgical Attending###Memorial Sloan Kettering Cancer Center###
Author: Madalyn Neuwirth, MD – Memorial Sloan Kettering Cancer Center
### @@@ Benjamin Ferguson, MD, PhD – Memorial Sloan Kettering Cancer Center ### 1850466###Author###Surgical Attending###Memorial Sloan Kettering Cancer Center###
Author: Benjamin Ferguson, MD, PhD – Memorial Sloan Kettering Cancer Center
### @@@ Shoji Shimada, MD, PhD (he/him/his) – Memorial Sloan Kettering Cancer Center ### 1849751###Author###Research Fellow###Memorial Sloan Kettering Cancer Center###
Author: Shoji Shimada, MD, PhD (he/him/his) – Memorial Sloan Kettering Cancer Center
### he/him/his @@@ Laura Tang, MD, PhD – Memorial Sloan Kettering Cancer Center ### 1849752###Author###Pathologist###Memorial Sloan Kettering Cancer Center###
Author: Laura Tang, MD, PhD – Memorial Sloan Kettering Cancer Center
### @@@ Santosh Vardhana, MD, PhD – Memorial Sloan Kettering Cancer Center ### 1850467###Author###Assistant Attending###Memorial Sloan Kettering Cancer Center###
Author: Santosh Vardhana, MD, PhD – Memorial Sloan Kettering Cancer Center
### @@@ Vivian E. Strong, MD – Memorial Sloan Kettering Cancer Center ### 1140722###Author###Iris Cantor Endowed Chair and Attending Surgeon, MSKCC and Professor of Surgery and Associate Dean, Weill Medical College of Cornell University###Memorial Sloan Kettering Cancer Center###
Author: Vivian E. Strong, MD – Memorial Sloan Kettering Cancer Center
###
94: Single-cell profiling of tumor-infiltrating T-cell clones in longitudinal peripheral blood samples for clinical studies

Eihab N. Abdelfatah, MD – NYU Long Island School of Medicine ### 1850569###Abstract Presenter###Assistant Professor###NYU Long Island School of Medicine###
Abstract Presenter: Eihab N. Abdelfatah, MD – NYU Long Island School of Medicine
### @@@ Eihab N. Abdelfatah, MD – NYU Long Island School of Medicine ### 1850569###First Author###Assistant Professor###NYU Long Island School of Medicine###
First Author: Eihab N. Abdelfatah, MD – NYU Long Island School of Medicine
### @@@ Mark Long, PhD – Roswell Park Comprehensive Cancer Center - Department of Biostatistics and Bioinformatics ### 1850576###Author###Assistant Professor###Roswell Park Comprehensive Cancer Center - Department of Biostatistics and Bioinformatics###
Author: Mark Long, PhD – Roswell Park Comprehensive Cancer Center - Department of Biostatistics and Bioinformatics
### @@@ Ryutaro Kajihara, PhD – Kumamoto University - Department of Biomedical Labarotory Sciences ### 1850570###Author###Assistant Professor###Kumamoto University - Department of Biomedical Labarotory Sciences###
Author: Ryutaro Kajihara, PhD – Kumamoto University - Department of Biomedical Labarotory Sciences
### @@@ Takaaki Oba – Roswell Park Cancer Institute ### 1184688###Author###Postdoctoral fellow###Roswell Park Cancer Institute###
Author: Takaaki Oba – Roswell Park Cancer Institute
### @@@ Takayoshi Yamauchi, PhD – University of Southern California - Department of Surgery ### 1850571###Author###Assistant Professor###University of Southern California - Department of Surgery###
Author: Takayoshi Yamauchi, PhD – University of Southern California - Department of Surgery
### @@@ Hongbin Chen, MD, PhD – Roswell Park Comprehensive Cancer Center ### 1850572###Author###Associate Professor of Oncology###Roswell Park Comprehensive Cancer Center###
Author: Hongbin Chen, MD, PhD – Roswell Park Comprehensive Cancer Center
### @@@ Junko Matsuzaki, PhD – University of Chicago Medicine Comprehensive Cancer Center ### 1850573###Author###Professor###University of Chicago Medicine Comprehensive Cancer Center###
Author: Junko Matsuzaki, PhD – University of Chicago Medicine Comprehensive Cancer Center
### @@@ Brahm Segal, MD – Roswell Park Comprehensive Cancer Center ### 1850574###Author###Professor of Medicine###Roswell Park Comprehensive Cancer Center###
Author: Brahm Segal, MD – Roswell Park Comprehensive Cancer Center
### @@@ Grace Dy, MD – Roswell Park Comprehensive Cancer Center ### 1850575###Author###Professor of Oncology###Roswell Park Comprehensive Cancer Center###
Author: Grace Dy, MD – Roswell Park Comprehensive Cancer Center
### @@@ Fumito Ito, MD, FACS, FSSO – Los Angeles County + University of Southern California (LAC+USC) Medical Center, Los Angeles, CA, USA. Department of Surgery and Norris Comprehensive Cancer Center, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA. ### 1850405###Author###Professor of Surgery###Los Angeles County + University of Southern California (LAC+USC) Medical Center, Los Angeles, CA, USA. Department of Surgery and Norris Comprehensive Cancer Center, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA.###
Author: Fumito Ito, MD, FACS, FSSO – Los Angeles County + University of Southern California (LAC+USC) Medical Center, Los Angeles, CA, USA. Department of Surgery and Norris Comprehensive Cancer Center, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA.
### @@@ Kristopher Attwood, PhD – Roswell Park Comprehensive Cancer Center ### 1850496###Author###Biostatistician###Roswell Park Comprehensive Cancer Center###
Author: Kristopher Attwood, PhD – Roswell Park Comprehensive Cancer Center
###
95: Cancer Testis Antigen and Interleukin Expression Correlates with Survival in Small Bowel Neuroendocrine Tumors

Y. David Seo, MD – University of Texas MD Anderson Cancer Center ### 1850864###Abstract Presenter###CGSO Fellow###University of Texas MD Anderson Cancer Center###
Abstract Presenter: Y. David Seo, MD – University of Texas MD Anderson Cancer Center
### @@@ Y. David Seo, MD – University of Texas MD Anderson Cancer Center ### 1850864###First Author###CGSO Fellow###University of Texas MD Anderson Cancer Center###
First Author: Y. David Seo, MD – University of Texas MD Anderson Cancer Center
### @@@ Russell G. Witt, MD, M.A.S. – University of Texas MD Anderson Cancer Center ### 1534603###Author###Complex General Surgical Oncology Fellow###University of Texas MD Anderson Cancer Center###
Author: Russell G. Witt, MD, M.A.S. – University of Texas MD Anderson Cancer Center
### @@@ Samuel H. Cass, MD – University of Texas MD Anderson Cancer Center ### 1850863###Author###Research Fellow###University of Texas MD Anderson Cancer Center###
Author: Samuel H. Cass, MD – University of Texas MD Anderson Cancer Center
### @@@ Rossana Lazcano Segura, MD – MD Anderson Cancer Center ### 1850953###Author###Research Scientist###MD Anderson Cancer Center###
Author: Rossana Lazcano Segura, MD – MD Anderson Cancer Center
### @@@ Courtney Hudgens, n/a – MD Anderson Cancer Center ### 1850954###Author###Senior Research Assistant###MD Anderson Cancer Center###
Author: Courtney Hudgens, n/a – MD Anderson Cancer Center
### @@@ Khalida Wani, n/a – MD Anderson Cancer Center ### 1850955###Author###Research Scientist###MD Anderson Cancer Center###
Author: Khalida Wani, n/a – MD Anderson Cancer Center
### @@@ Sharia Hernandez, n/a – MD Anderson Cancer Center ### 1850956###Author###Research Scientist###MD Anderson Cancer Center###
Author: Sharia Hernandez, n/a – MD Anderson Cancer Center
### @@@ Daniel M. Halperin, MD – University of Texas MD Anderson Cancer Center ### 917901###Author###Assistant Professor, Gastrointestinal Medical Oncology###University of Texas MD Anderson Cancer Center###
Author: Daniel M. Halperin, MD – University of Texas MD Anderson Cancer Center
### @@@ Alexander Lazar, MD – MD Anderson Cancer Center ### 1850758###Author###Professor###MD Anderson Cancer Center###
Author: Alexander Lazar, MD – MD Anderson Cancer Center
### @@@ Jen Wargo, MD, MMSc – The University of Texas MD Anderson Cancer Center ### 1529507###Author###Professor, Department of Genomic Medicine, Division of Cancer Medicine, Professor, Department of Surgical Oncology, Division of Surgery###The University of Texas MD Anderson Cancer Center###
Author: Jen Wargo, MD, MMSc – The University of Texas MD Anderson Cancer Center
### @@@ Jeannelyn Estrella, MD – The University of Texas MD Anderson Cancer Center ### 1850633###Author###Associate Professor###The University of Texas MD Anderson Cancer Center###
Author: Jeannelyn Estrella, MD – The University of Texas MD Anderson Cancer Center
### @@@ Jess Maxwell, MD, MBA (she/her/hers) – MD Anderson Cancer Center ### 1849817###Author###Assistant Professor###MD Anderson Cancer Center###
Author: Jess Maxwell, MD, MBA (she/her/hers) – MD Anderson Cancer Center
### she/her/hers
96: Serum IL-6 level predicts survival and treatment response in gastric and gastroesophageal junction cancer

John D. Karalis, MD – University of Texas Southwestern Medical Center ### 1530295###Abstract Presenter###Resident###University of Texas Southwestern Medical Center###
Abstract Presenter: John D. Karalis, MD – University of Texas Southwestern Medical Center
### @@@ John D. Karalis, MD – University of Texas Southwestern Medical Center ### 1530295###First Author###Resident###University of Texas Southwestern Medical Center###
First Author: John D. Karalis, MD – University of Texas Southwestern Medical Center
### @@@ Michelle Ju, MD – UT Southwestern ### 970073###Author###General Surgery Resident###UT Southwestern###
Author: Michelle Ju, MD – UT Southwestern
### @@@ Lynn Y. Yoon, BS – University of Texas Southwestern Medical Center ### 1850512###Author###Medical Student###University of Texas Southwestern Medical Center###
Author: Lynn Y. Yoon, BS – University of Texas Southwestern Medical Center
### @@@ Esther C. Castro-Dubon, BS – University of Texas Southwestern Medical Center ### 1850513###Author###Research Associate###University of Texas Southwestern Medical Center###
Author: Esther C. Castro-Dubon, BS – University of Texas Southwestern Medical Center
### @@@ Suntrea Hammer, MD – University of Texas Southwestern Medical Center ### 1850514###Author###Associate Professor###University of Texas Southwestern Medical Center###
Author: Suntrea Hammer, MD – University of Texas Southwestern Medical Center
### @@@ Matthew Porembka, MD – UT Southwestern Medical Center ### 969515###Author###Associate Professor ###UT Southwestern Medical Center###
Author: Matthew Porembka, MD – UT Southwestern Medical Center
### @@@ Sam C. Wang, MD – UT Southwestern Medical Center ### 969956###Author###Associate Professor###UT Southwestern Medical Center###
Author: Sam C. Wang, MD – UT Southwestern Medical Center
###
97: Long-term Oncologic Outcomes Following Pathologic Complete Response (pCR) for Esophageal Cancer

Andrew J. Sinnamon, MD, MSCE – Moffitt Cancer Institute ### 1530310###Abstract Presenter###Instructor of GI Surgery###Moffitt Cancer Institute###
Abstract Presenter: Andrew J. Sinnamon, MD, MSCE – Moffitt Cancer Institute
### @@@ Andrew J. Sinnamon, MD, MSCE – Moffitt Cancer Institute ### 1530310###First Author###Instructor of GI Surgery###Moffitt Cancer Institute###
First Author: Andrew J. Sinnamon, MD, MSCE – Moffitt Cancer Institute
### @@@ Samir Saeed, BS – Brown University ### 1850897###Author###Student Research Assistant###Brown University###
Author: Samir Saeed, BS – Brown University
### @@@ Rutika Mehta, MD, MPH – Moffitt Cancer Center ### 1850851###Author###Assistant Member, GI Medical Oncology###Moffitt Cancer Center###
Author: Rutika Mehta, MD, MPH – Moffitt Cancer Center
### @@@ Samer Naffouje, MD – Cleveland Clinic Foundation ### 1850488###Author###Assistant Professor of Surgery###Cleveland Clinic Foundation###
Author: Samer Naffouje, MD – Cleveland Clinic Foundation
### @@@ David T. Pointer, MD – Ochsner Health ### 1850898###Author###Surgical Oncologist###Ochsner Health###
Author: David T. Pointer, MD – Ochsner Health
### @@@ Justin A. Drake, MD – Moffitt Cancer Center ### 1850899###Author###Fellow in Complex General Surgical Oncology###Moffitt Cancer Center###
Author: Justin A. Drake, MD – Moffitt Cancer Center
### @@@ Gregory Lauwers, MD – Moffitt Cancer Center ### 1850900###Author###Senior Member, GI Pathology###Moffitt Cancer Center###
Author: Gregory Lauwers, MD – Moffitt Cancer Center
### @@@ Russell F. Palm, MD – Moffitt Cancer Center ### 1850901###Author###Assistant Member, GI Radiation Oncology###Moffitt Cancer Center###
Author: Russell F. Palm, MD – Moffitt Cancer Center
### @@@ Jessica M. Frakes, MD – Moffitt Cancer Center ### 1850902###Author###Associate Member, GI Radiation Oncology###Moffitt Cancer Center###
Author: Jessica M. Frakes, MD – Moffitt Cancer Center
### @@@ Sarah E. Hoffe, MD – Moffitt Cancer Center ### 1850903###Author###Senior Member, GI Radiation Oncology###Moffitt Cancer Center###
Author: Sarah E. Hoffe, MD – Moffitt Cancer Center
### @@@ Jobelle J. Baldonado, MD – Moffitt Cancer Center ### 1850904###Author###Assistant Member, Thoracic Surgical Oncology###Moffitt Cancer Center###
Author: Jobelle J. Baldonado, MD – Moffitt Cancer Center
### @@@ Jacques P. Fontaine, MD – Moffitt Cancer Center ### 1850905###Author###Senior Member, Thoracic and GI Surgical Oncology###Moffitt Cancer Center###
Author: Jacques P. Fontaine, MD – Moffitt Cancer Center
### @@@ Jose M. Pimiento, MD (he/him/his) – H. Lee Moffitt Cancer Center and Research Institute ### 969529###Author###Associate Member###H. Lee Moffitt Cancer Center and Research Institute###
Author: Jose M. Pimiento, MD (he/him/his) – H. Lee Moffitt Cancer Center and Research Institute
### he/him/his
98: Disparities in Receipt of Complex GI Cancer Surgery at a Small Geographic Scale

Richard S. Hoehn, MD – University Hospitals, Cleveland Medical Center ### 1849874###Abstract Presenter###Assistant Professor of Surgery###University Hospitals, Cleveland Medical Center###
Abstract Presenter: Richard S. Hoehn, MD – University Hospitals, Cleveland Medical Center
### @@@ Weichuan Dong, Ph. D. – Case Western Reserve University School of Medicine, Cleveland, Ohio ### 1849913###First Author###Research Associate###Case Western Reserve University School of Medicine, Cleveland, Ohio###
First Author: Weichuan Dong, Ph. D. – Case Western Reserve University School of Medicine, Cleveland, Ohio
### @@@ Matthew Kucmanic, PhD – University of Iowa ### 1850660###Author###Research Associate###University of Iowa###
Author: Matthew Kucmanic, PhD – University of Iowa
### @@@ Jordan Winter, MD – University Hospitals ### 1850661###Author###Professor of Surgery###University Hospitals###
Author: Jordan Winter, MD – University Hospitals
### @@@ Peter Pronovost, MD PhD – University Hospitals ### 1850662###Author###Chief Quality & Clinical Transformation Officer###University Hospitals###
Author: Peter Pronovost, MD PhD – University Hospitals
### @@@ Johnie Rose, MD PhD – Dept of Population and Quantitative Health Sciences ### 1850663###Author###Assistant Professor###Dept of Population and Quantitative Health Sciences###
Author: Johnie Rose, MD PhD – Dept of Population and Quantitative Health Sciences
### @@@ Uriel Kim, n/a – CWRU School of Medicine ### 1850664###Author###Student###CWRU School of Medicine###
Author: Uriel Kim, n/a – CWRU School of Medicine
### @@@ Siran Koroukian, PhD – Dept of Population and Quantitative Health Sciences ### 1850665###Author###Professor###Dept of Population and Quantitative Health Sciences###
Author: Siran Koroukian, PhD – Dept of Population and Quantitative Health Sciences
###
99: Technique of IVC Resection and Replacement During Liver Resection

Moran Slavin, MD (she/her/hers) – Digestive Health Institute Tampa ### 1850803###Video Presenter###Advanced Foregut and HPB Fellow###Digestive Health Institute Tampa###
Video Presenter: Moran Slavin, MD (she/her/hers) – Digestive Health Institute Tampa
### she/her/hers @@@ Sharona Ross, MD FSSO – Digestive Health Institute Tampa ### 1850629###First Author###Director Foregut and Pancreatic Surgery###Digestive Health Institute Tampa###
First Author: Sharona Ross, MD FSSO – Digestive Health Institute Tampa
### @@@ Iswanto Sucandy MD FACS, MD, FACS – AdventHealth Tampa ### 918124### Author###Associate Professor of Surgery, University of Central Florida, College of Medicine Advanced Gastrointestinal Surgery | Hepatobiliary and Pancreatic Surgery ###AdventHealth Tampa###
Author: Iswanto Sucandy MD FACS, MD, FACS – AdventHealth Tampa
### @@@ Iswanto Sucandy MD FACS, MD, FACS – AdventHealth Tampa ### 918124###Author###Associate Professor of Surgery, University of Central Florida, College of Medicine Advanced Gastrointestinal Surgery | Hepatobiliary and Pancreatic Surgery ###AdventHealth Tampa###
Author: Iswanto Sucandy MD FACS, MD, FACS – AdventHealth Tampa
### @@@ Kaitlyn Crespo, BS – AdventHealth Tampa ### 1850630###Author###Research Coordinator###AdventHealth Tampa###
Author: Kaitlyn Crespo, BS – AdventHealth Tampa
### @@@ Alexander Rosemurgy, MD FACS FSSO – Digestive Health Institute Tampa ### 1850631###Author###Attending HPB Surgeon###Digestive Health Institute Tampa###
Author: Alexander Rosemurgy, MD FACS FSSO – Digestive Health Institute Tampa
###